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The dissertation describes biosynthetic studies of lincomycin A, a thiosugar-
containing natural product. Lincomycin A was isolated from Streptomyces lincol-
nensis and has been used clinically as an effective antibiotic for more than 30 years.
The structure of lincomycin A contains an N-methyl-4-propyl-L-proline moiety
and a thiooctose. Although the clinical importance of lincomycin A has led to
extensive efforts to optimize the fermentation conditions for its production, how it
is biosynthesized, especially the construction of the thiooctose, remains poorly un-
derstood. The goal of my thesis research aims to identify the biosynthetic precur-
sors of lincomycin and investigate the mechanism of the transformations involved
in the biosynthetic pathway.
Based on the results of early feeding experiments and bio-informatic anal-
ysis of the biosynthetic gene cluster, a biosynthetic pathway of lincomycin could
be proposed. The enzymes predicted to be involved in the biosynthetic pathway
were purified in order to examine their functions. Organic synthesis was utilized
to construct the proposed sugar substrates and the anticipated products to support
the activity and the structural confirmation of the enzymatic products. With this
approach, ribose and fructose were found to be the precursors that are assembled
vii
in a transaldol condensation reaction catalyzed by LmbR to yield the eight-carbon
sugar backbone of lincomycin. The stereochemistry of the enzymatic products was
confirmed by the comparison with various synthetic stereoisomers.
The later parts of this research focus on the subsequent modifications of
the octose precursor. Our studies led to the identification of a key intermedi-
ate, guanosine diphosphate-activated octose, which was formed through a kinase-
phosphatase cascade reaction, catalyzed by LmbP (kinase), LmbK (phosphatase)
and LmbO (guanylyltransferase). Further transformations of this GDP-sugar in-
termediate including epimerization, dehydration and transamination were also
demonstrated via the catalysis of enzymes LmbM, LmbL/Z and LmbS, respec-
tively.
How the C-1 sulfur is incorporated into the highly decorated GDP-octose is
the most intriguing question in the biosynthesis of lincomycin A. Sequence anal-
ysis of the lincomycin gene cluster showed the presence of a putative S-glycosyl-
transferase, which likely catalyzes the displacement of GDP with an appropriate
sulfur donor. This proposal has been verified recently by others. In addition, the
amide bond formation between the proline moiety and thiooctose was shown to be
catalyzed by a protein complex consisted of LmbC, LmbN and LmbD. This process
resembles the biosynthesis of nonribosomal peptides.
In conclusion, this work unravels the biosynthetic origins of lincomycin A
and also characterizes the full sequences of the enzymatic transformations of the
octose intermediate. The significance of such biosynthetic studies of glycosylated
natural products like lincosamide derivatives is due to the fact that these natural
products are bioactive and pharmaceutically useful. Knowing their biosynthetic
pathways gives us the opportunity to manipulate the biosynthetic machineries.
Modifying the structure of the sugar components holds promise for varying their
viii
biological activities. Moreover, the information about the biosynthetic precursors
and the intermediates is useful for the optimization of the fermentation condition.
ix
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Chapter 1
Background and Significance∗
Carbohydrates are essential biomolecules for all types of living organisms.
A wide variety of sugar moieties can be found in lipopolysaccharides, glycopro-
teins, and numerous secondary metabolites. In many cases, the glyco-component
is an important determinant of bioactivity for the parent compound.1,2 Given that
glycosylation is a recurrent feature in natural products, one could reason that the
diverse biological activities and molecular targets of glycosylated compounds may
derive from the the great structural complexity of those sugar components.
The diverse structures of monosacchrides are largely resulted from func-
tional group transformations, including oxidoreduction, isomerization, methyla-
tion, acetylation and transamination, before or after glycosyl transfer. The com-
plexity observed in sugar structures is further enhanced by the heteroatom in-
corporation and high-carbon chain attachment. While carbohydrate is originally
named for its common chemical composition, (CH2O)n, numerous sugars are found
to contain covalent bonds between carbon and heteroatoms, such as nitrogen,
sulfur, halogens and arsenic. For example, several sugars derivatives with an-
tibiotic activities are found to contain C–N bonds in the forms of amine or oxi-
dized amine.3,4 A few naturally occurring thiosugars, in which the C–S bonds are
present, have also been identified as pharmaceutically useful secondary metabo-
∗Partial content of this chapter was published as “The biosynthesis of nitrogen-, sulfur-, and
high-carbon chain-containing sugars” Lin, C.-I; McCarty, R. M.; Liu, H.-w., Chem. Soc. Rev., 2013,
42, 4377–4407. This review was written by C.-I. L. and R. M. M., who contributed equally, and
edited by H.-w. Liu.
1
lites.5,6 Moreover, the carbohydrate intermediates containing C–X (X = F or Cl)
bonds were discovered during the characterization of enzymes capable of catalyz-
ing halogenation reactions.7 Arsenosugars with C–As bond represent one of the
major arsenicals in seafood.8 Interestingly, although sugar phosphates are criti-
cal components in metabolism and phosphonic/phosphinic natural products are
widely distributed,9 there is no C–P bond containing sugar discovered so far. The
focus of this chapter is the biosynthesis of sulfur-containing sugars. This class of
unusual sugars are interesting due to the existence of the thio-substituents which
pose impact on the molecular properties including the elctronegativity, hydrogen
bonding ability and steric hindrance. In addition to the thio-constituents, some
sugars feature “high-carbon” chains as their backbones. A greater than usual car-
bon number (> 6) not only extend the length of these unusual sugars, but also
allows multiple site functionalization and fused ring formation.
As far as glycosylated natural products are concerned, research efforts in
the biosynthesis of deoxysugars and the mechanism of glycosyltransferases have
made it possible for manipulation of natural products glycodiversification.10,11
The construction of the sulfur- and high-carbon chain-containing sugars are less
understood due to their relatively rare natural occurrences. Thus, exploring the
biosynthesis of these natural products may aid in the identification of novel com-
pounds with improved pharmacological properties. In this chapter, the known
sulfur- and high-carbon chain-containing sugars will be introduced and current
understanding regarding their biosynthesis will also be discussed.
1.1 Sulfur-containing Sugars
Sulfur is the fifth most abundant element in living organisms, after oxy-
gen, carbon, hydrogen and nitrogen. Sulfur-containing molecules are widely dis-
tributed in natural products, including amino acids, cofactors, antioxidants, nu-
2
cleotides and numerous secondary metabolites.5 However, only a few naturally
occurring thiosugars have been identified and the relative scarcity has hindered
investigation regarding their biosynthesis and biological activities.6,12 The term,
thiosugar, is used here to describe a carbohydrate molecule that carries a sulfur-
containing functional group or is connected to other molecules via a sulfide link-
age. In this section, the known thiosugars are categorized into four classes based
on the oxidation state of the sulfur-containing functional groups: thiols, sulfides,
sulfonium ions and sulfonic acids. Their biosynthetic pathways and the enzymes
catalyzing the sulfur incorporation step in each pathway are discussed based on
the data that are currently available.
1.1.1 Group I: Thiosugars Carrying a Free Thiol Group
The only two members of group I are the angucycline-type antibiotics rhodono-
cardin A (1-1) and B isolated from Nocardia sp. No. 53 (Figure 1.1).13 In rhodono-
cardin A, the benz[a]anthraquinone skeleton is decorated with three sugar units,
rhodinose (1-2), 2-thioglucose (1-3), and glucose, which are joined via O-glycosidic
bonds to C-12b, C-5, and C-4a, respectively. Rhodonocardin B contains only the
first two sugars. The biosynthesis of rhodonocardins has not been studied.
1.1.2 Group II: Thiosugars Carrying a Sulfide Linkage
Sulfides are compounds containing C–S–C connectivity. Compared to the
free thiols, which display a much higher tendency toward oxidation and stronger
nucleophilicity, sulfides are more resistant to chemical reactions and are generally
more stable. For this reason, most of the known naturally occurring thiosugars
belong to group II. In this class of compounds, the sulfur atom either exists in
the endocyclic ring, or serves as a linkage between the sugar molecule and the
aglycone. Compounds within group II are further divided into five subgroups
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Figure 1.1: The angucycline-type antibiotic rhodonocardin A.
according to their overall chemical structures.
1.1.2.1 Thiocycle Ring
The first example of a thiocyclic sugar, 5-thio-D-mannose (1-3), was isolated
from the marine sponge Clathria pyramida in 1987 (Figure 1.2). This is so far the
only free thiocycle-containing monosaccharide identified in nature.14 It has been
speculated that 5-thio-D-mannose may be produced by a sulfate reducing bacterial
symbiont of C. pyramida, rather than by C. pyramida itself.
The albomycin δ1 (1-4), isolated from Streptomyces subtropicus, contain a 6-
amino-6-deoxy-4-thio-heptofuranose uronic acid nucleoside (1-5) and a ferrichrome
siderophore moiety (1-6).15,16 These two subunits are linked via a serine residue
(Figure 1.2). The iron-chelating siderophore can be recognized by the bacterial
siderophore-dependent iron acquisition system. This allows albomycins to be ac-
tively transported across the membranes leading to their designation as “Trojan
horse” antibiotics.17 The seryl-1-5 has been demonstrated to be a potent inhibitor
against bacterial seryl-tRNA synthetase (SerRS).18 The presence of sulfur in al-
bomycin is critical for the observed antimicrobial activity, because the oxygen-ring
4
analogue of albomycin is totally inactive.19
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Figure 1.2: Thiosugars containing a thiocycle ring.
The identification of the albomycin biosynthetic gene cluster was recently
reported by Chen and coworkers.20 It has been speculated that the sulfur incor-
poration step proceeds via a mechanism analogous to that employed by BioB, the
biotin synthase (BioB) (Figure 1.3A).21,22 BioB is a member of the radical SAM en-
zyme superfamily.23 Radical SAM enzymes harbor a [4Fe–4S] cluster, which af-
ter reduction can trigger the reductive cleavage of SAM to give methionine and
the 5′-deoxyadenosyl radical (1-7). The latter is a powerful oxidant that can ab-
stract a hydrogen atom from substrates to yield radical intermediates, which then
undergo radical-mediated transformations. In BioB, the 5′-deoxyadenosyl radical
(1-7) abstracts hydrogen from dethiobiotin (1-8) and the resulting substrate rad-
ical (1-9) takes sulfur out of a [2Fe–2S] cluster bound in the active site of BioB.
Since abmM appears to encode a radical SAM enzyme with both the [4Fe–4S] and
[2Fe–2S] cluster bound, the same sulfur insertion mechanism may be operative in
AbmM (1-10→1-11, Figure 1.3B). It should be noted that the biosynthesis of 4-thio-
heptofuranose uronic acid moiety 1-5 will be discussed in Section 1.2.1.
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Figure 1.3: (A) Proposed mechanism for BioB-catalyzed sulfur incorporation in biotin
biosynthesis. (B) Proposed mechanism for sulfur incorporation in albomycin biosynthesis.
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1.1.2.2 Angucycline-type Antibiotics
BE-7585A (1-12) from Amycolatopsis orientalis subsp. Vinearia is a constitu-
tional isomer of the aforementioned group I thiosugar-containing rhodonocardin
A (1-1).24 In BE-7585A, 2-thioglucose (1-3) and glucose are joined together as a
1,1′-O-linked disaccharide that is attached to the C-5 of aglycone via a thioether
linkage. The biosynthetic studies of BE-7585A led to the identification and char-
acterization of a 2-thioglucose-6-phosphate synthase, BexX.25 This enzyme shows
significant sequence homology to the thiazole synthase ThiG, which catalyzes the
C–S bond formation of the thiazole moiety (1-13) during thiamine biosynthesis
(Figure 1.4).26 It is therefore proposed that BexX may perform an analogous func-
tion in the biosynthesis of 2-thioglucose (Figure 1.5). Using BexX and glucose-6-
phosphate (G6P, 1-14), a covalent adduct (1-15) between Lys-110 of BexX and C-1 of
a 2-ketosugar derived from G6P was detected in the crystal structure.27 This result
strongly supports that BexX is the enzyme responsible for priming G6P to accept
a nucleophilic sulfur donor at C-2 (1-15→1-16, Figure 1.5). However, no potential
sulfur delivery protein, such as ThiS, which works along with ThiG in thiazole
biosynthesis (Figure 1.4), is encoded in the bex gene cluster. Through genome se-
quencing, it was later discovered that BexX actually co-opts the sulfur-delivery sys-
tems from primary metabolism, such as those used in cysteine and molybdopterin
biosynthesis to deliver the sulfur atom to the sugar substrate bound in the active
site of BexX.27
1.1.2.3 Lincosamides
Lincomycin A (1-17), isolated from Streptomyces lincolnensis, displays an-
tibiotic activity against Gram-positive bacteria.28,29 It has been suggested that lin-
comycin A blocks protein synthesis by binding to the peptidyltransferase domain
of the 50S ribosomal subunit.30 Lincomycin A contains a 1-thiooctose core (1-20),
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which is also found in Bu-2545 (1-18) from Streptomyces strain H230-570 and ce-
lesticetin (1-19) from Streptomyces caelestis (Figure 1.6).31–33 This eight-carbon skele-
ton of lincomycin makes it also recognized as a high-carbon sugar (Section 1.2.2).
Progress has been made in learning the biosynthesis of lincomycin and celesticetin.
The available data will be discussed in later chapters of this dissertation.
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Figure 1.6: The family of lincosamide-containing antibiotics.
1.1.2.4 Endiyne-type Natural Products
Several 4-thiosugars (sulfide-xx) have been found as structural components
of endiyne-containing natural products: calicheamicin (1-21) from Micromonospora
echinospora ssp. Calichensis,34 namenamicin from Polysyncraton lithostrotum,35 es-
peramicin from Actinomadura verrucosospora,36 and shishijimicin from Didemnum
proliferum.37 Based on the analysis of the calicheamicin biosynthetic gene clus-
ter, the translated product of the calS4 (or calK) gene, which encodes a putative
C–S lyase, has been proposed to catalyze the conversion of a TDP-2,6-dideoxy-4-
ketosugar (1-22) to the corresponding 4-thiosugar (1-23, Figure 1.7).38 However,
this hypothesis has not been verified and it is unclear whether other proteins are
also required for the sulfur incorporation step.
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1.1.2.5 Glucosinolates
Glucosinolates (1-24) are 1-thiosugar-containing natural products produced
by Brassicales plants and are utilized for defense against insects and pathogens.39
Damage to the plant tissues will trigger the hydrolysis of the C–S glycosidic bond
of glucosinolates by myrosinases to release unstable thiohydroximate-O-sulfates.
The sulfate moiety is then lost via a spontaneous Lossen rearrangement resulting in
the formation of various toxic compounds including isothiocyanates. Structurally,
glucosinolates are β-thioglucoside N-hydroxysulfates containing a side chain that
is derived from an amino acid.
The biosynthesis of glucosinolates has been extensively investigated and
reviewed.40–42 As depicted in Figure 1.8, an amino acid precursor is converted
to a nitrile oxide (1-25) or aci-nitro (1-26) intermediate via consecutive oxidations
catalyzed by cytochrome P450 monooxygenases. The critical sulfur incorpora-
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tion step has been proposed to occur nonenzymatically with cysteine as the sul-
fur donor. Subsequent cleavage of the thio-conjugate (1-27) by PLP-dependent
C–S lyase SUR1 yields thiohydroximate (1-28), which is then glycosylated and
sulfonated to yield the glucosinolate core. Although cysteine has long been con-
sidered to be the sulfur source in glucosinolate biosynthesis, some reports have
indicated that glutathione (GSH) might be a more plausible sulfur donor and a
specific GSH-S-transferase (GST) may catalyze the sulfur incorporation step (Fig-
ure 1.8).43–45
1.1.3 Group III: Thiosugars Carrying a Sulfonium Ion
Isolated from the medicinal herb Salacia reticulate, salacinol (1-29) and ko-
talanol (1-30) are both naturally occurring thiosugars that contain a sulfonium ion
moiety (Figure 1.9).46,47 Several analogues, including ponkolanol and salaprinol,
were later found from other Salacia species.48 The unique zwitterionic structure
of salacinol (1-29) and its analogues includes a 1-deoxy-4-thio-D-arabinofuranosyl
cationic core with 1-deoxy-aldosyl-3-sulfate as the anionic branched-chain. These
compounds exhibit high α-glucosidase inhibitory activity and have consequently
emerged as anti-diabetic drug candidates.48 While extensive structure activity re-
lationship studies have been carried out,49 the biosynthetic pathways for the for-
mation of these sulfonium-containing sugars remain unknown.
1.1.4 Group IV: Thiosugars Carrying a Sulfonic Acid
The unusual sulfosugar was found as a component of sulfoquinovosyl di-
acylglycerol (SQDG, 1-31).50 SQDG comprises about 47% of total lipids in chloro-
plast membranes of most photosynthetic organisms.51 Feeding studies using [35S]-
sulfate traced the sulfolipid biosynthetic pathway to a nucleotide-activated sulfo-
quinovose intermediate (1-32, Figure 1.10).52 It was later identified that sqdB en-
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codes the enzyme catalyzing the insertion of inorganic sulfite into UDP-glucose.53–55
However, the exact physiological sulfite source and the detailed mechanism of sul-
fonyl incorporation awaits further investigation.
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1.2 High-carbon Chain-containing Sugars
Unusual sugars with high carbon numbers are found in an array of micro-
bially produced antibiotics and in the outer walls of some Gram-negative bacteria.
They are generally formed via condensation reactions between the C-5 and C-6
sugars of primary metabolism, or derivatives thereof, and an exogenous carbon
source. The known mechanisms employed for condensation during the biosyn-
thesis of high-carbon sugars are as varied as the mechanisms for biological C–C
bond formation in general. It should be noted that highly oxygenated hydrocar-
bons may cyclize to form a multi-hydroxylated ring structure, which appears as
high-carbon chain-containing sugars. These high-carbon sugars recorded in the
literature are classified by the carbon numbers and their biosynthesis are discussed
in the following sections.
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1.2.1 Heptoses
A number of heptoses have been identified as essential components of the
lipopolysaccharides (LPS), the amphipathic glycolipids found as a part of the outer
membrane of Gram-negative bacteria.56 The common structure of LPS comprises
the lipid A with a bisphosphorylated and acylated β-(1→6) glucosamine disaccha-
ride, the inner-core part containing heptoses and 3-deoxy-D-manno-oct-2-ulosonic
acid (KDO), and a polysaccharide chain. Most of the LPS heptoses have a glycero-
D-manno configuration. Biosynthetic pathways from D-sedoheptulose 7-phosphate
to these heptoses have been characterized57,58 and will be discussed in later chap-
ters due to their similarity to the biosynthesis of lincomycin.
Liposidomycin (1-33), caprazamycin (1-34), and A-90289 (1-35) share a seven-
carbon 5′-C-glycyluridine core (1-36).59 These uridyl lipopeptides inhibit the en-
zyme MraY, phopho-MurNAc-pentapeptide translocase, involved in the bacterial
peptidoglycan biosynthetic pathway.59,60 Gene clusters have recently been iden-
tified for the biosynthesis of liposidomycin in Streptomyces sp. SN1061M (lpm),
caprazamycin in Streptomyces sp. MK730-62F2 (cpz), muraymycin in Streptomyces
sp. NRRL 30471 (mur), and A-90289 in Streptomyces sp. SANK 60405 (lip).61–64
Among the four compounds, the biosynthesis of A-90289 has been extensively
characterized (Figure 1.11). The pathway is initiated by the oxidation of uridine-
5′-monophosphate (UMP) to uridine 5′-aldehyde (1-37→1-38). This reaction is
catalyzed by a non-heme iron(II)-dependent α-ketoglutarate dioxygenase, LipL.65
Subsequently, a putative serine hydroxymethyltransferase (SHMT) encoded by
lipK was shown to catalyze the condensation between uridine 5′-aldehyde (1-38)
and the PLP-bound glycine.66 The homologs of LipL and LipK can be found in
most of uridyl lipopeptide biosynthetic pathways since they are essential for the
construction of the heptose unit.
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Albomycin δ1 (1-4) has been briefly mentioned in Section 1.1.2.1. Although
currently there is no biochemical data regarding the biosynthesis of the 4-thio-
heptouronic acid moiety 1-5 in albomycin, three possible pathways have been pro-
posed based on sequence analysis of the albomycin biosynthetic gene cluster.20 As
illustrated in Figure 1.12, in pathway A the reaction is initiated by the nucleophilic
addition of cysteine sulfur to C-3 of phosphoenolpyruvate (PEP, 1-39) to form a
thioether adduct (1-40). This intermediate may undergo a series of enzymatic re-
action to yield (1-5). An analogous reaction sequence is also proposed for pathway
B where homocysteine instead of cysteine is used as the substrate. In the path-
way C, either serine or glycine is joined with threose or ribose, respectively, via
an intermolecular aldol condensation reaction. This is followed by sulfur insertion
and cyclization to give 1-41, which could then be phosphorylated at C-1 by the
deoxynucleoside kinase homologue AbmG to give 1-5.
The antitumor compound spicamycin (1-42) from Streptomyces alanosinicus
87-MT3 and its C-2 epimer septacidin (1-43) from Streptomyces fimbriatus were both
isolated as mixtures of similar compounds carrying fatty acyl substituents of vari-
able lengths.67,68 The structures of both septacidin and spicamycin contain 4-amino-
4-deoxyheptose (1-45) as does anicemycin (1-44) from Streptomyces sp. TP-A0648,
which was identified recently.69
Amipurimycin (1-46), isolated from the culture media of Streptomyces novogu-
ineensis, was shown to display antibiotic activity against Pyricularia oryzae, a fungal
phytopathogen that causes sheath blight in rice plants.70 The structure of amipurimycin
includes an unusual branched heptose.71 The similar heptose structure was also
found in Miharamycin A (1-47), an adenine-containing nucleoside isolated from
Streptomyces miharaensis SF-4890.72 So far, there were no further information re-
garding the biosynthesis of these two antibiotics.
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1.2.2 Octoses
In addition to the bacterial heptoses described above (Section 1.2.1), KDO
(1-48), is also an important component of the LPS in Gram-negative bacteria.73
KDO is biosynthesized via an aldol condensation between arabinose-5-phosphate
(1-49) and PEP (1-39) catalyzed by KDO-8-phosphate synthase (Figure 1.14).74
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Figure 1.14: Biosynthetic pathway of KDO.
Octosyl acid A (1-50) is a bicyclic, anhydrooctose uronic acid nucleosides
isolated from media of Streptomyces cacaoi var. asoensis.75 This strain also produces
polyoxin C (1-51), an active antifungal agent via inhibition of chitin synthase.76
Feeding experiments using isotope labeled precursors revealed that octosyl acids
and polyoxins may be derived from a common octose intermediate (1-52), which
likely results from the condensation between PEP and a uridine derivative (Fig-
ure 1.15. Biosynthetic gene cluster involved in the production of polyoxins in S.
cacaoi (pol) has been identified.77 The gene product of polA was shown to catalyze
the formation of 3′-enoylpyruvoyl-UMP from PEP and UMP. However, it remains
unclear how the subsequent cyclization of 1-52 occurs and finally yields the bi-
cyclic structure of octosyl acids.
Apramycin (1-53) is an aminoglycoside antibiotic that contains an unusual
bicyclic octose sugar (1-54).78 Labeling studies have indicated that the carbon atoms
from C-1′ to C-6′ of the octose moiety are derived from glucose while C-7′ and
C-8′ may originate from C-2 and C-3 of pyruvate.79 Gene clusters for the biosyn-
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Figure 1.15: Proposed pathways for the biosynthesis of octosyl acid A and polyoxin C.
thesis of apramycin in Streptoalloteichus tenebrarius DSM 40477T and Streptoallote-
ichus hindustanus DSM 44523T have been identified (designated apr).80 A possible
biosynthetic pathway has been proposed based on the gene annotations in the apr.
As shown in Figure 1.16, AprQ, a protein homolog of putative paromamine 6′-
dehydrogenase, is predicted to oxidize the intermediate (1-55) to the correspond-
ing aldehyde (1-56), which may undergo an aldol condensation with a two-carbon
unit to give the octose sugar (1-57). However, the precise source of this two-carbon
species and the mechanism of the octose formation remain unknown.
The lincosamide antibiotics were introduced earlier (Section 1.1.2.3). The
biosynthetic precursors of the octose moiety in lincosamide have been shown to be
D-fructose 6-phosphate (F6P) or D-sedoheptulose 7-phosphate as the three-carbon
donor and D-ribose 5-phosphate (R5P) as the five-carbon acceptor. The detailed
mechanism of octose formation will be further described in later chapters of this
dessertation.
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1.2.3 Nonose
As it has been mentioned in sections 1.2.1 and 1.2.2, there are several high-
carbon sugars identified as crucial constituents of microbial cell walls. Perhaps
the most widely recognized high-carbon sugar in this class is N-acetyl-neuraminic
acid (NeuNAc, 1-58). This nine-carbon sugar is a key component of the eukaryotic
extracellular matrix, and is also found to a lesser extent in bacteria. In bacterial
systems, it is formed via an aldol condensation between N-acetyl-mannosamine
(ManNAc, 1-59) and either PEP (1-39) or pyruvate by N-acetyl-neuraminic acid
synthase or aldolase, respectively (Figure 1.17).81,82 The reaction is very similar as
the condensation catalyzed by KDO-8-phosphate synthase (Figure 1.14).
Griseolic acid A (1-60) is a cyclic AMP analog that contains an unusual nine-
carbon bicyclic sugar, dicarboxylate glycone.83 Griseolic acid A and its analogs
were identified and isolated from culture media of Streptomyces griseoaurantiacus
during a search for inhibitors of cyclic nucleotide phosphodiesterase. Feeding ex-
periments showed that adenosine, oxaloacetate and succinate may be the biosyn-
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thetic precursors for griseolic acid A, but no further characterization was per-
formed to elucidate its biosynthetic pathway.84
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Figure 1.17: A. Biosynthetic pathway of N-acetyl-neuraminic acid. B. Griseolic acid A.
1.2.4 Decoses and Sugars Containing More Than Ten Carbon Atoms
Mildiomycin (1-61) is a peptidyl nucleoside antibiotic produced by Strep-
toverticillium rimofaciens that inhibits protein synthesis by blocking the peptidyl-
transferase site on the ribosomal subunit.85,86 It is structurally similar to the an-
tibiotics blasticidin S 1-62, both sharing a common core structure.87 Mildiomycin,
however, contains a unique decose carbon skeleton. The identification and sub-
sequent sequencing of the blasticidin S biosynthetic gene cluster in Streptomyces
griseochromogenes (bls)88 laid the foundation for the discovery of the mildiomycin
biosynthetic gene cluster (mil).89 Several initial steps regarding the biosynthesis
of mildiomycin have been demonstrated. As shown in Figure 1.18, MilA, MilB
and MilC have been demonstrated to convert cytidine monophosphate (CMP) to
an early intermediate 5-hydroxymethyl-cytosylglucuronic acid (5-hydroxymethyl-
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CGA, 1-63).88,89 MilG, a member of the radical SAM enzyme superfamily, is thought
to be involved in the formation of the 2,3-deoxy-4-keto-2,3-ene-sugar moiety (1-64)
of mildiomycin, since the milG disruption mutant accumulated 5-hydroxymethyl-
CGA (1-63) in the fermentation broth. MilM and MilN are homologous to aspar-
tate aminotransferase and dihydropicolinate synthetase, respectively. MilM is pro-
posed to catalyze the deamination of arginine (1-65) to give 1-66, which is subse-
quently coupled to the nucleoside by MilN (1-64 + 1-66→ 1-67, Figure 1.18).
The S-adenosyl-L-methionine analogues, sinefungin (1-68) and dehydrosine-
fungin (1-69), were first isolated from the culture media of Streptomyces griseus
(Figure 1.19).90 Both radiotracer feeding experiments and cell-free assays have pro-
vided preliminary clues regarding sinefungin biosynthesis.91 It was proposed that
adenosine and L-arginine are the biosynthetic precursors. However, the genes or
enzymes involved in the process remain unidentified.
Tunicamycin (1-70) is a nucleoside antibiotic that was first isolated from cul-
ture media of Streptomyces lysosuperificus and subsequently Streptomyces chartreusis
NRRL 3882.92,93 Tunicamycin is extracted as a complex composed of closely re-
lated components having a general structure that includes an unusual 11-carbon
aminodialdolose core, known as tunicamine (1-71), joined to N-acetylglucosamine
(GlcNAc), uracil, and an amide-linked fatty acid (Figure 1.20).94 Similar as uridyl
lipopeptides (Section 1.2.1), tunicamycin disrupt the assembly of the bacterial cell
wall via inhibition of MraY.59
The biosynthesis of the tunicamine core is only partially understood. Label-
ing studies with [2-14C]-uridine, [6,6-2H2]-D-glucose, and D-[1-
13C]-glucose showed
that the tunicamine core is derived from uridine (1-72) and UDP-GlcNAc (1-73).95
The S. chartreusis genome was recently sequenced and a gene cluster for tuni-
camycin biosynthesis was identified (tun).96,97 Within the gene cluster, TunB is
identified as a putative member of the radical SAM enzyme superfamily. It was
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then proposed that TunB catalyzes the condensation of uridine (1-72) with UDP-
6-deoxy-GalNAc-5,6-ene (1-76) to yield UDP-N-acetyltunicamineuracil (1-77, Fig-
ure 1.20). This hypothesis is supported by the finding that a TunB knockout strain
accumulates UDP-6-deoxy-GlcNAc-5,6-ene (1-73), which is believed to be the pre-
cursor of 1-76).
The in vitro activities of purified recombinant proteins, TunA and TunF,
were demonstrated after the discovery of gene cluster.98 TunA is homologous to
TDP-glucose 4,6-dehydratase, which carries out the conversion of TDP-glucose to
TDP-4-keto-6-deoxy-glucose during the biosynthesis of 6-deoxyhexoses.10,11 How-
ever, unlike a typical 4,6-dehydratase-catalyzed reaction involving an internal hy-
drogen transfer from C-4 to C-6, the TunA catalytic cycle is concluded by a 1,2-
hydride addition to the 4-keto group of the 4-keto-6-deoxy-GlcNAc-5,6-ene in-
termediate (1-74), rather than 1,4-hydride addition to the adjacent C5–C6 double
bond, to give UDP-6-deoxy-GlcNAc-5,6-ene (1-75) as the product (Figure 1.20).
Herbicidins are antibiotics with herbicidal activity produced by Streptomyces
sagamonensis.99,100 The herbicidins are adenosine nucleoside analogues that con-
tain a tricyclic undecose scaffold. The array of herbicidins produced by a series of
S. sagamonensis mutants led to a proposal that herbicidin A is derived from her-
bicidin F, of which the precursor is herbicidin G (1-78→1-80, Figure 1.21).101 Hik-
izimycin (1-81), also named as anthelmycin, was isolated from the culture media
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of Streptomyces sp. strain A-5 and exhibits antifungal activity.102 Hikizimycin is
a cytosine nucleoside analogue containing hikosamine (1-82), a 4-amino-4-deoxy-
undecose sugar (Figure 1.21).103,104
1.3 Summary and Thesis Statement
The intricate chemical structures of natural products has inspired research
to study their mode of actions, structure-activity relationships and biosynthesis.
Development of methods and strategies for the total synthesis of natural products
remains one of the most important fields in organic chemistry.105 Investigating the
construction of the elaborately structured natural products by enzymatic catalysis
is also an important topic in enzymology. The accumulated knowledge has al-
lowed pathway engineering and synthetic biology to become useful tools for drug
development106 and biofuel research.107 Moreover, the strategy combining the in-
formation of natural product biosynthesis and the capability of organic synthesis
serves as a powerful approach used in modern pharmaceutical research. A recent
success in the production of antimalarial artemisinin fully demonstrated the poten-
tial of cross-field integration.108 The rarity of thio- and high-carbon sugars does not
prevent them being used as important therapeutic agents. However, knowledge
about how thiosugars and high-carbon sugars are biosynthesized sugars mostly
remains elusive due to the scarcity of their natural occurrence. Thus, the focus
of this study is to investigate the biosynthesis of the natural products possessing
these two structural features.
Lincomycin A (1-17) is a clinically important antibiotic noted for its unusual
C-1 methylthio-substituted octose moiety. Based on previous feeding experiments
and sequence analysis, a proposed biosynthetic pathway of lincomycin has been
proposed and is described in Chapter 2. LmbR (transaldolase) was shown to cat-
alyze the condensation of D-ribose 5-phosphate and D-fructose 6-phosphate or D-
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sedoheptulose 7-phosphate. The resulting octulose 8-phosphate was subsequently
was isomerized to octose 8-phosphate through the catalysis of LmbN (isomerase).
Chemical synthesis of the expected product was carried out and the products were
used for the structural confirmation of LmbN-product. In Chapter 3, the identifi-
cation of GDP-octose as a key intermediate in the biosynthesis of lincomycin A
is described. The conversion of octose 1,8-bisphosphate intermediate to octose
1-phosphate by LmbK (phosphatase) was demonstrated. The following C-1 acti-
vation of octose 1-phosphate catalyzed by LmbO (guanylyltransferase) resulted in
the formation of GDP-octose.
Chapter 4 focuses on the characterization of enzymes involved in GDP-
octose modifications, including C-4 epimerization, C-8 dehydration and C-6 ami-
nation. Overexpression and purification of the proteins LmbM (epimerase), LmbL
(dehydrogenase), LmbZ (oxidoreductase) and LmbS (aminotrasnferase) allowed
further investigation of their proposed functions. Finally, in Chapter 5, sulfur in-
corporation was pursued using the GDP-aminosugar with a series of sulfur donors
and the putative S-glycosyltransferase, LmbT. Moreover, a unique condensation
system resembling nonribosomal peptide synthetase was shown to catalyze the
amide bond formation between the proline derivative and methylthiolincosamide.
The final key step of lincomcyin A is the C–S bond cleavage to yield C-1 free thiol
group. The pyridoxal 5′-phosphate-dependent enzyme, LmbF, was purified. A
mechanistic proposal regarding the bifurcation point of the lincomcyin A and ce-
lesticetin biosynthetic pathways is also described. These results represent the first
characterization of the biosynthesis of a thiooctose-containing natural product.
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Chapter 2
Biosynthetic Studies of Lincomycin A (I):
Identification of the Octose 8-Phosphate as the
Biosynthetic Intermediate∗
2.1 Introduction
Lincomycin A (2-1) is a clinically important antibiotic against Gram-positive
bacteria.109 It was isolated from a soil actinomycete, Streptomyces lincolnensis, which
was named after the city of Lincoln in Nebraska where the strain was discovered.28
Similar to macrolide antibiotics, lincomycin interacts with peptidyltransferase do-
main of the 50S ribosomal subunit due to its structural resemblance to the 3′-end of
L-Pro-Met-tRNA and deacetylated-tRNA. This, in turn, inhibits the bacterial pro-
tein synthesis.30,110 Nowadays, lincomycin A, clindamycin (2-8) and pirlimycin (2-
9) are three lincosamide compounds widely used to treat Staphylococcal and Strep-
tococcal infections as both human and veterinary medicine (Figure 2.1B). Both clin-
damycin (2-8) and pirlimycin (2-9) are semisynthetic derivatives of lincomycin A
(2-1).111,112
Resistance to lincosamides has been observed in several strains of Staphy-
lococcus due to the SAM-dependent methylation of 23S rRNA. This modification
greatly decreases the affinity between the ribosome and the antibiotics, which
leads to coresistance to macrolide and streptogramin B-type compounds.113 The
∗Partial content of this chapter was published as “Construction of the Octose 8-Phosphate Inter-
mediate in Lincomycin A Biosynthesis: Characterization of the Reactions Catalyzed by LmbR and
LmbN.” Sasaki, E.; Lin, C.-I; Lin, K.-Y.; Liu, H.-w., J. Am. Chem. Soc., 2012, 134, 17432–17435. The
experiments were designed by E. S. and performed by E. S. and C.-I L. One of the enzymes was
prepared by E. S. with the help from K.-Y. Lin. This research project was supervised by H.-w. Liu.
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other type of resistance to lincomycin is more specific and is due to adenylation
of the C3′-hydroxyl group of the sugar moiety of lincomycin A. This nucleotidyl-
transfer reaction is catalyzed by an O-nucleotidyltransferase, encoded by the gene
linA.114
The structure of lincomycin A consists of an amino acid derivative, N-methyl-
4-propyl-L-proline (N-methyl-PPL, 2-2), and an unusual methylthiolincosamide
(MTL, 2-3) moiety.31 Similar thiooctoses are also found in several antimicrobial
agents, such as celesticetin (2-5) from Streptomyces caelestis33 and Bu-2545 (2-7)
from Streptomyces strain H230-532 (Figure 2.1A). The biosynthetic pathway of lin-
comycin A is believed to proceed through a heterogeneously rooting biphasic path-
way producing PPL (2-4) and MTL (2-3) separately.115 The two units are later con-
densed and methylated to yield lincomycin A.
About thirty years ago, feeding experiments were conducted in order to
identify the biosynthetic origin of the octose sugar in lincomycin A (2-1). When
S. lincolnensis was grown with a blend of unlabeled and [13C6]-glucose as the sole
carbon source, the 13C labeling pattern of the resulting MTL (2-3) suggested that
MTL is formed via the condensation of a three-carbon (C3) and a five-carbon (C5)
unit derived from glucose.116 This led to a proposal that the C5 unit might be an in-
termediate from the pentose phosphate pathway and that the C3 unit might be de-
rived from D-sedoheptulose 7-phosphate (S7P, 2-11, Figure 2.2B). These two units
may be joined together by a transaldolase-catalyzed reaction analogous to that in-
volved in the pentose phosphate pathway (Figure 2.2A).
The genes required for lincomycin A biosynthesis were later identified and
sequenced from S. lincolnensis strains 78-11115 and ATCC 25466 (designated as
lmb).117 When Streptomyces coelicolar was transformed with a cosmid containing the
lmb cluster from S. lincolnensis ATCC 25466, heterologous lincomycin A production
was observed.117 Hybridization analysis using probes designed according to the
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lincomcyin A biosynthetic gene cluster allowed the identification of the celesticetin
biosynthetic gene cluster in S. caelestis ATCC 1584 (designated as ccb).118 Interest-
ingly, both gene clusters encode a putative transaldolase (LmbR and CcbR) that
may catalyze an aldol condensation to produce the octose sugar precursor of MTL
(Figure 2.2B). Moreover, several genes, lmbO, lmbM and lmbS, showing sequence
homology to those found in various NDP-deoxyhexose pathways also exist in both
lmb and ccb clusters. This finding led to the hypothesis that an NDP-activated oc-
topyranose is a possible intermediate in the MTL biosynthetic pathway.115
In this chapter, the genes in both lincomycin A and celesticetin gene clusters
are annotated using the updated database. The proposed biosynthetic pathway of
the thiooctose moiety is build based on the sequence similarity of each gene prod-
uct to known enzymes reported in literature. The enzymatic function of the puta-
tive transaldolase, LmbR, is characterized and the biosynthetic origin of octose is
elucidated. This validation is crucial for establishing the entire pathway. Another
enzyme predicted to involve in the early state of lincosamide biosynthesis is an
isomerase, LmbN. Investigation and stereochemical analysis of LmbN-catalyzed
reaction product is also presented in this chapter.
2.2 Experimental Procedures
2.2.1 General
Materials
All chemicals and reagents were purchased from Sigma-Aldrich Chemical
Co. (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) except for D-sedoheptulose
7-phosphate from Carbosynth (San Diego, CA), and were used without further
purification unless otherwise specified. Enzymes and molecular weight standards
used for the cloning experiments were obtained from Invitrogen (Carlsbad, CA) or
New England Biolabs (Ipswich, MA). Reagents for sodium dodecyl sulfate poly-
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acrylamide gel electrophoresis (SDS-PAGE) were purchased from Bio-Rad (Her-
cules, CA), with the exception of the protein molecular weight markers, which
were obtained from Invitrogen. Analytical C18 HPLC columns were products of
Varian (Palo Alto, CA). Amicon YM-10 ultrafiltration membranes were bought
from Millipore (Billerica, MA).
Instrumentation
HPLC was performed on a Beckman Coulter System Gold HPLC equipped
with a UV detector or a Corona CAD (charged aerosol detector, ESA Biosciences,
Chelmsford, MA). Analytical thin layer chromatography (TLC) was carried out on
precoated TLC glass plates (silica gel, grade 60, F254, 0.25 mm layer thickness)
purchased from EMD chemicals (Madison, WI). Flash column chromatography
was performed on silica gel (40–63 µm, 60 A˚) obtained from SiliCycle Inc (Quebec
City, Canada). NMR spectra were acquired using a Varian Unity 400 MHz, 500
MHz or 600 MHz spectrometer, and chemical shifts (in ppm) are reported relative
to that of the solvent peak (δH = 7.24 and δC = 77.0 for deuterated chloroform, δH
= 4.67 for deuterium oxide). Mass spectra were recorded at the Mass Spectrometry
core facility in the Department of Chemistry and the Proteomics Facility in College
of Pharmacy at the University of Texas, Austin. Optical rotations were measured
using an ATAGO AP-300 automatic polarimeter at a path length of 1 dm.
2.2.2 Sequence Analysis and Function Prediction of Proteins
The primary amino acid sequence of each protein encoded in the lincom-
cyin A biosynthetic gene cluster from S. lincolnensis ATCC 25466 (accession num-
ber EU124663) and the celesticetin biosynthetic gene cluster from S. caelestic ATCC
1584 were analyzed using The Universal Protein Resource (UniProt) database by
the basic local alignment search (BLAST).
34
2.2.3 ESI-MS Analysis of LmbR
D-Sedoheptulose 7-phosphate was used as substrate in the LmbR reaction.
The purified C-His6-LmbR protein stock solution was added to 50 mM Tris ·HCl
buffer (pH 8.0) (final concentration of protein was 40 µM) and incubated with D-
sedoheptulose 7-phosphate (S7P, 2-11, 10 mM) at 30 ◦C for 15 min. The resulting
solution (200 µL) was cooled on ice. To this solution was added 20 µL of cold
NaBH4 solution in methanol (500 mM; final concentration of NaBH4 was 45 mM).
The mixture was incubated on ice for 1 h. The excess salts and glycerol were re-
moved at 4 ◦C using an Amicon ultrafiltration unit through a YM-10 membrane.
The resulting protein solution was subjected to ESI-MS analysis. As a control, the
purified C-His6-LmbR protein (40 µM) in 50 mM Tris ·HCl buffer (pH 8.0) in the
absence of S7P was also treated with NaBH4 and subjected to ESI-MS analysis. The
recombinant LmbR was prepared by another graduate student, Eita Sasaki.
2.2.4 Synthesis of 1,2,3,4,6,7,8-Hepta-O-acetyl-α,β-D-erythro-D-gluco-octopyra
-nose (2-27)
As shown in Figure 2.3, compound 2-27 was synthesized from methyl α-D-
glucopyranose (2-16) following a previously reported procedure with minor mod-
ifications.119
Methyl 2,3,4-tri-O-benzyl-α-D-gluco-pyranoside (2-19).
Compound 2-16 (18.05 g, 93.0 mmol) and 4-dimethylaminopyridine (DMAP, 0.56
g, 4.58 mmol) were dissolved in anhydrous DMF (150 mL) and the reaction mix-
ture was cooled to 0 ◦C. The reaction mixture was then mixed with triethylamine
(45 mL, 320 mmol) and stirred at 0 ◦C for 10 min. To this solution was added TBSCl
(15.73 g, 104.4 mmol) portion-wise and the reaction mixture was brought to room
temperature slowly with stirring. After 16 h, the reaction mixture was quenched
by adding water and concentrated in vacuo. The resulting residue was dissolved
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Figure 2.3: Synthetic scheme of 1,2,3,4,6,7,8-hepta-O-acetyl-α,β-D-erythro-D-gluco-
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in ethyl acetate. The organic solution was washed with water (1×) and brine (1×),
and then dried over anhydrous Na2SO4. After the volatiles were removed by ro-
tary evaporation under reduced pressure, the crude product was purified by flash
chromatography (silica gel; EtOAc only) to yield 2-17 (C13H28O6Si, 22.64 g, 83%)
as a white solid. TLC (EtOAc only) R f = 0.18.
Compound 2-17 (13.32 g, 43.18 mmol) and tetrabutylammonium iodide (TBAI, 0.8
g, 4.6 mmol) were dissolved in anhydrous DMF (150 mL) and cooled to 0 ◦C. The
solution was then treated with sodium hydride (60%, 9.20 g, 230.0 mmol) portion-
wise and stirred at 0 ◦C for 15 min. Benzyl bromide (21.0 mL, 176 mmol) was added
slowly and the reaction mixture was brought to room temperature gradually. After
16 h, the reaction mixture was quenched by adding saturated ammonium chloride
solution and concentrated in vacuo. The resulting residue was mixed with water
and extracted with ethyl ether (3×). The combined organic layers were dried over
anhydrous Na2SO4. After the volatiles were removed by rotary evaporation un-
der reduced pressure, the crude product was purified using flash chromatography
(silica gel; EtOAc/hexanes (1:19→1:9)) to yield 2-18 (C34H46O6Si, 7.55 g, 30%) as a
white solid; TLC (EtOAc/hexanes (1:9)) R f = 0.27.
Compound 2-18 (7.55 g, 13.0 mmol) was dissolved in anhydrous THF (200 mL) and
added tetrabutylammonium fluoride solution (1.0 M in THF, 40 mmol). The result-
ing mixture was stirred at room temperature for 16 h. The reaction was quenched
by adding saturated ammonium chloride solution and extracted with ethyl acetate
(3×). The combined organic layers were dried over anhydrous Na2SO4. After the
volatiles were removed by rotary evaporation under reduced pressure, the crude
product was purified using flash chromatography (silica gel; EtOAc/hexanes (1:1))
to yield 2-19 (C28H32O6, 4.57 g, 75%) as a colorless solid. TLC (EtOAc/hexanes
(1:9)) R f = 0.08. 1H NMR (CDCl3, 400 MHz) δ (ppm) 7.37-7.26 (15 H, m, Bn×3),
4.98 (1 H, d, J = 11.2 Hz, CH2 of Bn), 4.87 (1 H, d, J = 11.2 Hz, CH2 of Bn), 4.83 (1
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H, d, J = 11.2 Hz, CH2 of Bn), 4.79 (1 H, d, J = 12.4 Hz, CH2 of Bn), 4.65 (1 H, d, J
= 12.4 Hz, CH2 of Bn), 4.63 (1 H, d, J = 11.2 Hz, CH2 of Bn), 4.56 (1 H, d, J1,2 = 3.6
Hz, H1), 4.00 (1 H, dd, J3,4 = 9.2 Hz, J4,5 = 9.2 Hz, H4), 3.77–3.62 (3 H, m, H5, H6a,
H6b), 3.51 (1 H, dd, J2,3 = 9.6 Hz, J3,4 = 9.2 Hz, H3), 3.49 (1 H, d, J1,2 = 3.6 Hz, J2,3 =
9.6 Hz, H2), 3.35 (3 H, s, OMe). The 1H NMR spectral data of 2-19 are consistent
with those previously reported.119
Methyl 2,3,4-tri-O-benzyl-α-D-gluco-hexodialdo-1,5-pyranoside (2-20).
Under argon, a mixture of anhydrous dichloromethane (15 mL) and DMSO (2.9
mL, 37.5 mmol) was cooled to −78 ◦C in dry ice-acetone bath and then added ox-
alyl chloride (1.6 mL, 18.3 mmol) dropwise. The reaction mixture was stirred at
−78 ◦C for 10 min and then added anhydrous dichloromethane solution of alco-
hol 2-19 (4.28 g, 9.22 mmol) dropwise. The reaction mixture was stirred at −78 ◦C
for 1 h. At −78 ◦C, the reaction mixture was added triethylamine (6.5 mL, 46.6
mmol) slowly. After addition, the reaction was brought to 0 ◦C in an ice-water
bath and stirred for an additional 30 min. The reaction was then diluted with
dichloromethane and quenched by adding water. The resulting mixture was ex-
tracted with dichloromethane (3×) and the combined organic layers were dried
over anhydrous Na2SO4. After the volatiles were removed by rotary evaporation,
the crude aldehyde 2-20 was used for the next step without further purification.
Methyl 2,3,4-tri-O-benzyl-7,8-dideoxy-D-glycero-α-D-gluco-oct-7-enopyranoside
(2-21).120
Aldehyde 2-20 (∼9.22 mmol) was generated in situ as described above and dis-
solved in anhydrous THF (90 mL). The aldehyde solution was cooled to 0 ◦C and
then added vinylmagnesium bromide solution (0.7 M in THF, 37 mL) slowly. The
reaction mixture was stirred at room temperature for 16 h. It was then diluted with
ethyl acetate and quenched by adding water. The reaction mixture was extracted
with ethyl acetate (3×) and the combined organic layers were dried over anhy-
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drous Na2SO4. After the volatiles were removed by rotary evaporation, the crude
product was purified using flash chromatography (silica gel; EtOAc/hexanes (1:9
→ 1:4)) to elute the undesired L-glycero-α-D-gluco-isomer 2-22 (1.56 g, 34%). The
desired product 2-21 (C30H34O6, 0.92 g) was then eluted by EtOAc/hexanes (1:2)
to give a white solid in 20% yield; TLC (EtOAc/hexanes (1:1)) R f = 0.48. 1H NMR
(CDCl3, 400 MHz) of 2-21 δ (ppm) 7.36-7.25 (15 H, m, Bn×3), 5.90 (1 H, ddd, J6,7 =
6.8 Hz, J7,8cis =10.8 Hz, J7,8trans = 17.2 Hz, H7), 5.25 (1 H, ddd, J6,8trans = J8cis,8trans =
1.6 Hz, J7,8trans = 17.2 Hz, H8trans), 5.19 (1 H, ddd, J6,8cis = J8cis,8trans = 1.6 Hz, J7,8cis
= 10.8 Hz, H8cis), 5.00 (1 H, J = 10.8 Hz, CH2 of Bn), 4.92 (1 H, J = 10.8 Hz, CH2
of Bn), 4.78 (1 H, J = 10.8 Hz, CH2 of Bn), 4.78 (1 H, J = 12 Hz, CH2 of Bn), 4.65 (1
H, J = 12 Hz, CH2 of Bn), 4.60 (1 H, J = 10.8 Hz, CH2 of Bn), 4.59 (1 H, d, J1,2 = 3.6
Hz, H1), 4.34 (1 H, m, H6), 4.02 (1 H, dd, J2,3 = J3,4 = 9.2 Hz, H3), 3.79 (1 H, dd, J5,6
= 3.6 Hz, J4,5 = 10.4 Hz, H5), 3.48 (1 H, dd, J2,3 = 9.2 Hz, J1,2 = 3.6 Hz, H2), 3.43 (1
H, dd, J3,4 = 9.2 Hz, J4,5 = 10.4 Hz, H4), 3.38 (3 H, s, OMe). The 1H NMR spectral
data of 2-21 are consistent with those previously reported.120 The configuration at
the C-6 position of 2-21 was determined by Moshers ester analysis as described in
Section 2.2.6.
The undesired L-glycero-α-D-gluco-isomer 2-22: 7.38-7.26 (15 H, m, Bn×3), 5.95 (1
H, ddd, J6,7 = 4.8 Hz, J7,8cis =10.4 Hz, J7,8trans = 17.2 Hz, H7), 5.32 (1 H, ddd, J6,8trans
= J8cis,8trans = 1.6 Hz, J7,8trans = 17.2 Hz, H8trans), 5.19 (1 H, ddd, J6,8cis = J8cis,8trans =
1.6 Hz, J7,8cis = 10.4 Hz, H8cis), 5.00 (1 H, J = 11.2 Hz, CH2 of Bn), 4.94 (1 H, J = 10.8
Hz, CH2 of Bn), 4.85 (1 H, J = 10.8 Hz, CH2 of Bn), 4.80 (1 H, J = 12.4 Hz, CH2 of
Bn), 4.70 (1 H, J = 11.2 Hz, CH2 of Bn), 4.65 (1 H, J = 12.4 Hz, CH2 of Bn), 4.57 (1 H,
d, J1,2 = 3.6 Hz, H1), 4.38 (1 H, m, H6), 4.02 (1 H, dd, J2,3 = J3,4 = 9.2 Hz, H3), 3.70
(1 H, dd, J3,4 = 9.2 Hz, J4,5 = 10.0 Hz, H4), 3.61 (1 H, dd, J5,6 = 1.6 Hz, J4,5 = 10.0 Hz,
H5), 3.51 (1 H, dd, J2,3 = 9.2 Hz, J1,2 = 3.6 Hz, H2), 3.19 (3 H, s, OMe).
Methyl 6-O-acetyl-2,3,4-tri-O-benzyl-7,8-dideoxy-D-glycero-α-D-gluco-oct-7-eno
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-pyranoside (2-23).
Alcohol 2-21 (1.75 g, 3.57 mmol) was dissolved in anhydrous pyridine (9 mL) and
added acetic acid (9 mL). The reaction mixture was stirred at room temperature
for 16 h. The reaction was quenched by adding methanol slowly and then concen-
trated in vacuo. The resulting residue was dissolved in ethyl acetate. The organic
solution was washed with brine (1×) and then dried over anhydrous Na2SO4. Af-
ter the volatiles were removed by rotary evaporation under reduced pressure, the
crude product was purified using flash chromatography (silica gel; EtOAc/hexanes
(1:4)) to give 2-23 (C32H36O7, 1.19 g, 63%) as a light yellow syrup. TLC (EtOAc /
hexanes (1:1)) R f = 0.32. 1H NMR (CDCl3, 400 MHz) δ (ppm) 7.39-7.28 (15 H, m,
Bn×3), 5.86 (1 H, ddd, J6,7 = 7.6 Hz, J7,8cis =10.8 Hz, J7,8trans = 17.2 Hz, H7), 5.66-5.64
(1 H, m, H6), 5.29 (1 H, ddd, J6,8trans = J8cis,8trans = 1.2 Hz, J7,8cis = 10.8 Hz, H8cis),
5.24 (1 H, ddd, J6,8cis = J8cis,8trans = 1.2 Hz, J7,8trans = 17.2 Hz, H8trans), 5.01 (1 H, J
= 10.8 Hz, CH2 of Bn), 4.93 (1 H, J = 10.8 Hz, CH2 of Bn), 4.81 (1 H, J = 10.8 Hz,
CH2 of Bn), 4.80 (1 H, J = 12 Hz, CH2 of Bn), 4.68 (1 H, J = 12 Hz, CH2 of Bn), 4.65
(1 H, J = 10.8 Hz, CH2 of Bn), 4.65 (1 H, d, J1,2 = 3.6 Hz, H1), 4.05 (1 H, dd, J2,3 =
9.6 Hz, J3,4 = 8.8 Hz, H3), 3.91 (1 H, dd, J5,6 = 1.6 Hz, J4,5 = 10 Hz, H5), 3.50 (1 H,
dd, J2,3 = 9.6 Hz, J1,2 = 3.6 Hz, H2), 3.41 (1 H, dd, J3,4 = 8.8 Hz, J4,5 = 10.4 Hz, H4),
3.41 (3 H, s, OMe), 2.07 (3 H, s, OAc). 13C NMR (CDCl3, 100 MHz) δ (ppm) 169.6,
138.4, 137.89, 137.86, 131.3, 128.34, 128.29, 127.94, 127.85, 127.63, 127.55, 120.47,
97.6, 82.0, 79.8, 77.7, 75.7, 74.4, 73.7, 73.2, 71.5, 54.9, 21.0. ESI-HRMS Calcd. for
C32H36O7[M + Na]
+ 555.2359, Found: 555.2354.
Methyl 6-O-acetyl-2,3,4-tri-O-benzyl-α-D-erythro-D-gluco-octopyranoside (2-24).
Compound 2-23 (1.19 g, 2.23 mmol) was suspended in 20 mL of co-solvent tBuOH :
H2O (1:1). The mixture was cooled to 4
◦C in cold room and added AD-mix α (3.31
g) and methanesulfonamide (0.22 g, 2.31 mmol). The reaction mixture was stirred
at 4 ◦C until the starting material was all consumed as judged by TLC analysis. The
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reaction was quenched by adding sodium metabissulfite and then concentrated in
vacuo. The resulting residue was dissolved in ethyl acetate. The organic solu-
tion was washed with water (1×) and brine (1×), and then dried over anhydrous
Na2SO4. After the volatiles were removed by rotary evaporation, the crude diol
2-24 was collected and used for the next step without further purification.
Methyl 6,7,8-tri-O-acetyl-2,3,4-tri-O-benzyl-α-D-erythro-D-gluco-octopyranoside
(2-25).
The crude diol 2-24 (2.23 mmol) was dissolved in anhydrous pyridine (9 mL)
and added acetic anhydride (9 mL). The reaction mixture was stirred at room
temperature for 16 h. The reaction was quenched by adding ethanol slowly and
then concentrated in vacuo. The resulting residue was dissolved in ethyl acetate.
The organic solution was washed with brine (1×) and then dried over anhydrous
Na2SO4. After the volatiles were removed by rotary evaporation under reduced
pressure, the crude 2-25 was used for the later step without further purification.
1,2,3,4,6,7,8-Hepta-O-acetyl-α,β-D-erythro-D-gluco-octopyranose (2-27).
A methanol solution (5 mL) of compound 2-25 (0.30 g, 0.46 mmol) and 5% Pd/C
(50 mg) was stirred under hydrogen atmosphere (1 atm) for 16 h. The reaction mix-
ture was filtered through Celite and washed with methanol. The filtrate was con-
centrated and re-dissolved in anhydrous pyridine (5 mL). The solution was then
added acetic anhydride (5 mL). The reaction mixture was stirred at room temper-
ature for 16 h and concentrated to yield 2-26.
Compound 2-26 (0.10 g, 0.2 mmol) was dissolved in acetic acid (3 mL) and added
acetic anhydride (3 mL). The reaction mixture was cooled to 0 ◦C in an ice-water
bath and then added concentrated sulfuric acid (0.3 mL) dropwise. After stirring at
4 ◦C in the cold room for 16 h, the reaction mixture was diluted with dichloromethane
and then quenched by adding saturated sodium bicarbonate solution slowly. The
resulting solution was extracted with dichloromethane (3 ). The combined organic
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layers were washed with water (1×) and brine (1×), and then dried over anhy-
drous Na2SO4. After the volatiles were removed by rotary evaporation, the crude
product was purified using flash chromatography (silica gel; EtOAc/hexanes (1:1))
to yield 2-27 (C22H30O15, 75 mg, 71%, > 99.5% α anomer based on the
1H NMR)
as a white solid; TLC (EtOAc/hexane (1:1)) R f = 0.26. 1H NMR (CDCl3, 500 MHz)
δ (ppm) 6.28 (1 H, d, J1,2 = 3.5 Hz, H1), 5.37 (1 H, dd, J2,3 = 10.5 Hz, J3,4 = 9.0 Hz,
H3), 5.27 (1 H, dd, J5,6 = 3.5 Hz, J6,7 = 6.0 Hz, H6), 5.16 (1 H, dd, J3,4 = 9.0 Hz, J4,5 =
10.5 Hz, H4), 5.17–5.14 (1 H, m, H7), 4.99 (1 H, dd, J1,2 = 3.5 Hz, J2,3 = 10.5 Hz, H2),
4.31 (1 H, dd, J7,8a = 2.5 Hz, J8a,8b = 12.5 Hz, H8a), 4.15 (1 H, dd, J4,5 = 10.5 Hz, J5,6
= 3.5 Hz, H5), 4.10 (1 H, dd, J7,8b = 6.0 Hz, J8a,8b = 12.5 Hz, H8b), 2.14 (3 H, s, OAc),
2.06 (3 H, s, OAc), 2.05 (3 H, s, OAc), 2.03 (3 H, s, OAc), 2.01 (3 H, s, OAc), 1.98 (3
H, s, OAc), 1.97 (3 H, s, OAc). 13C NMR (CDCl3, 125 MHz) δ (ppm) 170.6, 170.2,
169.7, 169.6, 169.4, 169.3, 168.5, 88.7, 70.6, 70.1, 69.6, 69.5, 68.9, 68.8, 61.8, 20.8, 20.7,
20.64 (×2), 20.59 (×2), 20.4. ESI-HRMS Calcd. for C22H30O15[M + Na]+ 557.1482,
Found: 557.1474.
2.2.5 Synthesis of 1,2,3,4,6,7,8-Hepta-O-acetyl-α,β-D-erythro-D-galacto-octopyra
-nose (2-39)
As shown in Figure 2.4, compound 2-39 was synthesized from methyl α-
D-galactopyranose (2-28) following a previously reported procedure with minor
modifications.121
Methyl 2,3,4-tri-O-benzyl-α-D-galacto-pyranoside (2-31).
Compound 2-28 (9.02 g, 42.5 mmol) was dissolved in anhydrous DMF (100 mL)
and the solution was cooled to 0 ◦C in an ice-water bath. To this solution was
added imidazole (7.27 g, 107 mmol) and the resulting mixture was stirred at 0 ◦C
for 5 min. TBSCl (7.84 g, 52.0 mmol) was added portion-wise and the reaction
mixture was brought to room temperature gradually. After 16 h, the reaction
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Figure 2.4: Synthetic scheme of 1,2,3,4,6,7,8-hepta-O-acetyl-α,β-D-erythro-D-galacto-
octopyranose (2-39).
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was quenched by adding water and then concentrated in vacuo. The resulting
residue was dissolved in ethyl acetate. The organic solution was washed with
water (2×) and brine (1×), and then dried over anhydrous Na2SO4. After the
volatiles were removed by rotary evaporation under reduced pressure, the crude
product was purified using flash chromatography (silica gel; EtOAc only) to yield
2-29 (C13H28O6Si, 2.80 g, 21%) as a white solid; TLC (EtOAc only) R f = 0.22.
Subsequent benzylation of compound 2-29 (5.39 g, 17.5 mmol) using sodium hy-
dride (60%, 2.52 g, 63.0 mmol) and benzyl bromide (9.0 mL, 75 mmol) in anhy-
drous DMF (50 mL) yielded 2-30 (C34H46O6Si, 6.07 g, 60%) as a white solid; TLC
(EtOAc/petroleum ether (1:9)) R f = 0.39.
Removal of the silyl protecting group at C-6 of compound 2-30 (0.29 g, 0.50 mmol)
was achieved using a tetrabutylammonium fluoride solution (1.0 M in THF, 1.5
mmol) in anhydrous THF (200 mL). The crude product was purified using flash
chromatography (silica gel; EtOAc/hexanes (1:1)) to give 2-31 (C28H32O6; 0.16 g,
69%) as a colorless solid; TLC (EtOAc/hexanes (1:1)) R f = 0.32. 1H NMR (CDCl3,
400 MHz) δ (ppm) 7.42–7.24 (15 H, m, Bn×3), 4.97 (1 H, d, J = 11.6 Hz, CH2 of Bn),
4.89 (1 H, d, J = 12.0 Hz, CH2 of Bn), 4.84 (1 H, d, J = 12.0 Hz, CH2 of Bn), 4.75 (1
H, d, J = 11.6 Hz, CH2 of Bn), 4.70 (1 H, d, J1,2 = 4.0 Hz, H1), 4.69 (1 H, d, J = 11.6
Hz, CH2 of Bn), 4.64 (1 H, d, J = 11.6 Hz, CH2 of Bn), 4.05 (1 H, dd, J1,2 = 4.0 Hz,
J2,3 = 10 Hz, H2), 3.94 (1 H, dd, J2,3 = 10 Hz, J3,4 = 2.8 Hz, H3), 3.87 (1 H, d, J3,4 =
J4,5 = 2.8 Hz, H4), 3.743.68 (2 H, m, H6), 3.52–3.44 (1 H, m, H5), 3.36 (3 H, s, OMe).
The 1H NMR spectral data of 2-31 is consistent with those previously reported.121
Methyl 2,3,4-tri-O-benzyl-α-D-galacto-hexodialdo-1,5-pyranoside (2-32).121
Following a similar procedure used for the preparation of the aldehyde 2-20, com-
pound 2-31 (2.60 g, 5.60 mmol) was converted to 2-32 by reacting with oxalyl chlo-
ride (1.0 mL, 11.46 mmol) and triethylamine (3.9 mL, 28.0 mmol) in anhydrous
dichloromethane (10 mL) and DMSO (1.7 mL, 21.98 mmol). The crude aldehyde
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2-32 was used for later steps without further purification.
Methyl 2,3,4-tri-O-benzyl-7,8-dideoxy-D-glycero-α-D-galacto-oct-7-enopyrano
-side (2-33).
Following a similar procedure used for the preparation of 2-21, aldehyde 2-32
(∼ 5.60 mmol) generated as described above was reacted with vinylmagnesium
bromide (0.7 M in THF, 30 mL) in anhydrous THF (50 mL). The reaction product
was purified by flash chromatography (silica gel) using EtOAc/hexanes (1:4→1:2)
to elute the desired product 2-33 (C30H34O6; 0.21 g, 8%) as a white solid; TLC
(EtOAc/hexanes (1:1)) R f = 0.54. The epimeric L-glycero-α-D-galacto-isomer 2-34
(0.41 g, 15%) was eluted using EtOAc/hexanes (1:1). 1H NMR (CDCl3, 400 MHz)
of 2-33 δ (ppm) 7.40–7.24 (15 H, m, Bn×3), 5.91 (1 H, ddd, J6,7 = 5.2 Hz, J7,8cis = 10.4
Hz, J7,8trans = 17.2 Hz, H7), 5.32 (1 H, ddd, J6,8trans = J8cis,8trans = 1.6 Hz, J7,8trans =
17.2 Hz, H8trans), 5.17 (1 H, ddd, J6,8cis = J8cis,8trans = 1.6 Hz, J7,8cis = 10.4 Hz, H8cis),
5.02 (1 H, d, J = 11.6 Hz, CH2 of Bn), 4.86 (1 H, d, J = 11.6 Hz, CH2 of Bn), 4.82 (1
H, d, J = 12.4 Hz, CH2 of Bn), 4.75 (1 H, d, J = 11.6 Hz, CH2 of Bn), 4.68 (1 H, d, J =
12.4 Hz, CH2 of Bn), 4.68 (1 H, d, J1,2 = 3.6 Hz, H1), 4.65 (1 H, d, J = 11.6 Hz, CH2 of
Bn), 4.22 (1 H, m, H6), 4.13 (1 H, dd, J4,5 = 1.2, J3,4 = 2.8 Hz, H4), 4.05 (1 H, dd, J1,2
= 3.6 Hz, J2,3 = 10 Hz, H2), 3.90 (1 H, dd, J3,4 = 2.8 Hz, J2,3 = 10 Hz, H3), 3.44 (1 H,
dd, J4,5 = 1.2 Hz, J5,6 = 7.6 Hz, H5), 3.31 (3 H, s, OMe). 13C NMR (CDCl3, 100 MHz)
δ (ppm) 138.6, 138.3, 138.0 128.4, 128.33, 128.26, 128.1, 127.9, 127.7, 127.5, 127.4,
115.6, 98.8, 79.2, 76.1, 74.39, 74.37, 73.5, 73.3, 72.1, 70.7, 55.2. ESI-HRMS Calcd. for
C30H34O6[M + Na]
+ 513.2253, Found: 513.2247. The configuration at C-6 position
of 2-33 was determined by Mosher’s ester analysis as described in Section 2.2.6.
The undesired epimer L-glycero-α-D-galacto-isomer 2-34: 7.39–7.24 (15 H, m, Bn×3),
5.68 (1 H, ddd, J6,7 = 6.8 Hz, J7,8cis = 10.4 Hz, J7,8trans = 17.2 Hz, H7), 5.30 (1 H, ddd,
J6,8trans = J8cis,8trans = 1.6 Hz, J7,8trans = 17.2 Hz, H8trans), 5.18 (1 H, ddd, J6,8cis =
J8cis,8trans = 1.6 Hz, J7,8cis = 10.4 Hz, H8cis), 5.08 (1 H, d, J = 10.8 Hz, CH2 of Bn), 4.88
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(1 H, d, J = 11.6 Hz, CH2 of Bn), 4.82 (1 H, d, J = 12.4 Hz, CH2 of Bn), 4.75 (1 H, d, J
= 11.6 Hz, CH2 of Bn), 4.73 (1 H, d, J1,2 = 3.6 Hz, H1), 4.68 (1 H, d, J = 12.4 Hz, CH2
of Bn), 4.57 (1 H, d, J = 10.8 Hz, CH2 of Bn), 4.35 (1 H, m, H6), 4.06 (1 H, dd, J1,2 =
3.6 Hz, J2,3 = 9.6 Hz, H2), 3.95 (1 H, dd, J4,5 = 1.2 Hz, J3,4 = 2.8 Hz, H4), 3.92 (1 H,
dd, J3,4 = 2.8 Hz, J2,3 = 9.6 Hz, H3), 3.51 (1 H, m, H5), 3.36 (3 H, s, OMe).
Methyl 6-O-2,3,4-tri-O-benzyl-7,8-dideoxy-D-glycero-α-D-galacto-oct-7-enopyra
-noside (2-35).
Alcohol 2-33 (0.21 g, 0.43 mmol) was dissolved in anhydrous pyridine (3 mL) and
added acetic anhydride (3 mL). The reaction mixture was stirred at room temper-
ature for 16 h. The reaction was quenched by adding ethanol slowly and then
concentrated in vacuo. The crude product was purified by flash chromatography
(silica gel; EtOAc/hexanes (1:4)) to yield 2-35 (C32H36O7, 0.17 g, 75%) as a light
yellow syrup. 1H NMR (CDCl3, 400 MHz) δ (ppm) 7.42–7.26 (15 H, m, Bn×3), 5.88
(1 H, ddd, J6,7 = 6.0 Hz, J7,8cis =10.4 Hz, J7,8trans = 17.2 Hz, H7), 5.42–5.38 (1 H, m,
H6), 5.27 (1 H, ddd, J6,8trans = J8cis,8trans = 1.2 Hz, J7,8trans = 17.2 Hz, H8trans), 5.22 (1
H, ddd, J6,8cis = J8cis,8trans = 1.2 Hz, J7,8cis = 10.4 Hz, H8cis), 4.94 (1 H, J = 10.8 Hz,
CH2 of Bn), 4.91 (1 H, J = 12.0 Hz, CH2 of Bn), 4.82 (1 H, J = 12.4 Hz, CH2 of Bn),
4.77 (1 H, J = 12.0 Hz, CH2 of Bn), 4.68 (1 H, J = 12.4 Hz, CH2 of Bn), 4.66 (1 H, d,
J1,2 = 3.6 Hz, H1), 4.51 (1 H, J = 10.8 Hz, CH2 of Bn), 4.06 (1 H, dd, J1,2 = 3.6 Hz, J2,3
= 9.6 Hz, H2), 3.96–3.93 (2 H, m, H3, H4), 3.67 (1 H, d, J5,6 = 9.2, H5), 3.31 (3 H, s,
OMe), 1.98 (3 H, s, OAc). 13C NMR (CDCl3, 100 MHz) δ (ppm) 169.0, 138.7, 138.3,
138.1, 134.2, 128.52, 128.33, 128.30, 128.2, 128.1, 127.7, 127.6, 127.5, 127.4, 117.6,
98.7, 79.4, 76.2, 74.6, 74.0, 73.54, 73.51, 71.4, 71.3, 55.2, 21.0. ESI-HRMS Calcd. for
C32H36O7[M + Na]
+ 555.2359, Found: 555.2351.
Methyl 6-O-acetyl-2,3,4-tri-O-benzyl-α-D-erythro-D-galacto-octopyranoside
(2-36).
The same procedure used to prepare 2-24 was followed to convert compound 2-35
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(0.17 g, 0.32 mmol) to 2-36 using AD-mix α (0.50 g) and methanesulfonamide (30
mg, 0.32 mmol) in 5 mL of co-solvent tBuOH : H2O (1:1). The crude diol 2-36 was
used for the next step without further purification.
Methyl 6,7,8-tri-O-acetyl-2,3,4-tri-O-benzyl-α-D-erythro-D-galacto-octopyrano
-side (2-37).
The above crude diol 2-36 (0.32 mmol) was reacted with acetic anhyide (5 mL) in
anhydrous pyridine (5 mL). The crude 2-37 was used for the next step without fur-
ther purification.
1,2,3,4,6,7,8-Hepta-O-acetyl-α,β-D-erythro-D-galacto-octopyranose (2-39).
Similar to the method used to prepare compound 2-27, compound 2-37 and 5%
Pd/C (50 mg) in a methanol solution (5 mL) were stirred under hydrogen atmo-
sphere (1 atm) for 16 h. The reaction mixture was filtered through Celite and the
filtrate after concentration was reacted with acetic anhydride (5 mL) in anhydrous
pyridine (5 mL). The resulting intermediate 2-38 (0.14 g, 0.22 mmol) was subjected
to acetic acid (3 mL), acetic anhydride (3 mL) and concentrated sulfuric acid (0.4
mL). After stirring at 4 ◦C in cold room for 16 h, the reaction was quenched by
adding saturated sodium bicarbonate solution. After routine work-up, purifica-
tion of the organic extracts using flash chromatography (silica gel; EtOAc/hexanes
(1:1)) gave 2-39 (C22H30O15; 0.075 g, 71%) in a white solid form as a mixture of α
: β isomers (9:2 ratio). 1H NMR (CDCl3, 400 MHz) δ (ppm) α anomer: 6.35 (1 H,
d, J1,2 = 3.0 Hz, H1), 5.43 (1 H, dd, J6,7 = 3.0 Hz, J5,6 = 1.5 Hz, H6), 5.32–5.27 (3
H, m, H2, H3 and H7), 5.18 (1 H, dd, J4,5 = 10.0 Hz, J3,4 = 3.0 Hz, H4), 4.33 (1 H,
dd, J4,5 = 10.0 Hz, J5,6 = 1.5 Hz, H5), 4.27 (1 H, dd, J7,8a = 3.0 Hz, J8a,8b = 12.0 Hz,
H8a), 4.10 (1 H, dd, J7,8b = 8.0 Hz, J8a,8b = 12.0 Hz, H8b), 2.17 (3 H, s, OAc), 2.08 (3
H, s, OAc), 2.04 (3 H, s, OAc), 2.02 (3 H, s, OAc), 2.01 (3 H, s, OAc), 1.97 (3 H, s,
OAc), 1.96 (3 H, s, OAc). 13C NMR (CDCl3, 100 MHz) δ (ppm) α anomer: 170.7,
170.6, 170.4, 170.04, 169.99, 169.4, 169.0, 89.6, 71.0, 70.0, 67.9, 67.5, 66.6, 66.4, 62.0,
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21.00, 20.94, 20.79, 20.77, 20.73, 20.67. ESI-HRMS Calcd. for C22H30O15[M + Na]
+
557.1482; Found: 557.1477.
1H NMR (CDCl3, 400 MHz) δ (ppm) β anomer: 5.62 (1 H, d, J1,2 = 8.0 Hz, H1), 5.38
(1 H, dd, J6,7 = 3.5 Hz, J5,6 = 1.5 Hz, H6), 5.32–5.27 (3 H, m, H2, H3 and H7), 5.06 (1
H, dd, J3,4 = 3.5 Hz, J4,5 = 10.5 Hz, H4), 4.34–4.32 (1 H, m, H5), 4.16 (1 H, dd, J7,8a =
5.5 Hz, J8a,8b = 12.0 Hz, H8a), 3.91 (1 H, dd, J7,8b = 7.5 Hz, J8a,8b = 12.0 Hz, H8b), 2.12
(3 H, s, OAc), 2.10 (3 H, s, OAc), 2.07 (3 H, s, OAc), 2.03 (3 H, s, OAc), 2.03 (3 H, s,
OAc), 2.00 (3 H, s, OAc), 1.95 (3 H, s, OAc).
2.2.6 Mosher’s Ester Analysis
Determination of C6-(R) configuration of compound 2-21.
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Figure 2.5: Preparation of (S)- and (R)-MTPA esters of 2-21 and 2-33 for stereochemical
analysis.
To determine the C6 configuration of 2-21, the (S)- and (R)-MTPA (α-methoxy-
α-trifluoromethylphenylacetic acid) ester (2-40 and 2-41) were prepared (Figure 2.5,
Table 2.1).122 To a stirred solution of alcohol 2-21 (75.5 mg, 0.15 mmol) and an-
hydrous pyridine (0.4 mL) in anhydrous chloroform (1 mL) at room tempera-
ture, R-(−)-MTPA-Cl (61 mg, 0.24 mmol) was added. The reaction mixture was
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Table 2.1: Mosher’s ester analysis for C-6 configuration determination of 2-21 and 2-33.
∆δ = δS − δR.
δS 2-40 δR 2-41 ∆δ δS 2-42 δR 2-43 ∆δ(ppm) (ppm) (ppm) (ppm)
H7 5.89 5.79 + 0.10 5.82 5.78 + 0.04
H8trans 5.27 5.23 + 0.04 5.41 5.30 + 0.11
H8cis 5.33 5.23 + 0.10 5.34 5.26 + 0.08
H1 4.50 4.56 − 0.06 4.58 4.60 − 0.02
H3 3.96 4.00 − 0.04 3.82 3.87 − 0.05
H5 3.77 3.91 − 0.14 3.70 3.73 − 0.03
OMe 3.01 3.29 − 0.28 3.25 3.27 − 0.02
H2 3.37 3.42 − 0.05 3.97 4.00 − 0.03
H4 3.28 3.39 − 0.11 3.70 3.79 − 0.09
stirred at room temperature and the progress of the reaction was monitored by TLC
(EtOAc/hexanes (1:4)). After the consumption of the starting material was com-
pleted (2 h), the reaction was quenched by adding water and dichloromethane.
The aqueous layer was extracted with dichloromethane (3×) and the combined
organic layers were dried over anhydrous Na2SO4. After the volatiles were re-
moved by rotary evaporation, the crude product was purified using flash chro-
matography (silica gel; EtOAc/hexanes (1:9→1:4)) to yield the (S)-MTPA ester 2-40
(C40H41F3O8) as a colorless solid; TLC (EtOAc/hexanes (1:4)) R f = 0.53.
1H NMR
(CDCl3, 400 MHz) δ (ppm) 7.51–7.26 (20 H, m, Bn×3, Ph-Hs of ester), 5.89 (1 H,
ddd, J6,7 = 8.8 Hz, J7,8cis = 10.4 Hz, J7,8trans = 17.2 Hz, H7), 5.82 (1 H, ddd, J6,8cis
= 1.6 Hz, J5,6 = 2.0 Hz, J6,7 = 8.8, H6), 5.33 (1 H, ddd, J6,8cis = J8cis,8trans = 1.6 Hz,
J7,8cis =10.4 Hz, H8cis), 5.27 (1 H, ddd, J6,8trans = J8cis,8trans = 1.6 Hz, J7,8trans = 17.2
Hz, H8trans), 4.97 (1 H, J = 10.8 Hz, CH2 of Bn), 4.86 (1 H, J = 10.8 Hz, CH2 of Bn),
4.76 (1 H, J = 10.8 Hz, CH2 of Bn), 4.74 (1 H, J = 12.4 Hz, CH2 of Bn), 4.61 (1 H, J =
12.4 Hz, CH2 of Bn), 4.55 (1 H, J = 10.8 Hz, CH2 of Bn), 4.50 (1 H, d, J1,2 = 3.2 Hz,
H1), 3.96 (1 H, dd, J3,4 = 8.8 Hz, J2,3 = 9.6 Hz, H3), 3.77 (1 H, dd, J5,6 = 2.0 Hz, J4,5 =
10.0 Hz, H5), 3.53 (3 H, s, OMe of ester), 3.37 (1 H, dd, J1,2 = 3.2 Hz, J2,3 = 9.6 Hz,
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H2), 3.28 (1 H, dd, J3,4 = 8.8 Hz, J4,5 = 10.0 Hz, H4), 3.01 (3 H, s, OMe).
In an analogous fashion, the (R)-MTPA ester 2-41 was prepared using (S)-(+)-
MTPA-Cl. 1H NMR (CDCl3, 400 MHz) δ (ppm) 7.51–7.23 (20 H, m, Bn×3, Ph-Hs
of ester), 5.79 (1 H, ddd, J6,7 = 7.6 Hz, J7,8cis = 16.4 Hz, J7,8trans = 20.0 Hz, H7), 5.79
(1 H, m, H6), 5.23 (1 H, m, H8trans), 5.23 (1 H, m, H8cis), 4.98 (1 H, J = 10.8 Hz, CH2
of Bn), 4.84 (1 H, J = 10.8 Hz, CH2 of Bn), 4.78 (1 H, J = 10.8 Hz, CH2 of Bn), 4.78
(1 H, J = 12.4 Hz, CH2 of Bn), 4.64 (1 H, J = 12.4 Hz, CH2 of Bn), 4.56 (1 H, d, J1,2 =
3.2 Hz, H1), 4.51 (1 H, J = 10.8 Hz, CH2 of Bn), 4.00 (1 H, dd, J3,4 = 8.8 Hz, J2,3 = 9.2
Hz, H3), 3.91 (1 H, dd, J5,6 = 1.2 Hz, J4,5 = 10.4 Hz, H5), 3.50 (3 H, s, OMe of ester),
3.42 (1 H, dd, J1,2 = 3.2 Hz, J2,3 = 9.2 Hz, H2), 3.39 (1 H, dd, J3,4 = 8.8 Hz, J4,5 = 10.4
Hz, H4), 3.29 (3 H, s, OMe).
Determination of C6-(R) configuration of compound 2-33.
The (S)- and (R)-MTPA esters (2-42 and 2-43) of 2-33 (63 mg, 0.13 mmol)
were prepared according to the same procedure described above for the synthe-
sis of 2-40 and 2-41 using R-(−)-MTPA-Cl (61 mg, 0.24 mmol) (Figure 2.5, Ta-
ble 2.1).122 The reaction mixture was purified using flash chromatography (silica
gel; EtOAc/hexanes (1:9)) to yield (S)-MTPA ester 2-42 (C40H41F3O8) as a colorless
solid; TLC (EtOAc/hexanes (1:4)) R f = 0.30. 1H NMR (CDCl3, 400 MHz) δ (ppm)
7.52–7.25 (20 H, m, Bn×3, Ph-Hs of ester), 5.82 (1 H, ddd, J6,7 = 7.6 Hz, J7,8cis = 10.4
Hz, J7,8trans = 17.2 Hz, H7), 5.66 (1 H, ddd, J6,8cis = 1.2 Hz, J6,7 = 7.6 Hz, J5,6 = 9.2
Hz, H6), 5.41 (1 H, ddd, J6,8trans = J8cis,8trans = 1.2 Hz, J7,8trans =17.2 Hz, H8trans), 5.34
(1 H, ddd, J6,8cis = J8cis,8trans = 1.2 Hz, J7,8cis = 10.4 Hz, H8cis), 4.89 (1 H, J = 10.8 Hz,
CH2 of Bn), 4.78 (1 H, J = 12.4 Hz, CH2 of Bn), 4.74 (1 H, J = 12.0 Hz, CH2 of Bn),
4.64 (1 H, J = 12.0 Hz, CH2 of Bn), 4.64 (1 H, J = 12.4 Hz, CH2 of Bn), 4.58 (1 H, d,
J1,2 = 3.6 Hz, H1), 4.27 (1 H, J = 10.8 Hz, CH2 of Bn), 3.97 (1 H, dd, J1,2 = 3.6 Hz, J2,3
= 10.4 Hz, H2), 3.82 (1 H, dd, J3,4 = 2.8 Hz, J2,3 = 10.4 Hz, H3), 3.70–3.69 (2 H, m,
50
H4, H5), 3.50 (3 H, s, OMe of ester), 3.25 (3 H, s, OMe).
The (R)-MTPA ester 2-43 was prepared in a same manner using (S)-(+)-MTPA-Cl.
1H NMR (CDCl3, 400 MHz) δ (ppm) 7.48–7.25 (20 H, m, Bn×3, Ph-Hs of ester),
5.78 (1 H, ddd, J6,7 = 7.6 Hz, J7,8cis = 10.4 Hz, J7,8trans = 17.6 Hz, H7), 5.63 (1 H, ddd,
J6,8cis = 1.2 Hz, J6,7 = 7.6 Hz, J5,6 = 9.2 Hz, H6), 5.30 (1 H, ddd, J6,8trans = J8cis,8trans =
1.2 Hz, J7,8trans =17.6 Hz, H8trans), 5.26 (1 H, ddd, J6,8cis = J8cis,8trans = 1.2 Hz, J7,8cis
= 10.4 Hz, H8cis), 4.92 (1 H, J = 10.8 Hz, CH2 of Bn), 4.82 (1 H, J = 12.0 Hz, CH2 of
Bn), 4.79 (1 H, J = 12.8 Hz, CH2 of Bn), 4.68 (1 H, J = 12.8 Hz, CH2 of Bn), 4.65 (1
H, J = 12.0 Hz, CH2 of Bn), 4.60 (1 H, d, J1,2 = 3.6 Hz, H1), 4.32 (1 H, J = 10.8 Hz,
CH2 of Bn), 4.00 (1 H, dd, J1,2 = 3.6 Hz, J2,3 = 10.0 Hz, H2), 3.87 (1 H, dd, J3,4 = 2.4
Hz, J2,3 = 10.0 Hz, H3), 3.79–3.78 (1 H, m, H4), 3.73 (1 H, broad d, J5,6 = 9.2 Hz, H5),
3.42 (3 H, s, OMe of ester), 3.27 (3 H, s, OMe).
Determination of C7-(R) configuration of compound 2-24.
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Figure 2.6: Derivatization of diols 2-24 and preparation of (S)- and (R)-MTPA esters of
2-44 for stereochemical analysis.
To determine the C7 configuration of 2-24, this diol compound was first
converted to 2-44 and then derivatized to make the (S)- and (R)-MTPA esters 2-
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Table 2.2: Mosher’s ester analysis for C-7 configuration determination of 2-24. ∆δ =
δS − δR.
δS 2-45 δR 2-46 ∆δ(ppm) (ppm)
OMe 3.21 3.35 −0.14
H1 4.53 4.57 −0.04
H2 3.22 3.35 −0.13
H3 3.83 3.91 −0.08
H4 3.1 3.42 −0.32
H5 3.98 4.11 −0.13
H6 5.48 5.40 0.08
OAc 2.02 2.00 0.02
H7 4.21 4.13 0.08
H8a 4.23 4.02 0.21
H8b 3.79 3.64 0.15
tBu of TBS 0.81 0.78 0.03
Me1 of TBS −0.093 −0.18 0.087
Me2 of TBS −0.193 −0.34 0.147
45 and 2-46 (Figure 2.6, Table 2.2).122 Specifically, compound 2-24 (230 mg, 0.41
mmol) was dissolved in anhydrous DMF (10 mL) and the reaction mixture was
cooled to 0 ◦C. To this solution was added triethylamine (0.20 mL, 1.4 mmol), and
the resulting mixture was stirred at 0 ◦C for 10 min. TBSCl (0.080 g, 0.53 mmol)
was added and the reaction mixture was brought to room temperature slowly.
After stirring for 16 h, the reaction was quenched by adding water and concen-
trated in vacuo. The residue was dissolved in ethyl acetate and the organic solu-
tion was washed with water (1×) and brine (1×), and then dried over anhydrous
Na2SO4. After the volatiles were removed by rotary evaporation under reduced
pressure, the crude product was purified using flash chromatography (silica gel;
EtOAc/hexanes (1:4→1:2)) to yield 2-44 (C38H52O9Si; 0.11 g, 40%) as a colorless
syrup. 1H NMR (CDCl3, 400 MHz) δ (ppm) 7.48–7.37 (15 H, m, Bn×), 5.13 (1 H, J
= 10.8 Hz, CH2 of Bn), 5.10 (1 H, J = 10.8 Hz, CH2 of Bn), 4.95 (1 H, J = 10.8 Hz,
CH2 of Bn), 4.90 (1 H, J = 11.6 Hz, CH2 of Bn), 4.80 (1 H, J = 10.8 Hz, CH2 of Bn),
4.77 (1 H, J = 11.6 Hz, CH2 of Bn), 4.67 (1 H, d, J1,2 = 3.6 Hz, H1), 4.32–4.20 (2 H,
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m, H8a, H8b), 4.16 (1 H, ddd, J7,8a = 2.0 Hz, J6,7 = 6.0 Hz, J7,8b = 8.0 Hz, H7), 4.22
(1 H, dd, J2,3 = J3,4 = 9.2 Hz, H3), 4.06 (1 H, dd, J4,5 = 9.2 Hz, J5,6 = 4.0 Hz, H5),
3.82 (1 H, dd, J4,5 = J3,4 = 9.2 Hz, H4), 3.75 (1 H, dd, J6,7 = 6.0 Hz, J5,6 = 4.0 Hz,
H6), 3.63 (1 H, dd, J1,2 = 3.6 Hz, J2,3 = 9.2 Hz, H2), 3.51 (3 H, s, OMe), 2.16 (3 H, s,
OAc), 0.97 (9 H, s, tBu of TBS), 0.095 (3 H, s, Me of TBS), 0.022 (3 H, s, Me of TBS).
13C NMR (CDCl3, 125 MHz) δ (ppm) 171.3, 171.1, 138.6, 137.97, 137.8, 128.4, 128.3,
128.04, 128.01, 127.9, 127.8, 127.7, 127.5, 97.9, 82.3, 79.9, 79.6, 75.6, 74.8, 74.5, 73.2,
71.9, 67.8, 66.4, 60.3, 55.5, 25.7, 21.0, 20.9, 18.0, 14.1, 4.7, 5.0. ESI-HRMS Calcd. for
C38H52O9Si[M + Na]
+ 703.3278, Found: 703.3276.
The (S)- and (R)-MTPA esters (2-45 and 2-46) of 44 (63 mg, 0.13 mmol) were pre-
pared according to the same procedure described above for the synthesis of 2-40
and 2-41 using R-(−)-MTPA-Cl (61 mg, 0.24 mmol), respectively. 1H NMR (CDCl3,
400 MHz) of 2-45: δ (ppm) 7.57–7.18 (20 H, m, Bn×3, Ph-Hs of ester), 5.48 (1 H,
broad d, J6,7 = 8.0 Hz, H6), 4.94 (1 H, J = 11.0 Hz, CH2 of Bn), 4.75 (1 H, J = 11.0
Hz, CH2 of Bn), 4.75 (1 H, J = 10.5 Hz, CH2 of Bn), 4.71 (1 H, J = 12.0 Hz, CH2 of
Bn), 4.63 (1 H, J = 12.0 Hz, CH2 of Bn), 4.53 (1 H, d, J1,2 = 3.5 Hz, H1), 4.33 (1 H, J
= 10.5 Hz, CH2 of Bn), 4.23 (1 H, dd, J7,8a = 2.0 Hz, J8a,8b = 12.0 Hz, H8a), 4.21 (1 H,
ddd, J7,8a = 2.0 Hz, J7,8b = 5.5 Hz, J6,7 = 8.0 Hz, H7), 3.98 (1 H, broad d, J4,5 = 10.0
Hz, H5), 3.83 (1 H, dd, J3,4 = 9.5 Hz, J2,3 = 10.5 Hz, H3), 3.79 (1 H, dd, J7,8b = 5.5 Hz,
J8a,8b = 12.0 Hz, H8b), 3.62 (3 H, s, OMe of ester), 3.22 (1 H, dd, J1,2 = 3.5 Hz, J2,3 =
10.5 Hz, H2), 3.10 (1 H, dd, J3,4 = 9.5 Hz, J4,5 = 10.0 Hz, H4), 3.21 (3 H, s, OMe), 2.02
(3 H, s, OAc), 0.81 (9 H, s, tBu of TBS), −0.093 (3 H, s, Me of TBS), −0.193 (3 H, s,
Me of TBS).
1H NMR (CDCl3, 400 MHz) of 2-46: δ (ppm) 7.53–6.98 (20 H, m, Bn×3, Ph-Hs of
ester), 5.40 (1 H, broad d, J6,7 = 9.2 Hz, H6), 4.96 (1 H, J = 10.8 Hz, CH2 of Bn), 4.81
(1 H, J = 10.8 Hz, CH2 of Bn), 4.79 (1 H, J = 10.4 Hz, CH2 of Bn), 4.77 (1 H, J = 12.4
Hz, CH2 of Bn), 4.66 (1 H, J = 12.4 Hz, CH2 of Bn), 4.57 (1 H, d, J1,2 = 3.2 Hz, H1),
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4.24 (1 H, J = 10.4 Hz, CH2 of Bn), 4.13 (1 H, ddd, J7,8a = 2.4 Hz, J7,8b = 4.8 Hz, J6,7 =
9.2 Hz, H7), 4.11 (1 H, broad d, J4,5 = 9.6 Hz, H5), 4.02 (1 H, dd, J7,8a = 2.4 Hz, J8a,8b
= 12.0 Hz, H8a), 3.91 (1 H, dd, J3,4 = 9.6 Hz, J2,3 = 9.6 Hz, H3), 3.64 (1 H, dd, J7,8b =
4.8 Hz, J8a,8b = 12.0 Hz, H8b), 3.50 (3 H, s, OMe of ester), 3.42 (1 H, dd, J3,4 = 9.6 Hz,
J4,5 = 9.6 Hz, H4), 3.35 (1 H, dd, J1,2 = 3.2 Hz, J2,3 = 9.6 Hz, H2), 3.35 (3 H, s, OMe),
2.00 (3 H, s, OAc), 0.78 (9 H, s, tBu of TBS), −0.18 (3 H, s, Me of TBS), −0.34 (3 H,
s, Me of TBS).
2.2.7 Peracetylation of the LmbN Products
The purified C-His6-LmbR and C-His6-LmbN were dialyzed against 100
mM NH4HCO3 buffer containing 10 mM MgCl2 at 4
◦C to remove glycerol and
salts. To the enzyme solution was then added R5P (2-52, 10 mM) and F6P (2-12,
10 mM). The final concentration of C-His6-LmbR and C-His6-LmbN were 40 µM
and 50 µM, respectively. As a control experiment, the reaction mixture containing
only C-His6-LmbR and the sugar substrates was similarly prepared. Each reaction
mixture (400 µL) was incubated at 30 ◦C for 4.5 h and an additional 3.5 h at 37 ◦C.
The mixture was then added calf intestinal alkaline phosphatase (CIP)(4 µL, 40
units), and the reaction was incubated at 37 ◦C for 12 h. The resulting solution was
added MeOH (400 µL) and MeCN (800 µL). After mixing the solution, the preciti-
pates were removed by centrifugation at 16,000 × g for 5 min. The supernatant
(400 µL) was evaporated in vacuo using a Speedvac SC100 (Savant). The resultant
residue was completely dried and then treated with anhydrous pyridine (20 µL)
and acetic anhydride (20 µL). This mixture was incubated at room temperature for
12 h, and quenched by the addition of water (150 µL). The peracetylated products
were extracted with ethyl acetate (150 µL) and subjected to HPLC analysis using
an analytical C18 column (4×250 mm). The sample (5 µL) was eluted with a gra-
dient of water (solvent A) and 80% MeCN (solvent B). The gradient was run from
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40-60% B over 15 min, 60-100% B over 5 min with a 3 min wash at 100% B, 100-40%
B over 2 min, followed by re-equilibration at 40% B for 5 min. The flow rate was
set at 1 mL/min and a corona CAD detector was used for the detection. Authen-
tic standards of peracetylated octose derivatives were synthesized (Sections 2.2.4
and ??) and analyzed using the same HPLC method. The recombinant LmbR and
LmbN were prepared by another graduate student, Eita Sasaki.
2.3 Results and Discussion
2.3.1 Proposed Biosynthetic Pathways of Lincomycin A and Celesticetin
To date, two biosynthetic gene clusters from S. lincolnensis strains 78-11115
and ATCC 25466117 were identified to be responsible for the production of lin-
comycins. The overall organizations of these two gene clusters is very similar. The
biosynthetic gene cluster of structurally related celesticetin from S. caeletis ATCC
1584 was disclosed using hybridization analysis.118 The complete sequence of both
clusters are available in the NCBI database (the accession numbers of lincomycin
A and celesticetin biosynthetic gene clusters are EU124663 and GQ844764, respec-
tively).
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Lincomycin A biosynthetic gene cluster (EU124663, 38217 bp)
Celesticetin biosynthetic gene cluster (GQ844764, 36543 bp)
Figure 2.7: Biosynthetic gene clusters of lincomycin A and celesticetin. Homologous
genes found in both cluster are shown in gray.
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Table 2.3: Sequence homology of the proteins found in lincomycin A and celesticetin
biosynthetic pathways
Lincomycin A Celesticetin identity /similarity (%)
LmbC CcbC 56 / 66
LmbD CcbD 56 / 65
LmbE CcbE 60 / 71
LmbF CcbF 40 / 55
LmbIH CcbIH 63 / 71
LmbJ CcbJ 62 / 71
LmbK CcbK 64 / 72
LmbL CcbL 64 / 75
LmbM CcbM 74 / 82
LmbN CcbN 72 / 80
LmbZ CcbZ 64 / 75
LmbP CcbP 59 / 70
LmbO CcbO 65 / 74
LmbS CcbS 74 / 81
LmbR CcbR 69 / 80
LmbQ CcbQ 44 / 54
LmbT CcbT 65 / 76
LmbV CcbV 56 / 68
Sequence analysis of the lincomycin and celesticetin biosynthetic gene clusters
Since the structures of lincomycin A and celesticetin share the same thiooc-
tose core, the genes encoding enzymes involved in the biosynthesis of the thio-
sugar moiety should exist in both clusters and serve similar roles. In fact, sequence
analysis has shown that there are eighteen homologous genes between lmb and ccb
clusters (Figure 2.7, Table 2.3). Naturally, the structural differences of lincomycin
A and celesticetin are reflected by the composition and organization of their re-
spective biosynthetic gene clusters. The genes found exclusively in lmb cluster but
not in ccb cluster are likely involved in the formation of the N-methyl-PPL (2-2)
moiety and the S-methyltransfer at C-1 position. On the other hand, the genes
which are absent in the lincomycin biosynthetic gene cluster are possibly associ-
ated with construction of the salicyloyloxyethyl (SaE, 2-6) substituent attached to
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the C-1 thiol group and the C-7 O-methylation of the octose (Figure 2.1). Here, the
BLAST seach of the protein database was carried out using the primary amino acid
sequence of each protein encoded in the lincomycin A and celesticetin biosynthetic
gene clusters as queries. The results of the sequence similarity analysis are shown
in Table 2.4 † and 2.5.
Table 2.4: Sequence analysis of proteins encoded in lmb gene cluster
Protein Entry Protein homolog Entry identity /number number similarity (%)
LmbA A9Y8R0 Por11 W5QK70 73 / 80
LmbB1 Q54354 SibV C0LTN6 57 / 65
LmbB2 A9Y8R3 D-Tyosine 3-hydroxylase H2JL10 50 / 58
LmbC A9Y8R4 Acyl-CoA synthetase H2JPE3 41 / 52
LmbD A9Y8R5 D-Lactate dehydrogenase A0A085HJV1 37 / 52
LmbE A9Y8R6 MshB R4Z6V6 40 / 51
LmbF A9Y8R7 Aminotransferase class I and II D3Q619 29 / 43
LmbG A9Y8R8 Methyltransferase M7A8U6 33 / 44
LmbIH Q9L6I6 Peptidase U62 Q1IK33 36 / 50
LmbJ A9Y8S0 Methyltransferase type 11 D3D5Y3 42 / 52
LmbK Q54364 Heptose 1,7-bisphosphate phosphatase V4YJX7 51 / 63
LmbL A9Y8S2 UDP-glucose 6-dehydrogenase Q1MNW7 35 / 50
LmbM A9Y8S3 NDP-sugar epimerase H8I9P6 46 / 61
LmbN A9Y8S4 Sedoheptulose 7-phosphate isomerase A9GWB8 41 / 56
LmbZ A9Y8S5 Oxidoreductase family U2QFS7 44 / 59
LmbP A9Y8S6 GHMP kinase R4Z470 37 / 52
LmbO A9Y8S7 Nucleotidyl transferase W9HCS3 39 / 53
LmbS A9Y8S8 PLP-dependent transferase A0A0A1VLN6 49 / 62
LmbR A9Y8S9 Transaldolase D5UDL8 45 / 62
LmbQ A9Y8T0 Protein pmbA G8S2W9 29 / 40
LmbT A9Y8T1 Glycosyltransferase C4U8A9 24 / 43
LmbV A9Y8T2 Uncharacterized protein W2ETW6 43 / 51
LmbW A9Y8T3 Methyltransferase A8W7D8 78 / 85
LmbX Q54378 TomK C0LTT2 49 / 60
LmbY Q54379 F-420 dependent reductase H0BQJ4 55 / 67
LmbU Q54380 Uncharacterized protein A0A075V0A8 56 / 70
†The homologous proteins were searched in organisms excluding strains of S. lincolnenses and
S. caelestic.
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Table 2.5: Sequence analysis of proteins encoded in ccb gene cluster
Protein Entry Protein homolog Entry identity /number number similarity (%)
Ccb1 E9JES1 Diacylglycerol O-acyltransferase W5QK70 35 / 44
Ccb2 E9JET8 CoA ligase B0BLM7 56 / 67
Ccb3 E9JET9 Anthranilate synthase component I A4FD46 57 / 69
Ccb4 E9JEU0 O-methyltransferase D2QXN7 39 / 60
Ccb5 E9JEU1 Alcohol dehydrogenase A0A024YV11 68 / 78
Biosynthesis of the 4-propyl-L-proline moiety (2-4)
Feeding experiments using L-[1-14C]-tyrosine indicated that seven of the
nine carbons in the propylproline unit are derived from tyrosine.123 The other two
carbons, including the N-methyl and terminal aliphatic side chain, are possibly
transferred from SAM. The results of the radio-tracing experiments with D-[13C6]-
glucose had led to a proposed pathway starting from L-tyrosine (2-47). The early
steps may involve the formation of L-3,4-dihydroxyphenyl-alanine (DOPA, 2-48),
followed by a 2,3-extradiol cleavage to yield five-membered ring amino acid pre-
cursor of lincomycin A (2-1).123 These two steps are likely catalyzed by LmbB2
and LmbB1. The availability of lincomycin A biosynthetic gene cluster allows the
biochemical characterization of LmbB2 and LmbB1 (Table 2.4).124,125
These first two biosynthetic steps resemble those observed in the biosynthe-
sis of pyrrolo[1,4]benzodiazepine antibiotics, sibiromycin, anthramycin, tomay-
mycin, and a highly modified depsipeptide hormaomycin (Table 2.6).126–129 Com-
parison of their gene clusters led to the functional assignments of LmbX, LmbW,
LmbA and LmbY (Figure 2.8). Specifically, LmbX may act as a potential hydrolase
catalyzing the C–C bond cleavage of the LmbB1-product (2-49) to yield the diene
(2-50), which is subsequently methylated by a putative SAM-dependent methyl-
trasnferase, LmbW. A mutant of the lincomycin producing strain impaired in the
biosynthesis of F-420 cofactor accumulated the diene (2-51), suggesting that LmbY
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(a putative F-420-dependent oxidoreductase) may mediate the reduction of the di-
ene system.130 LmbA, which is a putative γ-glutamyl transpeptidase, is possibly
involved in the maturation process of F-420 cofactor.
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Figure 2.8: (A) Natural products containing the PPL moiety. (B) Proposed biosynthesis of
the PPL moiety.
Biosynthetic precursors of the octose
The proposed overall biosynthetic pathway of lincomycin A is depicted in
Figure 2.9. A putative transaldolase, LmbR, has been proposed to catalyze the con-
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Table 2.6: Enzyme homologs from the lincomycin A, antramycin, sibiromycin,
tomaymycin and hormaomycin biosynthetic pathways.
Homologs found in the gene clusters
Lincomycin A LmbB2 LmbB1 LmbX LmbW LmbA LmbY
Antramycin ORF13 ORF12 ORF15 ORF5 ORF6 ORF14
Sibiromycin SibU SibV SibS SibZ SibY SibT
Tomaymycin TomI TomH TomK TomL TomJ
Hormaomycin HrmE HrmF HrmC HrmD HrmG
densation of a C5 and a C3 units to form the eight-carbon skeleton of lincomycin A
(Figure 2.2B). However, the exact identities of these two biosynthetic precursors are
unknown. The results of feeding experiments suggested that the C5 unit is likely
an intermediate from pentose phosphate pathway, such as D-ribose 5-phosphate
(R5P, 2-52) or D-xylose 5-phosphate (X5P, 2-53). In addition, the C3 unit may be
derived from S7P (2-11) or D-fructose 6-phosphate (F6P, 2-12) as observed in the
transaldolase reaction in the pentose phosphate pathway (Figure 2.2A).
Biosynthesis of the NDP-octose
The fact that several genes homologous to those found in various NDP-
deoxyhexose pathways exist in the lmb gene cluster prompted us to hypothesize
that an NDP-activated octopyranose (2-57) is a possible intermediate in the MTL
biosynthetic pathway.115,117 However, this hypothesis lacks literature precedence
because NDP-octose has never been reported as an biosynthetic intermediate.
In a typical NDP-sugar biosynthetic pathway, the sugar precursor is first
converted to the corresponding sugar 1-phosphate prior to nucleotidyl transfer to
yield the NDP-sugar (Figure 2.10). For the biosynthesis of NDP-deoxyhexoses,
generation of the hexose 1-phosphate is achieved either by direct C-1 phosphory-
lation or C-6 phosphorylation followed by a mutase-catalyzed 6→1 migration (2-
64→2-65, Figure 2.10A).11 A different scenario was observed in the biosynthesis of
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Figure 2.9: Proposed biosynthesis of the MTL moiety
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NDP-heptose (Figure 2.10B).57 Biosynthetic studies of ADP-D-glycero-β-D-manno-
heptose (ADP-D-β-D-heptose, 2-70) and GDP-D-glycero-α-D-manno-heptose (GDP-
D-α-D-heptose, 2-73) revealed a kinase/phosphatase cascade to produce heptose
1-phosphate in three steps:
1. Isomerization of S7P to D-glycero-D-manno-heptose (2-11→2-67).
2. Anomeric phosphorylation of 2-67 to heptose 1,7-bisphosphate by a kinase
(2-67→2-68 and 2-67→2-71).
3. Hydrolysis of the C-7 phosphate group to give heptose 1-phosphate cat-
alyzed by a phosphatase (2-68→2-69 and 2-71→2-72).
Sequence analysis of the lmb cluster found no mutase homolog required for
installation of the C-1 phosphoryl group via a CN →C1 migration route. However,
comparison of the lmb gene cluster with the NDP-heptose biosynthetic gene clus-
ters from Aneutinibacillus thermocerophilus DSM 10155/G+131 and E. coli K-12132
showed several genes, including lmbN, lmbP, lmbK and lmbO, whose translated
amino acid sequences have similarities to those involved in NDP-heptose biosyn-
thesis (Table 2.7). From this information, it is speculated that MTL biosynthesis
may follow a kinase/phosphatase cascade analogous to that observed in the NDP-
heptose biosynthetic pathway (Figure 2.10) involving LmbP, LmbK and LmbO to
produce the NDP-octose intermediate (2-57) (see Figure 2.9).
Table 2.7: Sequence analysis of the genes in lincomycin A and LPS biosyntheses.
LmbN LmbP LmbK LmbO
GDP-D-α-D-heptose GmhA HddA GmhB HddC
(2-73) 26 / 43 23 / 41 25 / 42 27 / 47
ADP-L-β-D-heptose GmhA HldE GmhB HldE
(2-70) 31 / 47 none 32 / 47 none
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Enzymatic modifications of NDP-octose
BLAST analysis revealed that lmbL, lmbM and lmbS share sequence homol-
ogy with those involved in various NDP-sugar pathways (Table 2.4). In addition
to the C-1 sulfur transfer, to convert NDP-octose (2-26) to MTL, three additional
enzymatic modifications can be envisioned: C-4 epimerization, C-6 amination and
C-8 dehydration (Figure 2.9). It is thus proposed that LmbM, an epimerase ho-
molog, may catalyze the C-4 epimerization. The C-6 oxidation and C-8 dehydra-
tion are possibly catalyzed by a putative NDP-sugar dehydrogenase, LmbL, or a
putative oxidoreductase, LmbZ, and the reaction mechanism should be reminis-
cent to that of TDP-glucose 4,6-dehydratase. However, the order of C-4 epimer-
ization and C-8 dehydration is uncertain. Installation of the amino group at C-6
position catalyzed by an aminotransferase homolog (LmbS) is believed to be the
last NDP-octose modification step. The above three modifications are proposed to
occur prior to C-1 sulfur transfer, because the translated products of lmbM, lmbL
and lmbS share the binding motif recognizing the NDP group.
Proposed pathway of sulfur incorporation at C-1 position
A glycosyltransferase homolog, LmbT, is proposed to incorporate a sul-
fur donor into the C-1 position of NDP-octose (Figure 2.9). One possible sulfur
donor is L-cysteine. To convert the thio-substituent to the free C1-thiol interme-
diate (2-63), LmbF, a PLP-dependent aminotransferase homolog, is proposed to
cleave the C–S bond of intermediate 2-62. Finally, a methyltransferase homolog,
LmbG, would complete the MTL biosynthesis (Figure 2.9).
An alternative sulfur donor for LmbT is mycothiol (MSH, 2-74). This hy-
pothesis is based on the finding that LmbE shows moderate sequence similarity to
MshB, a N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-D-glucopyranoside (GlcNAc-
Ins) deacetylase, and Mca, a mycothiol S-conjugate amidase (Table 2.4, Figure 2.11).
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Both enzymes, MshB and Mca, have been shown to be involved in the MSH biosyn-
thesis or MSH-conjugate catabolism.133 Therefore, the hypothetic MSH S-conjugate
(2-75) could be hydrolyzed by LmbE to give an intermediate (2-76).133 The subse-
quent deacetylation might also be catalyzed by LmbE or an unknown cytosolic
enzyme to yield the sugar-cysteine conjugate (2-62) (Figure 2.11).
MSH (2-74)
LmbTOHO
HO
OHH2N
HO
ONDP
Me
2-61
O
HO
HO
OHH2N
HO
S
Me
2-75 NHAc
O
HO
HO
OH
O
OH
OH
OH
OH
HO
HN
O
NHAc
HS O
NHR
LmbE OHO
HO
OHH2N
HO
S
Me
2-76 NHAc
O
O
Cytosolic
deacetylase
or LmbE OHO
HO
OHH2N
HO
S
Me
2-62 NH2
O
O
LmbV?
Figure 2.11: Mycothiol as an alternative sulfur donor.
In addition, the protein sequence of LmbV contains a MSH-dependent ma-
leylpyruvate isomerase (MDMPI) domain (Table 2.4). From the results of con-
served domains search, LmbV is classified as the member in the DinB superfam-
ily (Din represents the abbreviation of DNA damage-inducible), which contains 8
members so far. Among them, the domains DinB 2 and DUF664 have been found
in the known mycothiol and bacillithiol S-trasnferases, respectively.134 If MSH is
the sulfur donor, LmbV may serve as an activator enhancing the nucleophilicity of
the thiol group and catalyze the sulfur incorporation together with LmbT, which
recognizes the NDP-sugar and generates the oxocarbenium intermediate.
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Biosynthesis of celesticetin
Based on the sequence analysis shown in Table 2.5 and the discussion of
sulfur incorporation above, a modified biosynthetic pathway of SaE moiety (2-
6) in celesticetin is proposed (Figure 2.12). The sulfur transfer and later trans-
formation steps are speculated to produce intermediate (2-62) are believed to be
the same as as in lincomycin A biosynthesis (Figure 2.9). However, the fate of
the the sugar-cysteine conjugate (2-62) may divert due to different reactions car-
ried out by LmbF and CcbF in lincomycin A and celesticetin pathways, respec-
tively. (Figure 2.12). LmbF is annotated as a putative PLP-dependent aminotran-
ferase with 40% identity and 55% similarity to CcbF. While LmbF is proposed to
serve as a lyase to cleave the C–S bond (Figure 2.12A), CcbF may execute decar-
boxylation and aminotransfer to give 2-77 (Figure 2.12B). The resulting aldehyde
(2-77) can then be further reduced to alcohol (2-78) by Ccb5, a putative NADP-
dependent alcohol dehydrogenase. Ccb3 and Ccb2 display similarity to salicylate
synthase and salycyl-AMP ligase, respectively. Ccb1, annotated as diacylglycerol
O-acyltransferase, may catalyze the formation of SaE moiety (2-80) by ligating 2-78
with salicyl-AMP (2-79).
Amide bond formation between the amino acid and sugar moieties
The formation of the amide bond between the carboxylate group of PPL
(2-4) and the amino group of MTL (2-3) is believed to occur in later stages of the
biosynthesis of lincomycin A. It has been demonstrated that the cell-free extracts of
S. lincolnensis could catalyze an ATP-dependent, but ribosome-independent con-
densation reaction.135 After fractionization of the crude extract through a size-
exclusion column, no single fraction showed the condensation activity, which al-
ternatively could be restored by combining specific fractions. This observation
indicated that the nature of the condensation system may be an enzyme complex
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of several subunits.
Sequence analysis of the lincomycin gene cluster indicates that LmbC/CcbC
shows a sequence homology to adenylation domains (A-domains). Adenylation
domain is one of the three core domains in a minimal nonribosomal peptide syn-
thetase (NRPS) module.136 In an assembly line of NRPS, peptide bond formation
occurs on an elongating peptidyl chain attached to a carrier protein or thiolation
domain (T-domain). The A-domain is responsible for selecting the amino acid
monomer and the condensation domain (C-domain) catalyzes the C–N bond for-
mation. The fact that LmbC/CcbC contains an A-domain suggests that they may
activate the carboxyl groups of the recognized amino acids (Table 2.4). A recent
publication indeed demonstrated that LmbC and CcbC are capable of adenylating
propylproline and proline, respectively.137
The similarity of the amide bond formation within lincomycin A biosyn-
thesis and NRPS prompts us to search for the missing T- and C-domain in lmb
biosynthetic gene cluster. The search of homologous sequence of LmbD/CcbD
using BLAST in database returned absurd prediction of the enzymatic function.
Although these two proteins display high mutual sequence homology (identity
/ similarity = 56% / 65%, page 56), no significant homology could be found
in the known sequences in database. However, the fragments of LmbD actu-
ally showed slight homology (>30%) to fusaric acid resistance protein (residue
153-294), NRPS thioesterase (residue 132-306) and UDP-MurNAc-Ala-Glu ligase
(residue 230-342). Fusaric acid exhibits a similar chemical structure as that of
propylproline, which is the amino acid moiety of lincomycin A. Moreover, the un-
derstandings of the enzyme mechanisms of NRPS thioesterase and ligase led to the
proposal that LmbD, annotated as hypothetical protein, may serve as the putative
C-domain (Figure 2.13A).
Interestingly, the DNA sequence coding for a putative T-domain is found in
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the 5′-terminal part of lmbN gene in the lincomycin cluster, whereas in celesticetin
cluster, the putative T-domain is located in the 3′-terminal part of the ccbZ gene,
and is right next to the ccbN gene (Figure 2.13B). Thus, LmbN may be a bi-functional
protein playing different roles in two separate stages of lincomycin A biosynthesis.
The C-terminal motif is proposed to show isomerization activity in the formation
of MTL and the N-terminal domain serves as a peptidyl carrier protein (PCP) re-
quired for the amino acid condensation.
1 351
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Figure 2.13: (A) Sequence analysis of LmbD. (B) Bi-functional protein LmbN.
2.3.2 Functional Characterization of LmbR
To verify the proposed transalsolase activity of LmbR (Figure 2.2), the re-
combinant C-terminal His6-tagged LmbR was overexpressed in E. coli and puri-
fied. The mechanism of transaldolase reaction can be divided into two half re-
actions (Figure 2.14).138 The first half reaction involves the formation of a Schiff
base intermediate between the C2-keto group of the ketosugar substrate (F6P or
S7P) and a lysine residue of the enzyme. Then, the cleavage of Cα–Cβ bond via
a retro-aldol reaction results in a C3 unit covalently trapped in the enzyme active
site.
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To examine whether S7P (2-11) is a competent C3 donor for the LmbR-
catalyzed reaction, the purified enzyme was incubated with S7P (2-11) followed
by the reduction with sodium borohydride treatment. The reaction mixture was
subjected to MS analysis. Under this condition, MS signals corresponding to the
reduced forms of the C-His6-LmbR/S7P conjugate (reduced 2-81, calcd. 25231 Da;
obsd. 25231 Da) and C-His6-LmbR/dihydroxyacetone conjugate (reduced 2-82,
calcd. 25026 Da; obsd. 25030–25045 Da broad peak) were observed in addition
to the unmodified enzyme (Figure 2.15). This result indicate that S7P (2-11) is
a possible substrate of LmbR and the reaction proceeds in a similar manner as
other transaldolases involving the formation of an imine adduct followed by Cα–
Cβ bond cleavage via a retro-aldol reaction (Figure 2.14). The resulting C3 unit
bound in the active site of LmbR was later shown to react with R5P (2-52) to yield
an octulose 8-phosphate by another graduate student, Eita Sasaki, and the results
were published elsewhere.139
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Figure 2.15: Deconvoluted ESI-MS of C-His6-LmbR. (A) C-His6-LmbR treated with
NaBH4. (B) C-His6-LmbR in the presence of S7P (2-11) treated with NaBH4. Reduced
C-His6-LmbR/S7P conjugate (reduced 2-81, calcd. 25231 Da; obsd. 25231 Da); reduced
C-His6-LmbR/dihydroxyacetone conjugate (reduced 2-82, calcd. 25026 Da; obsd. 25030–
25045 Da). The broad peaks were not well-resolved due to the weak signal intensity and
the limitation of instrument.
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2.3.3 Stereochemical Analysis of LmbN-product
While it has been demonstrated that the recombinant LmbN can isomerize
the ketosugar product, resulting from LmbR-catalyzed reaction, to an aldose,139
the stereochemistry of the C-4 hydroxyl group remains elusive. The sterochemistry
uncertainty is due to the stereoselectivity of LmbR-catalyzed transaldol condensa-
tion. Based on the general stereochemistry established for most aldolase-catalyzed
reaction, the resulting octulose 8-phosphate is expected to inherit the stereochem-
istry at the C-3 and C-4 positions from the corresponding chiral centers of the C3
donor (Figure 2.14).138 This would yield an octose intermediate having C3-(S) and
C4-(R) configuration (2-83). However, the C4-(R) configuration is in contrast to the
C4-(S) configuration of the final product, MTL (2-3). This is the reason why we
proposed a putative C4-epimerase (encoded by the lmbM gene) may participate
in the later stage of lincomycin A biosynthetic pathway (Figure 2.9). Neverthe-
less, reactions catalyzed by aldolases giving the inverse sterochemistry are also
known.140 It is thus possible that the LmbR-catalyzed reaction may generate an
octose intermediate with C4-(S) hydroxyl group (2-85).
In order to fully characterize the LmbR and LmbN reactions, the stereo-
chemistry of the C-4 hydroxyl group has to be determined. Although a small
amount of enzymatic product could be isolated for MS analysis, it was difficult
to secure sufficient amounts for NMR characterization. Thus, we opted to chem-
ically synthesize the peracetylated C4-(R)- and C4-(S)-octose standars (2-27 and
2-39, respectivtly (Figure 2.3 and 2.4). For comparative analysis, the LmbR prod-
ucts were treated with alkaline phosphatase (to remove phosphate groups) and
the resulting sugars were peracetylated using acetic anhydride under basic con-
dition. The derivatized enzymatic product mixtures and the synthetic standards
were then analyzed by HPLC.
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Figure 2.16: (A1) & (B1) Control reaction with F6P (2-12) after dephosphorylation and
acetylation. (A2) & (B2) LmbR reaction after dephosphorylation and acetylation. (A3) &
(B3) LmbR and LmbN reactions after dephosphorylation and acetylation. (A4) Synthetic
standard 2-39. (A5) Coinjection of the sample derived from LmbR and LmbN reaction, and
the synthetic standard 2-39. (B4) Synthetic standard 2-27. (B5) Coinjection of the sample
derived from LmbR and LmbN reaction, and the synthetic standard 2-27.
As shown in Figure 2.16, two sets of signals (retention times ∼13.5 and
∼17.5 min) arise from the LmbR reaction (trace A2). The first set of two peaks
matches the signals observed for the control reaction, which generate pentaacety-
lated fructose as the product (trace A1). The splitting peak pattern likely reflects
the formation of α and β anomers during chemical derivatization. The second
set of two peaks (retention time ∼17.5 min, trace A2) can be attributed to the the
octulofuranose heptaacetate derived from the LmbR product (2-83). When both
LmbR and LmbN were used, a new peak with a retention time of∼18 min emerged
(trace A3). The MS analysis of this new peak agreed with the peracetylation deriva-
tive of the proposed LmbN product (2-84). Importantly, the retention time of this
peak matches that of the C4-(R) standard 2-27 (trace B4). Moreover, this product
and 2-27 coeluted when coinjected (trace B5). In contrast, the C4-(S) isomer (2-
39) eluted with a longer retention time (trace A4) than the peracetylated LmbN
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product (trace A4). These results unambiguously show that the C-4 position of the
LmbR/N reaction products has a (R)-configuration (Figure 2.14, route a).
2.4 Conclusion
In this chapter, the biosynthetic pathway of lincomycin A was proposed
based on the results from feeding experiments documented in the literature and
bioinformatic analysis. Moreover, our biochemical characterization of the two ini-
tial enzymatic steps in the MTL biosynthetic pathway led to the identification of an
important intermediate, D-erythro-D-gluco-octose 8-phospahte. Our experiments
demonstrated that this intermediate is formed via a transaldol reaction catalyzed
by LmbR. Subsequent 1,2-isomerization catalyzed by LmbN could convert the re-
sulting 2-ketose, octulose 8-phosphate, to an aldose, octose 8-phosphate. These
results are consistent with our proposed biosynthetic pathway of lincomycin A
(Figure 2.9). The HPLC analyses using the chemically synthesized peracetylated
octoses also supported the predicted functions of enzymes. More importantly, this
piece of information provides, for the first time, in vitro evidence for the biosyn-
thetic origin of the eight-carbon backbone of MTL, and lays a solid foundation for
later biosynthetic studies of lincomycin A.
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Chapter 3
Biosynthetic Studies of Lincomycin A (II): Formation
of the GDP-Octose Intermediate∗
3.1 Introduction
Having confirmed the biosynthetic origin of the thiooctose moiety in lin-
comycin A biosynthesis firmly lays a cornerstone supporting our proposed path-
way. In addition to the identification of octose 8-phosphate intermediate, the char-
acterization of LmbR and LmbN integrates the results of early feeding experiments
and updated bioinformative analysis. This piece of evidence, in turns, allows us to
pursue further investigation for lincomycin A biosynthesis.
Lincomycin A contains a highly modified sugar moiety, which is likely fab-
ricated through intensive enzymatic transformations of an unmodified octose pre-
cursor. Moreover, the sulfur incorporation is predicted to proceed in a similar
manner as the assembly of activated sugars with aglycon substrates catalyzed by
glycosyltransferase. In order to covert the unmodified octose to an intermediate
which could be used by the biosynthetic enzymes and glycosyltransferases, the
monosaccharaide must be activated as a nucleoside diphosphate (NDP) deriva-
tive. In the biosynthesis of secondary metabolites, activation usually involves the
coupling of a sugar 1-phosphate to an nucleoside monophosphate (NMP) moiety
∗Partial content of this chapter was published as “In vitro Characterization of LmbK and LmbO:
Identification of GDP-D-erythro-D-gluco-Octose as a Key Intermediate in Lincomycin A Biosynthe-
sis” Lin,C.-I; Sasaki, E.; Zhong, A.; Liu, H.-w., J. Am. Chem. Soc., 2014, 136, 906–909. The exper-
iments were designed and performed by C.-I L. One of the enzymes was prepared by E. S. One
of the substrates was synthesized by C.-I L. with the help from Z. A. This research project was
supervised by H.-w. Liu.
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from the corresponding nucleoside triphosphate (NTP) by a nucleotidylyltrans-
ferse.141
Based on the above-mentioned information and the sequence analysis of
the lmb gene cluster discussed in Chapter 2, we speculated that a NDP-octose in-
termediate manufactured via a kinase/phosphatase cascade may participate in the
biosynthesis of lincomycin A (Figure 3.1). After LmbN catalyzes the isomeriza-
tion to produce the corresponding octose 8-phosphate (3-1),139 the putative kinase,
LmbP, may phosphorylate the C-1 hydroxyl group of octose 8-phosphate (3-1) to
afford octose 1,8-bisphosphate (3-2). The C-8 phosphate group of this bisphos-
phate intermediate might be hydrolyzed by LmbK (annotated as phosphatase) to
give octose 1-phosphate (3-3), which is then converted to the nucleotide-activated
octose (3-5) by LmbO (annotated as nucleotidylyltransferase) (route a). It is also
conceivable that the reaction proceeds first with nucleotidylyltransfer by LmbO (3-
2→ 3-4) followed by LmbK-catalyzed C-8 dephosphorylation (3-4→ 3-5) (route b).
Because LmbP and LmbO exhibit sequence similarities only to their counterparts
in the GDP-D-α-D-heptose biosynthetic pathways (Table 2.7 in page 63), the C-1
activated octose intermediate in lincomycin biosynthesis is likely a GDP-octose.
However, it is well known that prediction of substrate specificity for enzymes
based solely on sequence alignment can be erroneous,10 and thus the chemical na-
ture of sugar phosphodinucleotide intermediate in the lincomycin A biosynthetic
pathway must be experimentally verified.
3.2 Experimental Procedures
3.2.1 General
Materials
All chemicals and reagents were purchased from Sigma-Aldrich Chemical
Co. (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) and were used without
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Figure 3.1: Proposed pathway for NDP-octose formation in MTL biosynthesis.
further purification unless otherwise specified. Oligonucleotide primers were pre-
pared by Integrated DNA Technologies (Coralville, IA). Kits for DNA gel extrac-
tion and spin minipreps were purchased from Qiagen (Valencia, CA). PureLink® Ge-
nomic DNA Mini Kit was bought from Invitrogen (Carlsbad, CA). KOD NDA
polymerase was acquired from Novagen (Madison, WI). Enzymes and molecu-
lar weight standards used for the cloning experiments were obtained from New
England Biolabs (Ipswich, MA). Reagents for sodium dodecyl sulfate polyacry-
lamide gel electrophoresis (SDS-PAGE) were purchased from Bio-Rad (Hercules,
CA), with the exception of the protein molecular weight markers, which were ob-
tained from Invitrogen. Growth medium components were acquired from Bec-
ton Dickinson (Sparks, MD). Sterile syringe filters are products of Fisher Scien-
tific. Amicon YM-10 ultrafiltration membranes were bought from Millipore (Bil-
lerica, MA). The CarboPac PA1 high-performance liquid chromatography (HPLC)
columns were obtained from Dionex (Sunnyvale, CA). Analytical C18 HPLC columns
are products of Varian (Palo Alto, CA). Simi-preparative C18 HPLC columns were
purchased from Fisher Scientific (Pittsburgh, PA).
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Bacterial Strains and Plasmids
Streptomyces lincolnensis NRRL ISP-5355 (identical to ATCC 25466) and Strep-
tomyces caelestis NRRL 2418 were obtained from the Agricultural Research Service
(ARS) Culture Collection of the National Center for Agricultural Utilization Re-
search (Peoria, IL). Escherichia coli DH5α, acquired from Bethesda Research Labo-
ratories (Gaithersburg, MD), was used for routine cloning experiments. The pro-
tein overexpression host E. coli BL21 star (DE3) was obtained from Invitrogen. Vec-
tors pET28b(+) and pET24b(+) for protein overexpression was purchased from No-
vagen (Madison, WI).
Instrumentation
Standard genetic manipulations of E. coli were performed as described by
Sambrook and Russell.142 DNA sequencing was conducted at the core facility of
the Institute of Cellular and Molecular Biology, The University of Texas at Austin.
Vector NTI Advance 10.1.1 from Invitrogen was used for sequence alignments.
DNA concentrations were measured using a NanoDrop ND-1000 UVvis instru-
ment from Thermo Fisher Scientific. HPLC was performed on a Beckman Coul-
ter System Gold HPLC equipped with a UV detector or a Corona CAD (charged
aerosol detector, ESA Biosciences, Chelmsford, MA). Analytical thin layer chro-
matography (TLC) was carried out on precoated TLC glass plates (silica gel, grade
60, F254, 0.25 mm layer thickness) purchased from EMD chemicals (Madison, WI).
Flash column chromatography was performed on silica gel (40–63 µm, 60 A˚) ob-
tained from SiliCycle Inc (Quebec City, Canada). NMR spectra were acquired us-
ing a Varian Unity 400 MHz, 500 MHz or 600 MHz spectrometer, and chemical
shifts (in ppm) are reported relative to that of the solvent peak (δH = 7.24 and δC
= 77.0 for deuterated chloroform, δH = 4.67 for deuterium oxide). Mass spectra
were recorded at the Mass Spectrometry core facility in the Department of Chem-
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istry and the Proteomics Facility in College of Pharmacy at the University of Texas,
Austin. Optical rotations were measured using an ATAGO AP-300 automatic po-
larimeter at a path length of 1 dm.
3.2.2 Genomic DNA Extraction
S. lincolnensis
Bacterial cells of S. lincolnensis NRRL ISP-5355 (identical to the ATCC 25466
strain) in a dormant state were inoculated into 7 mL of the International Strepto-
myces Project (ISP) medium 2 and grown in a rotary incubator at 30 ◦C and 250
rpm for 16 h. The resultant seed culture (1 mL) was transferred to 50 mL of ISP-2
medium and grown under the same conditions for 2 days. The mycelia were har-
vested by centrifugation at 5000×g for 10 min. The cells were resuspended in 10
mL of TES buffer (25 mM Tris, 25 mM EDTA, and 10.3% sucrose, pH 8) and treated
with lysozyme (15 mg) at 37 ◦C and 250 rpm for 1 h. To the resulting mixture was
added SDS (final concentration 0.3%) and proteinase K (1.5 mg), and the combined
solution was incubated under the same conditions for an additional 1 h. The re-
leased genomic DNA and RNA mixture was isolated through phenol-chloroform
extraction followed by sodium acetate-isopropyl alcohol precipitation. The result-
ing solution was treated with ribonuclease (RNase), and the genomic DNA was
isolated by another round of phenol-chloroform extraction and sodium acetate-
isopropyl alcohol precipitation. The final concentration of the genomic DNA ob-
tained was 160 ng/µL in 200 µL of 10 mM Tris ·HCl buffer (pH 8.5).
S. caelestis
The freeze-dried sample of S. caelestis NRRL 2418 bacterial cells were in-
oculated into 7 mL of the tryptic soy broth (TSB) medium and grown in a rotary
incubator at 30 ◦C and 250 rpm for 24 h. The resultant seed culture (1 mL) was
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transferred to 50 mL of TSB medium and grown under the same conditions for 1
day. The overnight culture (5 mL) was harvested by centrifugation at 4,500×g for
10 min. The cells were resuspended in 360 µL of lysozyme digestion buffer (25 mM
Tris ·HCl pH 8, 2.5 mM EDTA, 1% Triton X-100) and treated with lysozyme (final
concentration 20 mg/mL) at 37 ◦C for 30 min. To the resulting mixture was added
40 µL of proteinase K solution and 400 µL of PureLink™ Genomic Lysis/Binding
buffer supplied with the PureLink® Genomic DNA kit. The combined solution was
incubated at 55 ◦C for 30 min. To the lysate was added 400 µL 96-100% ethanol to
yield a homogenous solution. The lysate (∼ 1.28 mL) was transferred to the Pure-
Link™ Spin column and centrifuged at 10,000×g for 1 min. The flow-through was
discarded. The spin column was washed with 500 µL PureLink™ Wash buffer 1
(1×) and 500 µL PureLink™ Wash buffer 2 (1×) by centrifugation at 10,000×g for
1 min each. The spin column was then placed in a sterile 1.5-mL microcentrifuge
tube and the DNA was eluted with 100 µL of 10 mM Tris ·HCl buffer (pH 8.5). The
final concentration of the genomic DNA obtained was 60.4 ng/µL.
3.2.3 Cloning of lmbP, lmbK, lmbO, ccbP and ccbO
Plasmids containing lmbP, lmbK, lmbO, ccbP and ccbO were constructed by
amplifying the corresponding genes from genomic DNA isolated from S. lincolnen-
sis and S. caelestic with designed primer pairs (Table 3.1). The PCR products were
then digested with NdeI and HindIII and ligated into pET24b(+) and pET28b(+),
which had been digested with the same restriction enzymes. The resulting plas-
mids were sequenced using T7 or T7 terminal universal primer and used to trans-
form the E. coli BL21 star (DE3) for protein overexpression.
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Table 3.1: Primers used for constructing plasmids containing lmbP, lmbK, lmbO, ccbP and
ccbO genes.
Plasmid Primer pair
pET24b(+)-lmbP-CHis6 CIL001 / CIL002
pET28b(+)-lmbP-NHis6 CIL001 / CIL003
pET24b(+)-lmbP CIL001 / CIL003
pET28b(+)-lmbK-NHis6 CIL004 / CIL005
pET24b(+)-lmbO-CHis6 CIL006 / CIL007
pET28b(+)-lmbO-NHis6 CIL006 / CIL008
pET24b(+)-lmbO CIL006 / CIL008
pET24b(+)-ccbP-CHis6 CIL009 / CIL010
pET28b(+)-ccbP-NHis6 CIL009 / CIL011
pET24b(+)-ccbP CIL009 / CIL011
pET24b(+)-ccbO-CHis6 CIL012 / CIL013
pET28b(+)-ccbO-NHis6 CIL012 / CIL014
pET24b(+)-ccbO CIL012 / CIL014
Primer Primer Sequence
a
number name
CIL001 F-lmbP-24/28-NdeI 5′-ATCACTACATATGATCGACGTCACGGCGCC-3′
CIL002 R-lmbP-24-HindIII 5′-TCATAAGCTTTGCCCGCCCCTCTCCG-3′
CIL003 R-lmbP-28-HindIII 5′-TCATAAGCTTTCATGCCCGCCCCTCTCC-3′
CIL004 F-lmbK-24/28-NdeI 5′-ATGTGAACATATGGGACGCGAGGGACAGTCG-3′
CIL005 R-lmbK-28-HindIII 5′-AGATAAGCTTTCAGCGGCCGCCGTGCCCG-3′
CIL006 F-lmbO-24/28-NdeI 5′-ATCACTACATATGGTCGCGTCGACCGAACC-3′
CIL007 R-lmbO-24-HindIII 5′-ATCTAAGCTTTTTCTCACCTGTCCGCAGATAGC-3′
CIL008 R-lmbO-28-HindIII 5′-TCATAAGCTTCGATCATTTCTCACCTGTCCGC-3′
CIL009 F-ccbP-24/28-NdeI 5′-TCTATAACATATGATCACGACCACCGCTCC-3′
CIL010 R-ccbP-24-HindIII 5′-ATATAAGCTT-CGCTGTGCGCACCCCG-3′
CIL011 R-ccbP-28-HindIII 5′-TTACAAGCTTCACGCTGTGCGCACC-3′
CIL012 F-ccbO-24/28-NdeI 5′-TCTATAACATATGGTTGCGCTGCCCGG-3′
CIL013 R-ccbO-24-HindIII 5′-ATATAAGCTT-TATCGTCTCCGCGAATCG-3′
CIL014 R-ccbO-28-HindIII 5′-TTACAAGCTTCATATCGTCTCCGCGAATCG-3′
aThe engineered restriction sites are shown in bold; the start codon is shown in bold and under-
lined; the stop codon is shown in italic.
3.2.4 Protein Overexpression in E. coli
A typical procedure for the overexpression of the N-His6- or C-His6-tagged
proteins was performed. An overnight culture of E. coli BL21 star (DE3) transfor-
mant, grown in the LB medium (10 mL) containing 30 µg/mL of kanamycin at
37 ◦C, was used to inoculate 1 L of the same growth medium. The culture was in-
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cubated at 37 ◦C with shaking (200 rpm) until the OD600 reached ∼0.5. Protein ex-
pression was then induced by the addition of isopropylβ-D-1-thiogalactopyranoside
(IPTG) to a final concentration of 0.1 mM, and the cells were allowed to grow at
37 ◦C and 125 rpm for an additional 24 h. The cells were harvested by centrifuga-
tion at 4000×g for 15 min and stored at −80 ◦C until lysis.
3.2.5 Purification of N-His6-LmbK
All purification steps were carried out at 4 ◦C using Ni-NTA resin accord-
ing to the manufacturer’s protocol with minor modifications. Specifically, the
thawed cells (∼5 g) were resuspended in the lysis buffer (20 mL) containing 50 mM
Tris ·HCl (pH 8), 10% (v/v) glycerol and 10 mM imidazole. After incubation with
lysozyme (20 mg) for 30 min, the cells were disrupted by sonication using 10 ×
10-s pulses with a 20-s cooling pause between each pulse. The resulting lysate was
centrifuged at 20,000×g for 20 min, and the supernatant was subjected to Ni-NTA
chromatography. Bound protein was eluted using 250 mM imidazole buffer con-
taining 10% glycerol. The collected protein solution was dialyzed against 3 × 1-L
of 50 mM Tris ·HCl buffer (pH 8) containing 300 mM NaCl and 15% glycerol. The
protein solution was then flash-frozen in liquid nitrogen and stored at −80 ◦C un-
til use. Protein concentration was determined by the Bradford assay using bovine
serum albumin as the standard.143 The yield of N-His6-LmbK was approximately
40 mg from 1 L culture. The molecular mass and purity of N-His6-LmbK were
determined by SDS-PAGE analysis.
3.2.6 Refolding of N-His6-LmbO from Inclusion Bodies
After the cells were harvested, the cells (∼10 g) were resuspended in 40 mL
of the lysis buffer containing 50 mM Tris ·HCl (pH 8), 10% glycerol and 10 mM im-
idazole. After incubation with lysozyme (40 mg) for 1 h, the cells were disrupted
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by sonication using 10× 10-s pulses with a 20-s cooling pause between each pulse.
The cell lysate was centrifuged at 20,000×g for 20 min, and the supernatant was
discarded. The resulting pelleted inclusion bodies were washed three times with
10 mL of lysis buffer and dissolved in 15 mL of 10 mM Tris ·HCl buffer (pH 8) con-
taining 6 M guanidine and 100 mM NaH2PO4. The solution was incubated with
shaking at 37 ◦C for 1 h and centrifuged at 20,000×g for 20 min to remove insolu-
ble materials. The solublized N-His6-LmbO inclusion bodies (∼60 mg) were then
added dropwise to 40 mL of the refolding buffer composed of 100 mM Tris ·HCl
buffer (pH 8) containing 20% glycerol, 1 M urea, 50 mM NaCl, 400 mM arginine,
and 10 mM dithiothreitol (DTT) with vigorous stirring. This mixture was kept at
4 ◦C with gentle stirring for 20 hr. The collected protein solution was dialyzed
against 1 L of 50 mM Tris ·HCl buffer (pH 8) containing 20% glycerol, 300 mM
NaCl and 1 mM DTT. Afterward, the protein was centrifuged to remove precipi-
tated material and the supernatant was flash-frozen in liquid nitrogen and stored
at −80 ◦C until use. Protein concentration was determined by the Bradford assay
using bovine serum albumin as the standard.143 The molecular mass and purity of
the protein, N-His6-LmbO, were determined by SDS-PAGE analysis.
3.2.7 Synthesis of D-erythro-D-gluco-octose α-1,8-bisphosphate (3-2)
Methyl 2,3,4-tri-O-benzyl-7,8-dideoxy-D-glycero-α-D-gluco-oct-7-enopyranoside
(3-9).
The syntheses of compounds 3-7, 3-8 and 3-9 as illustrated in Figure 3.2 follow the
previously described procedures in Section 2.2.4.
Methyl 2,3,4,6-tetra-O-benzyl-7,8-dideoxy-D-glycero-α-D-gluco-oct-7-enopyrano
-side (3-11).
Compound 3-9 (0.89 g, 1.81 mmole) was dissolved in anhydrous DMF (10 mL)
and cooled to 0 ◦C. The solution was then treated with sodium hydride (60%, 0.25
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Figure 3.2: Synthesis of octose 1,8-bisphosphate (3-2)
84
g, 6.25 mmole) portion-wise and stirred at 0 ◦C for 15 min. Benzyl bromide (0.35
mL, 2.94 mmole) was added slowly and the reaction mixture was brought to room
temperature. After 16 h, the reaction mixture was quenched by adding methanol
slowly and concentrated in vacuo. The resulting residue was mixed with water
and extracted with ethyl acetate (3×). The combined organic layers were dried
over Na2SO4. After the volatiles were removed by rotary evaporation under re-
duced pressure, the crude product was purified using flash chromatography (silica
gel; EtOAC/hexanes (1:9 → 1:4)) to yield 3-11 (C37H40O6, 0.79 g, 75%) as syrup.
TLC (EtOAc/hexanes (1:2)) R f = 0.61. 1H NMR (CDCl3, 400 MHz) δ (ppm) 7.29–
6.99 (20 H, m, Bn×4), 5.83 (1 H, ddd, J6,7 = 8.8 Hz, J7,8cis =10.4 Hz, J7,8trans = 17.2
Hz, H7), 5.25 (1 H, dd, J8cis,8trans = 1.2 Hz, J7,8cis = 10.4 Hz, H8cis), 5.00 (1 H, dd,
J8cis,8trans = 1.2 Hz, J7,8trans = 17.2 Hz, H8trans), 4.92 (1 H, J = 10.8 Hz, CH2 of Bn),
4.76 (1 H, J = 11.2 Hz, CH2 of Bn), 4.70 (2 H, J = 11.2 Hz, CH2 of Bn), 4.59 (1 H, J
= 12.0 Hz, CH2 of Bn), 4.59 (1 H, d, J1,2 = 3.6 Hz, H1), 4.39 (1 H, J = 11.2 Hz, CH2
of Bn), 4.34 (1 H, J = 12.0 Hz, CH2 of Bn), 4.34 (1 H, J = 10.8 Hz, CH2 of Bn), 4.02
(1 H, dd, J5,6 = 1.6 Hz, J6,7 = 8.8 Hz, H6), 3.96 (1 H, dd, J2,3 = 9.6 Hz, J3,4 = 9.2 Hz,
H3), 3.91 (1 H, dd, J5,6 = 1.6 Hz, J4,5 = 10.4 Hz, H5), 3.40 (1 H, dd, J1,2 = 3.6 Hz, J2,3
= 9.6 Hz, H2), 3.36 (3 H, s, OMe), 3.28 (1 H, dd, J3,4 = 9.2 Hz, J4,5 = 10.4 Hz, H4).
13C NMR (CDCl3, 100 MHz) δ (ppm) 138.58, 138.23, 138.12, 138.03, 133.83, 129.39,
128.38, 128.34, 128.31, 128.24, 127.99, 127.90, 127.82, 127.52, 127.33, 120.60, 97.55,
82.25, 80.03, 78.79, 78.07, 75.68, 74.41, 73.19, 72.34, 70.01, 54.93. ESI-HRMS Calcd.
for C37H40O6Na
+ [M + Na]+ 603.2717, found 603.2725.
Methyl 2,3,4,6-tetra-O-benzyl-α-D-erythro-D-gluco-octopyranoside (3-12).
Compound 3-11 (0.79 g, 1.36 mmole) was suspended in 20 mL of co-solvent tBuOH
: H2O (1:1). The mixture was cooled to 4
◦C in the cold room and added AD-mix
α (2.0 g) and methanesulfonamide (0.13 g, 1.37 mmole). The reaction mixture was
stirred at 4 ◦C until the starting material was all consumed as judged by TLC analy-
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sis. The reaction was quenched by adding sodium metabissulfite and then concen-
trated in vacuo. The resulting residue was dissolved in ethyl acetate. The organic
layer was washed with water (1×) and brine (1×), and then dried over Na2SO4.
After the volatiles were removed by rotary evaporation, the crude product was pu-
rified using flash chromatography (silica gel; EtOAC/hexanes (1:2→2:1)) to yield
3-12 (C37H42O8, 0.67 g, 80%) as syrup. TLC (EtOAc/hexanes (1:1)) R f = 0.38.
1H
NMR (CDCl3, 600 MHz) δ (ppm) 7.37–7.24 (20 H, m, Bn×4), 5.02 (1 H, J = 10.8 Hz,
CH2 of Bn), 4.97 (1 H, J = 10.8 Hz, CH2 of Bn), 4.82 (1 H, J = 10.8 Hz, CH2 of Bn),
4.78 (1 H, J = 12.0 Hz, CH2 of Bn), 4.73 (1 H, J = 11.4 Hz, CH2 of Bn), 4.67 (1 H, J =
12.0 Hz, CH2 of Bn), 4.66 (1 H, J = 10.8 Hz, CH2 of Bn), 4.64 (1 H, d, J1,2 = 3.6 Hz,
H1), 4.48(1 H, J = 11.4 Hz, CH2 of Bn), 4.06 (1 H, dd, J5,6 = 1.2 Hz, J4,5 = 10.8 Hz,
H5), 4.03 (1 H, dd, J2,3 = 9.6 Hz, J3,4 = 9.0 Hz, H3), 3.82 (1 H, dd, J3,4 = 9.0 Hz, J4,5 =
10.8 Hz, H4), 3.79 (1 H, ddd, J6,7 = 8.4 Hz, J7,8a = 3.6 Hz, J7,8b = 5.4 Hz, H7), 3.69 (1
H, dd, J5,6 = 1.2 Hz, J6,7 = 8.4 Hz, H6), 3.67 (1 H, dd, J7,8a = 3.6 Hz, J8a,8b = 11.4 Hz,
H8a), 3.55 (1 H, dd, J7,8b = 5.4 Hz, J8a,8b = 11.4 Hz, H8b), 3.53 (1 H, dd, J1,2 = 3.6 Hz,
J2,3 = 9.6 Hz, H2), 3.38 (3 H, s, OMe). 13C NMR (CDCl3, 150 MHz) δ (ppm) 138.58,
138.13, 137.87, 128.52, 128.50, 128.49, 128.47, 128.44, 128.42, 128.39, 128.35, 128.05,
128.01, 127.96, 127.95, 127.93, 127.89, 127.78, 127.66, 97.86, 82.65, 80.22, 79.11, 77.83,
75.79, 75.06, 71.29, 70.34, 55.25. ESI-HRMS Calcd. for C37H42O8Na
+ [M + Na]+
637.2772, found 637.2777.
Methyl 2,3,4,6,7,8-hexa-O-benzyl-α-D-erythro-D-gluco-octopyranoside (3-13).
Compound 3-12 (0.45 g, 0.73 mmole) was dissolved in anhydrous DMF (10 mL)
and cooled to 0 ◦C. The solution was then treated with sodium hydride (60%, 0.10
g, 2.50 mmole) portion-wise and stirred at 0 ◦C for 15 min. Benzyl bromide (0.2
mL, 1.68 mmole) was added slowly and the reaction mixture was brought to room
temperature. After 16 h, the reaction mixture was quenched by adding methanol
slowly and concentrated in vacuo. The resulting residue was mixed with water and
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extracted with ethyl acetate (3×). The combined organic layers were dried over
Na2SO4. After the volatiles were removed by rotary evaporation under reduced
pressure, the crude product was purified using flash chromatography (silica gel;
EtOAC/hexanes (1:9→ 1:4)) to yield 3-13 (C51H54O8, 0.47 g, 81%) as syrup. TLC
(EtOAc/hexanes (1:4)) R f = 0.39. 1H NMR (CDCl3, 600 MHz) δ (ppm) 7.38–7.20
(30 H, m, Bn×6), 4.96 (1 H, J = 10.4 Hz, CH2 of Bn), 4.82 (1 H, J = 10.8 Hz, CH2 of
Bn), 4.81 (1 H, J = 10.4 Hz, CH2 of Bn), 4.79 (1 H, J = 12.0 Hz, CH2 of Bn), 4.72 (1 H,
J = 11.2 Hz, CH2 of Bn), 4.67 (1 H, J = 12.0 Hz, CH2 of Bn), 4.66 (1 H, J = 10.8 Hz,
CH2 of Bn), 4.61 (1 H, d, J1,2 = 3.6 Hz, H1), 4.59 (1 H, J = 11.2 Hz, CH2 of Bn), 4.49
(1 H, J = 11.2 Hz, CH2 of Bn), 4.48 (2 H, J = 12.4 Hz, CH2 of Bn), 4.43(1 H, J = 11.2
Hz, CH2 of Bn), 4.13 (1 H, dd, J5,6 = 1.2 Hz, J4,5 = 10.0 Hz, H5), 3.98 (1 H, dd, J2,3 =
9.6 Hz, J3,4 = 9.2 Hz, H3), 3.88 (2 H, brs, H8a and H8b), 3.82 (1 H, dd, J3,4 = 9.2 Hz,
J4,5 = 10.0 Hz, H4), 3.71 (1 H, dd, J5,6 = 1.2 Hz, J6,7 = 10.0 Hz, H6), 3.62 (1 H, ddd,
J6,7 = 10.0 Hz, J7,8a = 0.8 Hz, J7,8b = 2.4 Hz, H7), 3.47 (1 H, dd, J1,2 = 3.6 Hz, J2,3 = 9.6
Hz, H2), 3.34 (3 H, s, OMe). 13C NMR (CDCl3, 150 MHz) δ (ppm) 138.83, 138.62,
138.61, 138.48, 138.47, 138.29, 128.44, 128.36, 128.27, 128.26, 128.16, 128.01, 127.92,
127.86, 127.69, 127.57, 127.56, 127.55, 127.44, 127.43, 97.82, 82.83, 80.14, 78.76, 78.24,
78.16, 75.75, 74.73, 73.53, 73.29, 73.23, 72.49, 70.26, 69.58, 55.02. ESI-HRMS Calcd.
for C51H54O8Na
+ [M + Na]+ 817.3711, found 837.3710.
1,8-Di-O-acetyl-2,3,4,6,7-penta-O-benzyl-α,β-D-erythro-D-gluco-octopyranose (3-
14).
Compound 3-13 (1.98 g, 2.49 mmole) was dissolved in acetic acid (10 mL) and
added acetic anhydride (10 mL). The reaction mixture was cooled to 0 ◦C in an
ice-water bath and then added concentrated sulfuric acid (1 mL) dropwise. After
stirring at 0 ◦C for 2 h, the reaction mixture was diluted with dichloromethane and
quenched by adding saturated sodium bicarbonate solution slowly. The resulting
solution was extracted with dichloromethane (3×). The combined organic lay-
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ers were washed with water (1×) and brine (1×), and then dried over anhydrous
Na2SO4. After the volatiles were removed by rotary evaporation under reduced
pressure, the crude product was purified using flash chromatography (silica gel;
EtOAc/hexanes (1:9 → 1:2)) to yield 3-14 (C47H50O10, 1.02 g, α:β = 6:1, 53%) as
syrup. TLC (EtOAc/hexanes (1:2)) R f = 0.55. α anomer: 1H NMR (CDCl3, 600
MHz) δ (ppm) 7.32–7.19 (25 H, m, Bn×5), 6.32 (1 H, d, J1,2 = 3.6 Hz, H1), 4.96 (1 H,
J = 10.8 Hz, CH2 of Bn), 4.89 (1 H, J = 10.8 Hz, CH2 of Bn), 4.82 (1 H, J = 10.8 Hz,
CH2 of Bn), 4.72 (1 H, J = 11.6 Hz, CH2 of Bn), 4.70 (1 H, J = 10.8 Hz, CH2 of Bn),
4.63 (2 H, J = 10.8 Hz, CH2 of Bn), 4.51 (1 H, J = 11.6 Hz, CH2 of Bn), 4.49 (1 H, J
= 10.8 Hz, CH2 of Bn), 4.46 (1 H, dd, J7,8a = 2.4 Hz, J8a,8b = 12.0 Hz, H8a), 4.28 (1 H,
J = 10.8 Hz, CH2 of Bn), 4.24 (1 H, dd, J4,5 = 8.8 Hz, J5,6 = 9.6 Hz, H5), 4.04 (1 H,
dd, J7,8b = 3.6 Hz, J8a,8b = 12.0 Hz, H8b), 3.92 (1 H, dd, J2,3 = 9.2 Hz, J3,4 = 8.8 Hz,
H3), 3.89–3.84 (2 H, m, H4 and H7), 3.80 (1 H, dd, J5,6 = 9.6 Hz, J6,7 = 10.0 Hz, H6),
3.57 (1 H, dd, J1,2 = 3.6 Hz, J2,3 = 9.2 Hz, H2), 2.05 (3 H, s, OAc), 1.94 (3 H, s, OAc).
13C NMR (CDCl3, 150 MHz) δ (ppm) 170.85, 169.47, 138.58, 138.25, 138.05, 137.96,
137.64, 128.47, 128.37, 128.32, 128.32, 128.28, 128.04, 128.00, 127.97, 127.89, 127.76,
127.66, 89.65, 82.31, 79.15, 78.00, 77.62, 76.75, 75.60, 75.04, 73.54, 73.19, 72.73, 72.22,
62.56, 20.97, 20.84.
β anomer: 1H NMR (CDCl3, 600 MHz) δ (ppm) 7.32–7.19 (25 H, m, Bn×5), 5.61 (1
H, J1,2 = 8.0 Hz, H1), 4.89 (1 H, J = 10.8 Hz, CH2 of Bn), 4.84 (1 H, J = 11.6 Hz, CH2
of Bn), 4.82 (1 H, J = 10.8 Hz, CH2 of Bn), 4.78 (1 H, J = 11.2 Hz, CH2 of Bn), 4.77
(1 H, J = 11.6 Hz, CH2 of Bn), 4.61 (1 H, J = 12.0 Hz, CH2 of Bn), 4.46–4.41 (3 H,
m, CH2 of Bn×2 and H8a), 4.34–4.29 (2 H, CH2 of Bn and H5), 4.06–4.02 (1 H, H8b),
3.90–3.81 (3 H, H3, H4 and H6), 3.69 (1 H, ddd, J6,7 = 8.8 Hz, J7,8a = J7,8b = 4.4 Hz,
H7), 3.50 (1 H, dd, J1,2 = 8.0 Hz, J2,3 = 9.2 Hz, H2), 2.07 (3 H, s, OAc), 1.93 (3 H, s,
OAc). 13C NMR (CDCl3, 150 MHz) δ (ppm) 206.86, 169.02, 138.31, 138.20, 138.17,
137.96, 137.94, 128.42, 128.39, 128.34, 128.30, 128.13, 128.02, 127.93, 127.79, 127.69,
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127.56, 94.12, 85.24, 81.34, 78.16, 77.32, 76.46, 75.62, 75.45, 74.95, 74.80, 73.42, 72.20,
62.62, 30.88, 21.04, 20.82. ESI-HRMS Calcd. for C47H50O10Na
+ [M+Na]+ 797.3296,
found 797.3309.
2,3,4,6,7-Penta-O-benzyl-α,β-D-erythro-D-gluco-octopyranose (3-15).
Compound 3-14 (0.93 g, 1.2 mmole) was dissolved in anhydrous methanol (40 mL)
and added sodium methoxide methanol solution (0.5 M, 15 mL) dropwise. After
stirring at ambient temperature for 1 h, the reaction mixture was neutralized by
adding Dowex® 50W×8 (hydrogen form). The resins were removed by filtration,
the solution was concentrated by rotary evaporation under reduced pressure, and
the crude product 3-15 was used for later steps without further purification.
D-Erythro-D-gluco-octose α-1,8-bisphosphate (3-2).
Compound 3-15 (∼0.60 mg, 0.87 mmole) and tetrazole (0.45 M in acetonitrile,
12 mL, 5.4 mmole) was suspended in anhydrous toluene (10 mL) and the so-
lution was evaporated in vacuo. The residue was then dissolved in anhydrous
dichloromethane (60 mL) and cooled to−20 ◦C in a dry ice-acetone bath. Dibenzyl
N,N-diisopropylphosphoramidite (1.7 mL, 5.06 mmole) was added dropwise over
15 min. The reaction solution was stirred at −20 ◦C for 1 h and then warmed to
room temperature for another 1 h. The phosphorylation was complete as mon-
itored by TLC. The reaction solution was cooled to 0 ◦C, added mCPBA (77%,
2.1 g, 9.4 mmole) portion-wise and allowed to stir at room temperature for 1 h.
The oxidation was complete judging by TLC. The reaction mixture was diluted
by adding dichloromethane and quenched by adding saturated Na2S2O3 solu-
tion. The resulting solution was extracted with dichloromethane (3×). The com-
bined organic layers were washed with water (1×) and then dried over anhydrous
Na2SO4. After the volatiles were removed by rotary evaporation under reduced
pressure, the crude product was purified using flash chromatography (silica gel;
EtOAC/hexanes (1:2)). The eluted fractions containing product were concentrated
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and further purified using HPLC on an Econosil C18 semiprep column, 10 µm,
250 × 10 mm (Alltech) with detection at λ = 254 nm. Mobile phase A was wa-
ter, while mobile phase B was acetonitrile. The separation was obtained at a flow
rate of 4 mL/min with a gradient program that allowed for 8 min at 80% B fol-
lowed by a 2-min step that raised eluent B to 90%. Then washing at 90% B for
10 min and re-equilibration at 80% B was performed in a total time of 30 min.
The retention time of the product 2,3,4,6,7-penta-O-benzyl-α,β-D-erythro-D-gluco-
octopyranose 1,8-bis-[bis(benzyl) phosphate] (3-16) was 17 min (C71H72O14P2, 0.11
g, 10%). 1H NMR (CDCl3, 500 MHz) δ (ppm) 7.36–7.17 (45 H, m, Bn×9), 5.93 (1
H, dd, J1,2 = 3.0 Hz, J1,P = 7.5 Hz, H1), 5.02–4.84 (8 H, m, CH2 of P(O)(OBn)2×8),
4.91 (1 H, J = 11.0 Hz, CH2 of Bn), 4.84 (1 H, J = 10.5 Hz, CH2 of Bn), 4.79 (1 H, J
= 11.0 Hz, CH2 of Bn), 4.76 (1 H, J = 11.0 Hz, CH2 of Bn), 4.63 (2 H, J = 11.5 Hz,
CH2 of Bn×2), 4.57 (1 H, J = 11.0 Hz, CH2 of Bn), 4.49 (1 H, J= 11.5 Hz, CH2 of
Bn), 4.45 (1 H, J = 11.5 Hz, CH2 of Bn), 4.38 (1 H, d, J4,5 = 10.0 Hz, H5), 4.34 (1
H, ddd, J7,8a = 1.5 Hz, J8a,8b = 11.0 Hz, J8a,P = 6.0 Hz, H8a), 4.27 (1 H, J = 11.5 Hz,
CH2 of Bn), 4.11 (1 H, ddd, J7,8b = 3.5 Hz, J8a,8b = 11.0 Hz, J8b,P = 6.0 Hz, H8b), 3.91
(1 H, dd, J2,3 = 9.5 Hz, J3,4 = 9.5 Hz, H3), 3.87–3.83 (3 H, m, H4, H6 and H7), 3.48
(1 H, ddd, J1,2 = 3.0 Hz, J2,3 = 9.5 Hz, J2,P = 3.0 Hz, H2). 13C NMR (CDCl3, 125
MHz) δ (ppm) 138.48, 138.13, 137.88, 137.79, 137.61, 135.89 (d, JC−OBn,P = 7.3 Hz),
135.81 (d, JC,P = 6.9 Hz), 135.78 (d, JC,P = 7.3 Hz), 135.70 (d, JC,P = 6.9 Hz), 128.49,
128.46, 128.38, 128.36, 128.30, 128.29, 128.20, 128.07, 127.82, 127.77, 127.73, 127.63,
127.58, 95.22 (d, JC1,P = 5.9 Hz), 81.57, 79.45 (d, JC2,P = 7.4 Hz), 77.80, 77.15, 75.52,
74.95, 73.55, 72.97, 72.67, 72.32, 69.13 (d, JC−OBn,P = 3.8 Hz), 69.10 (d, JC−OBn,P = 5.5
Hz), 66.41 (d, JC8,P = 5.9 Hz). ESI-HRMS Calcd. for C71H72O14P2Na
+ [M + Na]+
1233.4290, found 1233.4290.
The purified 3-16 (110 mg, 0.09 mmole) and 5% Pd/C (50 mg) in a methanol solu-
tion (25 mL) was stirred under hydrogen atmosphere (1 atm) for 1 h. The reaction
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mixture was filtered through a pad of Celite and the filtrate after concentration
yield bisphosphate 3-2 (C8H18O14P2, 10 mg, 27%) as white solids.
1H NMR (D2O,
600 MHz) δ (ppm) 5.35 (1 H, dd, J1,2 = 3.6 Hz, J1,P = 6.6 Hz, H1), 3.99 (1 H, d, J4,5 =
9.0 Hz, H5), 3.92–3.82 (4 H, m, H6, H7, H8a and H8b), 3.64 (1 H, dd, J2,3 = 9.0 Hz,
J3,4 = 9.0 Hz, H3), 3.60 (1 H, dd, J3,4 = 9.0 Hz, J4,5 = 9.0 Hz, H4), 3.41 (1 H, brd, J2,3
= 9.0 Hz, H2). 13C NMR (D2O, 125 MHz) δ (ppm) 94.81, 72.87, 72.26, 71.11, 70.72,
70.39, 68.89, 66.72. 31P NMR (D2O, 243 MHz) δ (ppm) 2.53, 0.49. ESI-HRMS Calcd.
for C8H18O14P2Na
+ [M + Na]+ 423.0064, found 423.0063.
3.2.8 Synthesis of D-erythro-D-gluco-octose α-1-phosphate (3-3)
3-14
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Figure 3.3: Synthesis of octose 1-phosphate (3-3).
Methyl 8-O-Acetyl-2,3,4,6,7-penta-O-benzyl-α,β-D-erythro-D-gluco-octopyrano
-side (3-17).
The synthesis of 3-3 was shown in Figure 3.3. Compound 3-14 (0.70 g, 0.90 mmole)
was dissolved in methanol (50 mL) and added imidazole methanolic solution (1 M,
50 mL). The reaction mixture was heated to 40 ◦C in an oil bath. After stirring at
40 ◦C for 20 h, the reaction mixture was concentrated under reduced pressure. The
residue was extracted with EtOAc (3×). The combined organic layers were dried
over anhydrous Na2SO4. After the volatiles were removed by rotary evaporation
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under reduced pressure, the crude product was purified using flash chromatogra-
phy (silica gel; EtOAC/hexanes (1:4 → 1:2)) to yield 3-17 (C45H48O9, 0.40 g, α:β
= 3:2, 60%) as syrup. TLC (EtOAc/hexanes (1:2)) R f = 0.47. α anomer: 1H NMR
(CDCl3, 400 MHz) δ (ppm) 7.38–7.19 (25 H, m, Bn×5), 5.23 (1 H, dd, J1,2 = 4.0 Hz,
H1), 4.95 (1 H, J = 11.2 Hz, CH2 of Bn), 4.84 (2 H, J = 10.8 Hz, CH2 of Bn×2), 4.77
(1 H, J = 11.6 Hz, CH2 of Bn), 4.73 (1 H, J = 11.2 Hz, CH2 of Bn), 4.71 (1 H, J = 11.2
Hz, CH2 of Bn), 4.61 (1 H, J = 10.8 Hz, CH2 of Bn), 4.51 (1 H, J = 11.6 Hz, CH2 of
Bn), 4.49 (1 H, J = 11.2 Hz, CH2 of Bn), 4.47 (1 H, dd, J7,8a = 2.0 Hz, J8a,8b =11.6 Hz,
H8a), 4.39 (1 H, d, J4,5 = 10.4 Hz, H5), 4.36 (1 H, J = 11.2 Hz, CH2 of Bn), 4.06 (1 H,
dd, J7,8b = 3.2 Hz, J8a,8b =11.6 Hz, H8b), 3.98 (1 H, dd, J2,3 = 9.6 Hz, J3,4 = 9.2 Hz, H3),
3.90–3.86 (1 H, m, H7), 3.84 (1 H, d, J6,7 = 9.2 Hz, H6), 3.81 (1 H, dd, J3,4 = 9.2 Hz,
J4,5 = 9.2 Hz, H4), 3.49 (1 H, dd, J1,2 = 4.0 Hz, J2,3 = 9.6 Hz, H2), 1.92 (3 H, s, OAc).
13C NMR (CDCl3, 125 MHz) δ (ppm) 170.89, 138.68, 138.45, 137.95, 137.91, 137.90,
128.5, 128.41, 128.36, 128.31, 128.29, 128.24, 128.20, 128.15, 128.09, 127.94, 127.91,
127.87, 127.81, 127.75, 127.68, 127.61, 127.57, 127.55, 91.10, 82.25, 80.23, 78.64, 77.10,
76.63, 75.57, 74.74, 72.29, 70.28, 62.86, 20.82.
β anomer: 1H NMR (CDCl3, 400 MHz) δ (ppm) 7.38-7.19 (25 H, m, Bn×5), 4.96 (1
H, J = 11.6 Hz, CH2 of Bn), 4.93 (1 H, J = 11.6 Hz, CH2 of Bn), 4.84 (1 H, J = 10.8
Hz, CH2 of Bn), 4.81 (1 H, J = 11.6 Hz, CH2 of Bn), 4.77 (1 H, J = 11.6 Hz, CH2 of
Bn), 4.71 (1 H, J = 11.6 Hz, CH2 of Bn), 4.71 (1 H, J1,2 = 9.2 Hz, H1), 4.61 (1 H, J
= 10.8 Hz, CH2 of Bn), 4.54 (1 H, J = 11.6 Hz, CH2 of Bn), 4.52–4.45 (3 H, m, CH2
of Bn×2 and H8a), 4.39 (1 H, d, J4,5 = 10.4 Hz, H5), 4.06 (1 H, dd, J7,8b = 3.2 Hz,
J8a,8b =11.6 Hz, H8b), 3.90–3.86 (1 H, m, H7), 3.85–3.77 (2 H, m, H6 and H4), 3.63
(1 H, dd, J2,3 = 8.8 Hz, J3,4 = 8.8 Hz, H3), 3.35 (1 H, dd, J1,2 = 9.2 Hz, J2,3 = 8.8
Hz, H2), 1.93 (3 H, s, OAc). 13C NMR (CDCl3, 125 MHz) δ (ppm) 170.89, 138.52,
138.37, 138.34, 137.89, 137.78, 128.5, 128.41, 128.36, 128.31, 128.29, 128.24, 128.20,
128.15, 128.09, 127.94, 127.91, 127.87, 127.81, 127.75, 127.68, 127.61, 127.57, 127.55,
92
97.80, 85.04, 83.23, 78.45, 76.57, 75.57, 74.80, 62.78, 19.98. ESI-HRMS Calcd. for
C45H48O9Na
+ [M + Na]+ 755.3191, found 755.3195.
D-Erythro-D-gluco-octose α-1-phosphate (3-3).
Compound 3-17 (0.20 g, 0.27 mmole) and tetrazole (0.45 M in acetonitrile, 2.7 mL,
1.2 mmole) was suspended in anhydrous toluene (10 mL) and the solution was
evaporated in in vacuo. The residue was then dissolved in anhydrous dichloro-
methane (10 mL) and cooled to −20 ◦C in a dry ice-acetone bath. Dibenzyl N,N-
diisopropyl-phosphoramidite (0.35 mL, 1.06 mmole) was added dropwise over 15
min. The reaction solution was stirred at −20 ◦C for 1 h and then warmed to room
temperature for another 1 h. The phosphorylation was complete by checking TLC.
The reaction solution was cooled to 0 ◦C, added mCPBA (77%, 0.4 g, 1.79 mmole)
portion-wise and stirred at room temperature for 1 h. The oxidation was complete
by checking TLC. The reaction mixture was diluted by adding dichloromethane
and quenched by adding saturated Na2S2O3 solution. The resulting solution was
extracted with dichloromethane (3×). The combined organic layers were washed
with water (1×) and then dried over anhydrous Na2SO4. After the volatiles were
removed by rotary evaporation under reduced pressure, the crude product was
dissolved in methanol (5 mL) and added sodium methoxide methanol solution (0.5
M, 1 mL). After stirring at ambient temperature for 4 h, the reaction mixture was
neutralized by adding Dowex® 50W×8 (hydrogen form). The resins were removed
by filtration and the crude product was purified using flash chromatography (silica
gel; EtOAC/hexanes (1:2)) to yield 2,3,4,6,7-penta-O-benzyl-α-D-erythro-D-gluco-
octopyranose 1-[bis(benzyl) phosphate]. (3-18, C57H59O11P, 60 mg, 23%) as syrup.
TLC (EtOAc/hexanes (1:1)) R f = 0.61. 1H NMR (CDCl3, 500 MHz) δ (ppm) 7.37–
7.14 (35 H, m, Bn×7), 5.98 (1 H, dd, J1,2 = 3.0 Hz, J1,P = 7.0 Hz, H1), 5.04 (1 H, dd, J =
11.5 Hz, JH,P = 7.0 Hz, CH2 of P(O)(OBn)2), 5.03 (1 H, dd, J = 12.0 Hz, JH,P = 7.0 Hz,
CH2 of P(O)(OBn)2), 5.00 (1 H, dd, J = 12.0 Hz, JH,P = 7.0 Hz, CH2 of P(O)(OBn)2),
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4.94 (1 H, J = 11.0 Hz, CH2 of Bn), 4.93 (1 H, dd, J = 11.5 Hz, JH,P = 7.0 Hz, CH2 of
P(O)(OBn)2), 4.89 (1 H, J = 10.5 Hz, CH2 of Bn), 4.81 (1 H, J = 11.5 Hz, CH2 of Bn),
4.79 (1 H, J = 11.0 Hz, CH2 of Bn), 4.68 (1 H, J = 11.5 Hz, CH2 of Bn), 4.66 (1 H, J =
11.5 Hz, CH2 of Bn), 4.63 (1 H, J= 10.5 Hz, CH2 of Bn), 4.52 (1 H, J = 11.5 Hz, CH2
of Bn), 4.37 (1 H, J = 11.5 Hz, CH2 of Bn), 4.36 (1 H, d, J4,5 = 11.0 Hz, H5), 4.34 (1 H,
J = 11.5 Hz, CH2 of Bn), 3.94 (1 H, dd, J2,3 = 9.5 Hz, J3,4 = 9.0 Hz, H3), 3.85 (1 H, dd,
J3,4 = 9.0 Hz, J4,5 = 11.0 Hz, H4), 3.81 (1 H, d, J6,7 = 9.5 Hz, H6), 3.72 (1 H, ddd, J6,7
= 9.5 Hz, J7,8ab = 3.5 Hz, H7), 3.63 (2 H, brd, J7,8ab = 3.5 Hz, H8a and H8b), 3.52 (1 H,
ddd, J1,2 = 3.0 Hz, J2,3 = 9.5 Hz, J2,P = 3.0 Hz, H2). 13C NMR (CDCl3, 125 MHz) δ
(ppm) 138.45, 138.17, 137.89, 137.86, 137.60, 135.88 (d, JC−OBn,P = 8.0 Hz), 135.77 (d,
JC,P = 7.5 Hz), 128.39, 128.37, 128.35, 128.29, 128.22, 128.10, 128.05, 127.93, 127.92,
127.85, 127.82, 127.75, 127.71, 127.64, 127.62, 127.60, 95.19 (d, JC1,P = 5.9 Hz), 81.69,
79.48 (d, JC2,P = 6.9 Hz), 78.38, 78.36, 77.58, 75.62, 74.83, 73.70, 72.93, 72.78, 72.08,
69.14 (d, JC−OBn,P = 4.9 Hz), 69.05 (d, JC−OBn,P = 5.5 Hz). 31P (CDCl3, 202 MHz)
δ (ppm) 1.18. ESI-HRMS Calcd. for C57H59O11PNa
+ [M + Na]+ 973.3687, found
973.3686.
The purified 3-18 (∼60 mg, 0.08 mmole) was dissolved in methanol and added
5% Pd/C (5 mg). The reaction mixture was stirred under hydrogen atmosphere (1
atm) for 1 h. The reaction solution was filtered through a pad of Celite and the fil-
trate after concentration yield monophosphate 10 (C8H17O11P, 26 mg, quantitative
yield) as white solids. 1H NMR (D2O, 400 MHz) δ (ppm) 5.31 (1 H, dd, J1,2 = 3.2 Hz,
J1,P = 6.8 Hz, H1), 3.95 (1 H, dd, J4,5 = 10.0 Hz, J5,6 = 2.4 Hz, H5), 3.80 (1 H, ddd, J6,7
= 7.2 Hz, J7,8a = 3.2 Hz, J7,8b = 6.4 Hz, H7), 3.75 (1 H, dd, J4,5 = 2.4 Hz, J6,7 = 7.2 Hz,
H6), 3.67 (1 H, dd, J7,8a = 3.2 Hz, J8a,8b = 12.0 Hz, H8a), 3.62 (1 H, dd, J2,3 = 9.6 Hz,
J3,4 = 9.6 Hz, H3), 3.53 (1 H, dd, J3,4 = 9.6 Hz, J4,5 = 9.6 Hz, H4), 3.49 (1 H, dd, J7,8b
= 6.4 Hz, J8a,8b = 12.0 Hz, H8b), 3.36 (1 H, brd, J2,3 = 9.6 Hz, H2). 13C NMR (D2O,
125 MHz) δ (ppm) 93.49, 73.50, 72.02, 72.02, 71.57, 71.57, 70.61, 63.21. 31P (D2O, 202
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MHz) δ (ppm) 2.13. ESI-HRMS Calcd. for C8H16O11P
– [M−H]– 319.0436, found
319.0436.
3.2.9 Synthesis of GDP-D-erythro-D-octose (3-5)
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Figure 3.4: Synthesis of octose 1,8-bisphosphate (3-5)
Guanosine-5′-monophsophate morpholidate (3-19)
The overall synthetic scheme of compound 3-5 is shown in Figure 3.4. Guanosine
monophosphate disodium salt (4.10 g, 10.07 mmole) in water (50 mL) was ap-
plied to a column packed with Dowex® 50W×8 (hydrogen form). The eluted frac-
tions containing GMP concentrated by rotary evaporation and then lyophilized
overnight. The GMP were dissolved in 100 mL of tBuOH:H2O (1:1) co-solvent and
added morpholine (2.4 mL, 27.5 mmole). The reaction mixture was heated to re-
flux for 3 h, during which time a solution of N,N′-dicyclohexylcarbodiimide (6.2
g, 30.0 mmol) in tBuOH (15 mL) was added dropwise. After refluxing the reac-
95
tion solution for an additional 2 h, the reaction mixture was cooled down to room
temperature. The precipitates were removed by filtration and the resulting solu-
tion was concentrated by rotary evaporation. The residues were then re-dissolved
in water and the insoluble precipitates were removed by filtration. The solution
was then freeze dried. The 4-morpholine-N,N′-dicylcohexylcarboxamidine salt of
3-19 was obtained as a colorless powder (3.88 g, 77%). 1H NMR (D2O, 400 MHz) δ
(ppm) 7.92 (1 H, s, guanine), 5.79 (1 H, d, J1,2 = 5.2 Hz, H1), 4.38 (1 h, dd, J2,3 = J3,4 =
4.8 Hz, H3), 4.16 (1 H, brs, H4), 3.91–3.84 (2 H, m, H5), 3.58 (4 H, t, J = 4.8, CH2×2
of morpholine of counter ion), 3.43 (4 H, t, J = 4.4, CH2×2 of morpholine), 3.31 (4
H, t, J = 4.8, CH2×2 of morpholine of counter ion), 3.21–3.16 (2 H, m, CH×2 of
cyclohexyl of counter ion), 2.84–2.76 (4 H, m, CH2×2 of morpholine), 1.79–0.98 (20
H, m, CH2×10 of cyclohexyl of counter ion). 31P NMR (D2O, 162 MHz) δ (ppm)
7.40. Analytical data were consistent with the commercial standards.144
GDP-D-erythro-D-octose (3-5).
Compound 3-3 (6.4 mg, 0.02 mmol) was dissolved in water (5 mL) and added
Dowex® 50W×8 (tri-n-butylammonium salt form). The reaction mixture was stirred
at 4 ◦C for 16 h and then filtered to remove the resins. The solution was lyophilized
to afford the tri-n-butylammonium salt of 3-3. To the tri-n-butylammonium salt of
3-3 in anhydrous pyridine (10 mL) were added 1H-tetrazole (0.45 M in acetoni-
trile, 0.2 mL, 0.09 mmol) and GMP-morpholidate (3-19, 30 mg, 0.03 mmole). After
stirring for 3 days at room temperature, the reaction mixture was concentrated
in vacuo. The residue was dissolved in water (10 mL) and then washed with di-
ethyl ether (3×). The aqueous solution was concentrated and injected to a Dionex
CarboPacPA1 semiprep column, 250 × 9 mm with detector set at λ = 254 nm. Mo-
bile phase A was water, while mobile phase B was 1 M NH4HCO3. The separa-
tion was obtained at a flow rate of 3 mL/min with a gradient program: 0-2 min
30% B, 2-12 min 30-40% B, 12-20 min 40% B, 20-21 min 40-70% B, 21-31 min 70%
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B, 31-32 min 70-30% B, 32-40 min 30% B. The retention time of the product 3-5
N,N-dicyclohexyl-4-morpholinecarboxamidine salt was 15 min (C35H60N8O19P2,
3.7 mg, 19%). 1H NMR (D2O, 500 MHz) δ (ppm) 7.89 (1 H, s, guanine), 5.72 (1 H, d,
J1,2 = 6.0 Hz, ribose-H1), 5.29 (1 h, dd, J1,2 = 3.5 Hz, J1,P = 7.0 Hz, octose-H1), 4.54 (1
H, dd, J1,2 = 6.0 Hz, J2,3 = 5.5 Hz ribose-H2), 4.29 (1 H, brt, J2,3 = 5.5 Hz, ribose-H3),
4.15–4.14 (1 H, m, ribose-H4), 4.00 (2 H, brs, ribose-H5), 3.85 (1 H, brd, J4,5 = 9.5
Hz, octose-H5), 3.82–3.68 (2 H, m, octose-H6 and H7), 3.60 (1 H, brd, J8a,8b = 12.0
Hz, octose-H8a), 3.59–3.57 (4 H, m, morpholine), 3.37 (1 H, dd, J2,3 = J3,4 = 9.5 Hz,
octose-H3), 3.35 (1 H, dd, J3,4 = J4,5 = 9.5 Hz, octose-H4), 3.43 (1 H, dd, J7,8b = 6.5
Hz, J8a,8b = 12.0 Hz, octose-H8b), 3.34–3.18 (1 H, m, octose-H2), 3.23 (4 H, brs, mor-
pholine), 3.13–3.11 (2 H, m, C×H2 of cyclohexyl), 1.70–0.92 (20 H, m, CH2×10 of
cyclohexyl). 31P NMR (D2O, 202 MHz) δ (ppm) -10.42 (J = 20.0 Hz), -12.10 (J = 20.0
Hz). ESI-HRMS Calcd. for C18H28N5O18P2
– [M−H]– 664.0910, found 664.0922.
3.2.10 LmbK and LmbO Reaction Assays
LmbK reaction using the synthetic bisphosphate 3-2 as substrate
The N-His6-LmbK protein (44 µM final concentration) was incubated with
D-erythro-D-gluco-octose α-1,8-bisphosphate (3-2, 3 mM) and MgCl2 (10 mM) in 25
mM Tris buffer (pH 8.0) at ambient temperature for 2.5 h or 5 h. A control reaction
omitting the enzyme was similarly prepared. At the end of the incubation, each
reaction mixture was filtered through a YM-10 membrane using an Amicon ultra-
filtration unit to remove the protein. HPLC analysis of the filtrate was performed
using a Dionex CarboPac PA1 analytical column (4 × 250 mm). The samples were
eluted by using water as mobile phase A and 1 M NH4OAc as mobile phase B. The
separation was obtained at a flow rate of 1 mL/min with a gradient program: 0-0.5
min 5% B, 0.5-1.5 min 5-50% B, 1.5-10 min 50% B, 10-11 min 50-5% B, 11-20 min 5%
B. The elution was monitored by a Corona CAD detector.
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NMR characterization of LmbK reaction using the synthetic bisphosphate 3-2 as
substrate
The reaction solution (0.8 mL × 3) contained compound 3-2 (12.5 mM) and
N-His6-LmbK (18.8 M) in 50 mM NH4 · HCO3 buffer (pH 8) containing 10 mM
MgCl2. Prior to incubation, the N-His6-LmbK protein stock solution was dialyzed
against NH4 ·HCO3 buffer (pH 8) containing 10 mM MgCl2 to remove excess glyc-
erol. The reaction mixture was incubated at ambient temperature for 16 h and fil-
tered through a YM-10 membrane using an Amicon ultrafiltration unit to remove
the protein. The filtrate was then lyophilized and redissolved in D2O for the NMR
analysis.
LmbK and LmbO reaction using the synthetic bisphosphate 3-2 and various nu-
cleotide triphosphates as substrates
The purified N-His6-LmbK protein (10 µM final concentration) and the re-
folded N-His6-LmbO (19 µM final concentration) were incubated with bisphos-
phate 3-2 (2 mM), NTP (3 mM), inorganic pyrophosphatase (1 unit) and MgCl2 (10
mM) in 25 mM Tris buffer (pH 8.0) at ambient temperature for 8 h. At the end
of the incubation, each reaction mixture was filtered through a YM-10 membrane
using an Amicon ultrafiltration unit to remove the protein. HPLC analysis of the
filtrate was performed using a Dionex CarboPac PA1 analytical column (4 × 250
mm). Mobile phase A was water and mobile phase B was 1 M NH4OAc. The sepa-
ration was achieved at a flow rate of 1 mL/min. The samples containing CTP, TTP
and UTP were analyzed by gradient method (1): 0-2 min 30% B, 2-10 min 30-90%
B, 10-20 min 90% B, 20-22 min 90-30% B, 22-30 min 30% B. The samples contain-
ing ATP and GTP were analyzed by gradient method (2): 0-2 min 50% B, 2-10 min
50-90% B, 10-20 min 90% B, 20-22 min 90-50% B, 22-30 min 50% B. The detector
wavelength was set at 267 nm for cytosine and thymine, 262 nm for uracil, 259 nm
for adenine, and 254 nm for guanine. The HPLC fraction containing the product
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(retention time ∼9 min) was collected. The collected fraction was lyophilized and
redissolved in deionized water prior to ESI-MS analysis (negative ion detection
mode).
LmbO reaction using the synthetic monophosphate 3-3 and various nucleotide
triphosphates as substrates
The refolded N-His6-LmbO protein (19 µM final concentration) was incu-
bated with monophosphate 3-3 (2 mM), NTP (3 mM), inorganic pyrophosphatase
(1 unit) and MgCl2 (10 mM) in 25 mM Tris buffer (pH 8.0) at ambient temperature
for 8 h. At the end of the incubation, each reaction mixture was filtered through
a YM-10 membrane using an Amicon ultrafiltration unit to remove the protein.
HPLC analysis of the filtrate was performed using a Dionex CarboPac PA1 analyt-
ical column (4 × 250 mm) with the abovementioned methods.
LmbK and LmbO reaction using GTP and the synthetic bisphosphate 3-2 or
monophosphate 3-3 as substrates
The purified N-His6-LmbK protein (10 µM final concentration) and the re-
folded N-His6-LmbO protein (19 µM final concentration) was incubated with bis-
phosphate 3-2 (5 mM), GTP (2 mM), inorganic pyrophosphatase (1 unit) and MgCl2
(10 mM) in 25 mM Tris buffer (pH 8.0) at the ambient temperature for 18 h. A
control reaction omitting LmbK and another reaction containing the refolded N-
His6-LmbO protein (19 µM final concentration) and monophosphate 3-3 (5 mM)
were similarly prepared. At the end of incubation, each reaction mixture was fil-
tered through a YM-10 membrane to remove the protein. HPLC analysis of the
filtrate was performed using a Dionex CarboPac PA1 analytical column (4 × 250
mm) with the method: mobile phase A was water and mobile phase B was 1 M
NH4OAc. The separation was obtained at a flow rate of 1 mL/min with a gradient
program: 0-2 min 60% B, 2-14 min 60-90% B, 14-24 min 90% B, 24-26 min 90-60%
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B, 26-34 min 60% B. The detector wavelength was set at 254 nm.
NMR characterization of LmbO product
The reaction solution (0.5 mL× 6) containing N-His6-LmbO protein (19 µM
final concentration), monophoshate 3-3 (5 mM), GTP (8 mM), inorganic pyrophos-
phatase (1 unit) and MgCl2 (10 mM) in 25 mM Tris buffer (pH 8.0) was incubated
at the ambient temperature for 16 h. The reaction solution was filtered through a
YM-10 membrane using an Amicon ultrafiltration unit to remove the protein. The
filtrate was then purified using HPLC using a Dionex CarboPac PA1 semi-prep col-
umn (9 × 250 mm) with the method: mobile phase A was water and mobile phase
B was 1 M NH4OAc. The separation was obtained at a flow rate of 3 mL/min with
a gradient program: 0-2 min 60% B, 2-14 min 60-90% B, 14-24 min 90% B, 24-26 min
90-60% B, 26-34 min 60% B. The detector wavelength was set at 254 nm. The reten-
tion time of the LmbO-product was 20 min. GDP-D-erythro-α-D-gluco-octose (3-5).
1H NMR (D2O, 600 MHz) δ (ppm) 8.09 (1 H, s, guanine), 5.92 (1 H, d, J1,2 = 6.0 Hz,
ribose-H1), 5.57 (1 H, dd, J1,2 = 3.6 Hz, J1,P = 7.2 Hz, octose-H1), 4.49 (1 H, brt, J2,3
= 3.6 Hz, ribose-H3), 4.23 (1 H, brs, ribose-H4), 4.20 (2 H, brs, ribose-H5), 4.06 (1
H, dd, J4,5 = 9.6 Hz, J5,6 = 3.0 Hz, octose-H5), 3.91 (1 H, ddd, J6,7 = 7.8 Hz, J7,8a =
3.0 Hz, J7,8b = 6.6 Hz, octose-H7), 3.88 (1 H, J5,6 = 3.0 Hz, J6,7 = 7.8 Hz, octose-H6),
3.78 (1 H, dd, J7,8a = 3.0 Hz, J8a,8b = 12.0 Hz, octose-H8a), 3.71 (1 H, dd, J2,3 = J3,4
= 9.6 Hz, octose-H3), 3.68 (1 H, dd, J3,4 = J4,5 = 9.6 Hz, octose-H4), 3.58 (1 H, dd,
J7,8b = 6.0 Hz, J8a,8b = 12.0 Hz, octose-H8b), 3.55-3.50 (1 H, m, octose-H2). 31P NMR
(D2O, 243 MHz) δ (ppm) −11.16 (19.9 Hz), −12.85 (19.9 Hz). ESI-HRMS Calcd. for
C18H28N5O18P2[M−Na]– 664.0910; Found: 664.6922.
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LmbK and LmbO reaction using GTP and various glucose phosphates as sub-
strates
The purified N-His6-LmbK protein (10 µM final concentration) and the re-
folded N-His6-LmbO protein (19 µM final concentration) was incubated with D-
glucose α-1,6-bisphosphate (2 mM), GTP (2 mM), inorganic pyrophosphatase (1
unit) and MgCl2 (10 mM) in 25 mM Tris buffer (pH 8.0) at the ambient tempera-
ture for 6 h. Other reactions containing the refolded N-His6-LmbO protein only
(19 µM final concentration) and D-glucose α-1-phosphate (2 mM) or D-glucose β-
1-phosphate (2 mM) were similarly prepared. Each reaction mixture was filtered
through a YM-10 membrane to remove the protein. HPLC analysis of the filtrate
was performed using a Dionex CarboPac PA1 analytical column (4× 250 mm) with
the method: mobile phase A was water and mobile phase B was 1 M NH4OAc. The
separation was obtained at a flow rate of 1 mL/min with a gradient program: 0-2
min 50% B, 2-10 min 50-90% B, 10-20 min 90% B, 20-22 min 90-50% B, 22-30 min
50% B. The detector wavelength was set at 254 nm.
LmbO reaction using GTP and various sugar 1-phosphates as substrates
The refolded N-His6-LmbO protein (19 µM final concentration) was incu-
bated with different sugar 1-phosphates (5 mM), GTP (2 mM), inorganic pyrophos-
phatase (1 unit) and MgCl2 (10 mM) in 25 mM Tris buffer (pH 8.0) at the am-
bient temperature for 16 h. Sugar substrates includes D-glucose α-1-phosphate,
D-galactose α-1-phosphate, D-mannose α-1-phosphate, and compound 10. Each
reaction mixture was filtered through a YM-10 membrane to remove the protein.
HPLC analysis of the filtrate was performed using a Dionex CarboPac PA1 ana-
lytical column (4 × 250 mm) with the method: mobile phase A was water and
mobile phase B was 1 M NH4OAc. The separation was obtained at a flow rate of
1 mL/min with a gradient program: 0-2 min 10% B, 2-10 min 10-50% B, 10-25 min
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50-90% B, 25-30 min 90%B, 32-32 min 90-10% B, 32-40 min 10% B. The detector
wavelength was set at 254 nm.
3.3 Results and Discussion
3.3.1 Overexpression and Purification of LmbP, LmbK and LmbO in E. coli
To verify the proposed pathways shown in Figure 3.1, the lmbP, lmbK and
lmbO genes were amplified from the genomic DNA of S. lincolnensis ATCC 25466
and individually cloned into pET24b(+) or pET28b(+) vectors. The recombinant
LmbP, LmbK and LmbO with C- or N-terminal His6 tags were overexpressed in E.
coli. LmbK could be purified to near homogeneity as soluble protein (Figure 3.5),
but both LmbP and LmbO were expressed only as inclusion bodies. Since CcbP
and CcbO encoded in celesticetin biosynthetic were predicted to be functionally
identical to LmbP and LmbO, respectively, plasmids containing ccbP and ccbO
genes were constructed to pursue the soluble proteins. Despite the efforts, both
the overexpressed CcbP and CcbO proteins remained in the inclusion bodies. The
denatured LmbO and CcbO could be solubilized from the inclusion bodies and
refolded into soluble form through an optimized refolding protocol. However, at-
tempts to obtain the soluble form of LmbP or CcbP using a similar approach were
unsuccessful.
3.3.2 Functional Characterization of LmbK
The formation of intermediate 3-2 was proposed as the first reaction in
NDP-octose biosynthesis. Accordingly, the availability of intermediate 3-2 is not
only important for the verification of the proposed pathway, but also crucial for
the examination of which route is favored for the later steps. The lack of functional
LmbP, however, hampered the investigation of lincomycin A biosynthetis. To over-
come this obstacle, the putative substrate for the subsequent enzymes (LmbK in
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Figure 3.5: SDS-PAGE gel of the purified N-His6-tagged LmbK (22.5 kDa, lane 3) and
the refolded N-His6-tagged LmbO (26.6 kDa, lane 2). The molecular weight markers are
shown in lane 1. Minor impurities are possibly resulted from non-specific binding of other
proteins with Ni-NTA resins.
route A and LmbO in route B) were chemically synthesized (Figure 3.2).
The synthetic bisphosphate 3-2 was first incubated with LmbK and the re-
action mixtures were analyzed by HPLC equipped with a Corona charged aerosol
detector (CAD) using an anion exchange column (Dionex CarboPac PA-1). A new
peak was detected (Figure 3.6). This new product was collected and characterized
by NMR spectroscopy. The 1H−31P heteronuclear multiple quantum correlation
(HMQC) spectrum of the substrate, octose 1,8-bisphosphate (3-2), displayed two
31P signals. One is at δ 2.53 and is coupled to the two C-8 proton signals at δ 3.86
and δ 3.83, and the other is at δ 0.49 and is coupled to the anomeric proton at δ 5.35
(Figure 3.7). In contrast, the NMR spectrum of the isolated product displayed a sin-
gle 31P signal at δ 3.17, which is coupled to the anomeric proton at δ 5.34. The loss
of the C-8 phosphoryl group from 3-2 during the LmbK-catalyzed reaction is thus
evident. To gain more support for the structural assignment of the isolated prod-
uct, an octose 1-phosphate (3-3) standard was also prepared. The LmbK product
was found to co-elute with the synthetic octose 1-phosphate (3-3) on HPLC, and
the spectral characteristics of the enzymatic product are in good agreement with
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Figure 3.6: HPLC analysis of LmbK activity assays. (1) Control reaction without LmbK.
The peak with the retention time of 4.8 min comes from Tris of the protein stock solution.
(2) The synthetic bisphosphate 3-2 incubated with LmbK for 2.5 h. (3) The synthetic bis-
phosphate 3-2 incubated with LmbK for 5 h. (4) The synthetic standard of monophosphate
3-3. (5) Co-injection of LmbK-reaction (trace 2) and the synthetic standard 3-3.
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Figure 3.7: NMR characterization of LmbK-catalyzed reaction. The 1H−31P HMQC spec-
tra of (A) the synthetic compound 3-2 and (B) the LmbK-catalyzed reaction product 3-3.
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the synthetic standard. These results fully established the identity of the LmbK
product as 3-3 starting from 3-2.
3.3.3 Functional Characterization of LmbO
Nucleotide specificity of LmbO
After the formation of octose 1-phosphate (3-3), the next reaction step is
likely the nucleotide activation catalyzed by the putative nucleotidylyltransferase,
LmbO (Figure 3.1, route A). To test this hypothesis and verify which nucleotide
is utilized in the lincomycin biosynthetic pathway, the synthetic bisphosphate 3-2
was incubated with LmbK and the refolded LmbO in the presence of ATP, CTP,
GTP, TTP or UTP. The resulting mixtures were analyzed by HPLC (Figure 3.8). Al-
though no new peak was detected in the reaction mixture using ATP, CTP, TTP or
UTP, a sample derived from the incubation mixture with GTP showed a new peak
that eluted in-between those of GMP and GDP with a retention time of 9.45 min
(Figure 3.8, trace 5). The same results were obtained when the synthetic octose
1-phosphate (3-3) was incubated with the refolded LmbO (Figure 3.9). This new
product peak was collected and subjected to ESI-MS analysis. The recorded molec-
ular mass (calcd for C18H28N5O18P2
– [M−H]–, 664.0910; obsd, 664.0922) is consis-
tent with the proposed product, GDP-D-α-D-octose (3-5), which was also chemi-
cally prepared from 3-3. As expected, the isolated product from the LmbK/LmbO
reaction displayed an identical HPLC retention time as that of the synthetic stan-
dard (Figure 3.10, trace 1 and 2).
Substrate specificity of LmbO
These results clearly indicate that the refolded LmbO is catalytically active
and suggest a pathway in which C-8 dephosphorylation by LmbK preceeds prior
to nucleotidylyltransfer catalyzed by LmbO (Figure 3.1, route A). However, a re-
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(1) The synthetic standard of GDP-octose 3-5. (2) The synthetic bisphosphate 3-2 incubated
with GTP, LmbK and LmbO. (3) The synthetic bisphosphate 3-2 incubated with GTP and
LmbO. (4) The synthetic monophosphate 3-3 incubated with GTP and LmbO.
versal of the sequence of these two reactions is also conceivable for the biosynthesis
of GDP-octose 3-5 (Figure 3.1, route B). To check this possibility, the bisphosphate
3-2 was incubated with the refolded LmbO in the presence of GTP. As shown in
Figure 3.10 trace 3, no new peak in the range of GDP-activated sugars is observed.
In contrast, formation of GDP-sugar 3-5 (Figure 3.10, trace 4) is clearly visible when
the synthetic octose 1-phosphate (3-3) was incubated with the refolded LmbO and
GTP. Evidently, C-8 dephosphorylation is a prerequisite for the subsequent nu-
cleotidyl activation. These results unequivocally establish that GDP-octose (3-5) is
indeed an intermediate in MTL biosynthesis and formation of GDP-octose follows
route A, not route B.
To investigate whether LmbO tolerates flexibility in its anomeric specificity,
the refolded LmbO was incubated separately with GTP and each of the two anomers
of glucose 1-phosphate, which were used as substrate analogues. Since forma-
tion of GDP-glucose was found only in the sample of α-glucose 1-phosphate (Fig-
ure 3.11, trace 1 and 2), LmbO showed stringent α-anomeric stereospecificity for
hexose substrates. Interestingly, although LmbO is capable of processing six-carbon
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sugar 1-phosphate, LmbK could not hydrolyze α-D-glucose 1,6-bisphosphate (Fig-
ure 3.11, trace 3). A similar observation was reported for heptose 1,7-bisphosphate
phosphatase GmhB, which could not recognize α-D-glucose 1,6-bisphosphate as a
substrate.131,132 Apparently, the chain length of the sugar phosphate substrates is
essential for these phosphatases.
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Figure 3.11: Determination of the reaction sequence in NDP-octose biosynthesis. HPLC
analysis of the activity assays for LmbK and LmbO. (1) Glucotse α-1-phosphate incubated
with GTP and LmbO. (2) Glucotse β-1-phosphate incubated with GTP and LmbO. (3)
Glucotse α-1,6-bisphosphate incubated with GTP, LmbK and LmbO. (4) Co-injection of
the sample from LmbO reaction with glucose α-1-phosphate (trace 1) and the GDP-α-D-
glucose standard. (5) The GDP-α-D-glucose standard.
Moreover, while LmbO was able to attach nucleotide on octose or glucose
α-1-phosphate, other hexoses, such as galactose or mannose, were not accepted as
substrates (Figure 3.12). This results indicated that the stereochemistry of C2- and
C4-hydroxyl groups seems to be crucial for the LmbO-catalyzed nucleotidyl trans-
fer. It is an intriguing observation because GDP-α-mannose and GDP-D-glycero-D-
manno-heptose are the biosynthetic precursors of most naturally occurring GDP-
sugars.
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Figure 3.12: Sugar substrate specificity of LmbO. HPLC analysis of the activity assays for
LmbO. All reactions contained LmbO and GTP. (1) Octose α-1-phosphate 3-3, (2) Glucotse
α-1-phosphate, (3) Galactose α-1-phosphate, (4) Mannose α-1-phosphate, (5) GDP-α-D-
glucose standard, (6) GDP-α-D-mannose standard.
3.4 Conclusion
Taken together, these results provide insight into the lincomycin biosyn-
thetic pathway, part of which is reminiscent of the NDP-heptose pathway.131,132
The transformation of octose 8-phosphate (3-1) to GDP-D-α-D-octose (3-5) is shown
to involve kinase and phosphatase reactions as intermediary steps. Our data also
reveal that the dephosphorylation step, catalyzed by LmbK, is critical for the nu-
cleotide activation reaction. However, direct demonstration of the predicted ki-
nase activity of LmbP was unsuccessful due to the difficulty in refolding insol-
uble LmbP. Nevertheless, the involvement of a kinase-catalyzed step and the α-
stereospecificity of LmbP reaction are supported by the effective reconstitution of
the biosynthesis of GDP-D-α-D-octose using the synthetic bisphosphate (3-2) as
substrate.
The formation of a nucleotide-activated octose intermediate in the lincomycin
biosynthetic pathway likely serves two purposes: (1) the phosphonucleotidyl group
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might be an important recognition/binding element for the later enzymes in the
pathway, and (2) it can function as a good leaving group in a nucleophilic sub-
stitution reaction, which may eventually allow the installation of the C-1 thiol
group. Furthermore, the identification of the GDP-octose intermediate has settled
a long-standing dispute concerning whether the proteins encoded in the lmb gene
cluster with sequence similarity to some NDP-deoxyhexose modifying enzymes
play any roles in lincomycin biosynthesis.115 It should also be noted that most
GDP-activated sugars are used in the biosynthesis of bacterial cell-wall polysac-
charides and eukaryotic glycans.145 Only GDP-mannose has been demonstrated
or suggested to be a biosynthetic precursor of the sugar subunit in some secondary
metabolites including the polyene macrolide nystatin,146 amphotericin and candi-
cidin,147 the aminoglycoside hygromycin,148 and the antitumor drug bleomycin.149
Thus, these results identify several key intermediates in the lincomycin pathway
and expand our knowledge of the roles of nucleotide-activated sugars in natural
product biosynthesis.
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Chapter 4
Biosynthetic Studies of Lincomycin A (III): Enzymatic
Modifications of the GDP-Octose Intermediate
4.1 Introduction
In the previous chapters, the biosynthetic pathway of lincomycin A was
proposed based on the results from early feeding experiments and genetic analy-
sis. The C8 backbone of thiooctose moiety was demonstrated to be derived from
D-sedeheptulose 7-phosphate or D-fructose 6-phosphate and D-ribose 5-phosphate
via a transaldol reaction catalyzed by LmbR. Subsequent isomerization catalyzed
by LmbN converts the resulting octulose 8-phosphate to octose 8-phosphate. Fur-
thermore, a GDP-octose was identified as a key intermediate in the lincomycin A
biosynthetic pathway. The putative phosphatase and guanylyltransferase, LmbK
and LmbO, respectively, were found to catalyze the formation of GDP-octose from
a bisphosphate intermediate, octose 1,8-bisphosphate.
Compared to TDP- or UDP-activated sugars, the occurrence of GDP-activated
sugars in nature is relatively rare. A good example is trehalose 6-phosphate syn-
thase utilizing GDP-D-glucose, instead of other nucleotide diphosphate activated
glucoses, has been found in Streptomyces hydroscopicus.150 Most documented enzy-
matic urilization and/or modifications of GDP-sugars are involved in the biosyn-
thesis of microbial cell-surface polysaccarides. For example, 6-deoxyheptoses have
been discovered as part of the lipopolysaccharides or of the capsular polysaccha-
rides on the surface of several pathogens including Yersinia pseudotuberculosis and
Campylobacter jejuni.145 The biosynthetic precursor of 6-deoxyheptoses has been
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found to be GDP-D-glycero-α-D-manno-heptose (4-1), the biosynthesis of which has
been described in page 62. It was later shown that two enzymes, DmhA and
DmhB, catalyze the sequential C6-dehydration and C4-reduction to produce GDP-
6-deoxy-manno-heptose (4-3) in Y. pseudotuberculosis O:2a (Figure 4.1).151 A similar
C6-dehydratase (WcbK) and C4-reductase (WcaG) pair has also been identified in
C. jejuni.152 These two enzymes, in addition to Cjj1427 and Cjj1430, are involved
in the conversion of GDP-6-deoxy-manno-heptose to GDP-6-deoxy-D-altro-heptose
(4-1→ 4-5 as dispicted in Figure 4.1).153
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Figure 4.1: Biosynthetic pathway of GDP-6-deoxy-heptose derivatives.
On the other hand, GDP-D-mannose (4-9) and its derivatives are hexose
donors frequently found in O-antigens of Gram-negative bacteria.145 The biosyn-
thesis of these GDP-sugars starts from a three-step conversion of fructose 6-phos-
phate (4-6) to GDP-D-mannose (4-9), which is subsequently converted to GDP-4-
keto-6-deoxy-α-D-mannose (4-10) via the catalysis of Gmd, a GDP-D-mannose 4,6-
dehydratase.154 This ketosugar 4-10 serves as a central intermediate for the biosyn-
thesis of other GDP-6-deoxyhexoses including GDP-D-rhamnose (4-11),154 GDP-6-
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deoxy-D-talose (4-12),155 GDP-perosamine (4-13),156 GDP-L-fucose (4-14),157 and
GDP-colitose (4-15)158 (Figure 4.2). GDP-D-mannose has also been demonstrated
to be the precursor of vitamin C in plants, although the detailed pathway has yet
to be elucidated.159
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Figure 4.2: Biosynthetic pathway of GDP-α-D-mannose (4-9) and other hexose deriva-
tives.
Only a handful of GDP-sugars have been characterized to be the biosyn-
thetic intermediates in secondary metabolites. A well-studied example is the sugar
moiety of polyene macrolide antibiotics. Most of the polyene macrolides (includ-
ing nystatin,146 amphotericin and candicidin,147) contains one single deoxyamino-
sugar, mycosamine (4-17). However, the sugar moiety of perimycin is perosamine
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(4-13), a constitutional isomer of mycosamine (Figure 4.3). Both deoxyaminosug-
ars have been proposed to be biosynthesized from GDP-α-D-mannose (4-9), which
could be converted to GDP-4-keto-6-deoxy-α-D-mannose (4-10) by GDP-mannose
4,6-dehydratase in a similar manner as that observed in the biosynthesis of bacte-
rial O-antigens.146 The C4-ketosugar 4-10 then undergoes transamination to pro-
duce GDP-perosamine (4-13).160 For the biosynthesis of GDP-mycosamine (4-17),
the C4-ketosugar 4-10 is isomerized to GDP-3-keto-6-deoxymannose (4-16), which
serves as the putative substrate for the C3-aminotransferase.161 However, no ho-
mologous genes encoding GDP-4-keto-6-deoxymannose 3,4-isomerase have been
found in the polyene macrolide biosynthetic gene clusters. It is possible that the
isomerization is a non-enzymatic reaction or catalyzed by other cytosolic proteins.
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Figure 4.3: Biosynthetic pathway of the sugar moieties in polyene macrolide antibioties.
In the biosynthetic pathway of lincomycin A, the attachment of a guanosine-
diphosphate group at C-1 position may allow the octose intermediate to be recog-
nized and further utilized by the GDP-sugar modifying enzymes. Comparing the
chemical structures of lincomycin A and the GDP-octose intermediate, three possi-
ble modifications could be envisioned: C-4 epimerization, C-6 transamination and
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C-8 dehydration (Figure 4.4).
Based on the bioinformatic analysis of the lincomycin A biosynthetic gene
cluster, LmbM (an epimerase homolog) was proposed to catalyze the C-4 epimer-
ization. Following the reaction mechanism similar to that of NDP-hexose 4,6-
dehydratase, the C-8 dehydration is likely accompanied with the C-6 dehydro-
genation catalyzed by the nicotinamide adenine dinucleotide (NAD+) or nicoti-
namide adenine dinucleotide phosphate (NADP+)-dependent enzymes.11 Two pro-
tein candidates encoded in the lmb cluster are LmbL (a putative NDP-sugar dehy-
drogenase) and LmbZ (a putative oxidoreductase). Although the sequence of these
enzymatic modifications is uncertain, the C-8 dehydration is predicted to occur
prior to the C-6 transamination because the presence of a keto-group is a prereq-
uisite for the PLP-dependent transamination.162 Search of the conserved domains
within lmbS gene product led to the annotation of its encoded protein as a putative
NDP-ketosugar aminotransferase, which belongs to the DegT/DnrJ/EryC1/StrS
aminotransferase family. Three biosynthetic routes of GDP-octose modifications
with the presumed stereochemical changes are summarized in Figure 4.4.
4.2 Experimental Procedures
4.2.1 General
Materials
All chemicals and reagents were purchased from Sigma-Aldrich Chemical
Co. (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) and were used without
further purification unless otherwise specified. Oligonucleotide primers were pre-
pared by Integrated DNA Technologies (Coralville, IA). Kits for DNA gel extrac-
tion and spin minipreps were purchased from Qiagen (Valencia, CA). PureLink® Ge-
nomic DNA Mini Kit was obtained from from Invitrogen (Carlsbad, CA). KOD
NDA polymerase was purchased from Novagen (Madison, WI). QickChange site-
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Figure 4.4: Proposed biosynthetic pathway of the GDP-octose modifications.
directed mutagenesis kit was obtained from Stratagene, which was acquired by
Agilent (Santa Clara, CA). Enzymes and molecular weight standards used for the
cloning experiments were obtained from New England Biolabs (Ipswich, MA).
Reagents for sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
were purchased from Bio-Rad (Hercules, CA), with the exception of the protein
molecular weight markers, which were obtained from Invitrogen. Growth medium
components were acquired from Becton Dickinson (Sparks, MD). Sterile syringe
filters are products of Fisher Scientific. Amicon YM-10 ultrafiltration membranes
were bought from Millipore (Billerica, MA). The analytical and semi-preparative
CarboPac PA1 high-performance liquid chromatography (HPLC) columns were
obtained from Dionex (Sunnyvale, CA). Analytical C-18 HPLC columns are prod-
ucts of Varian (Palo Alto, CA). Simi-preparative C-18 HPLC columns were pur-
chased from Fisher Scientific (Pittsburgh, PA).
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Bacterial Strains and Plasmids
Streptomyces lincolnensis NRRL ISP-5355 (identical to ATCC 25466) and Strep-
tomyces caelestis NRRL 2418 were obtained from the Agricultural Research Service
(ARS) Culture Collection of the National Center for Agricultural Utilization Re-
search (Peoria IL). Escherichia coli DH5α, acquired from Bethesda Research Labora-
tories (Gaithersburg, MD), was used for routine cloning experiments. The protein
overexpression host E. coli BL21 star (DE3) was obtained from Invitrogen. Vec-
tor pET28b(+) for protein overexpression was purchased from Novagen (Madison,
WI).
Instrumentation
Standard genetic manipulations of E. coli were performed as described by
Sambrook and Russell.142 DNA sequencing was performed at the core facility of
the Institute of Cellular and Molecular Biology, The University of Texas at Austin.
Vector NTI Advance 10.1.1 from Invitrogen was used for sequence alignments.
DNA concentrations were measured using a NanoDrop ND-1000 UVvis instru-
ment from Thermo Fisher Scientific. HPLC was performed on a Beckman Coul-
ter System Gold HPLC equipped with a UV detector or a Corona CAD (charged
aerosol detector, ESA Biosciences, Chelmsford, MA). NMR spectra were acquired
using a Varian Unity 400 MHz, 500 MHz or 600 MHz spectrometer, and chemical
shifts (in ppm) are reported relative to that of the solvent peak (δH = 7.24 and δC
= 77.0 for deuterated chloroform, δH = 4.67 for deuterium oxide). Mass spectra
were recorded at the Mass Spectrometry core facility in the Department of Chem-
istry and the Proteomics Facility in College of Pharmacy at the University of Texas,
Austin. Optical rotations were measured using an ATAGO AP-300 automatic po-
larimeter at a path length of 1 dm.
117
4.2.2 Cloning of lmbL, lmbM, lmbS, lmbZ, ccbS and ccbZ
Table 4.1: Primers used for constructing plasmids containing lmbL, lmbM, lmbS, lmbZ, ccbS
and ccbZ genes.
Plasmid Primer pair
pET24b(+)-lmbL-CHis6 CIL015 / CIL016
pET28b(+)-lmbM-CHis6 CIL017 / CIL018
pET24b(+)-lmbS-CHis6 CIL019 / CIL020
pET28b(+)-lmbS-NHis6 CIL019 / CIL021
pET24b(+)-lmbZ-CHis6 CIL022 / CIL023
pET28b(+)-lmbZ-NHis6 CIL022 / CIL024
pET24b(+)-ccbS-CHis6 CIL025 / CIL026
pET28b(+)-ccbS-NHis6 CIL025 / CIL027
pET-MalE-ccbS CIL025 / CIL027
pET24b(+)-ccbZ-NHis6 CIL028 / CIL029
Primer Primer Sequence
a
number name
CIL015 F-lmbL-24/28-NdeI 5′-AGTTAAGCATATGACCGACGCGACGCACC-3′
CIL016 R-lmbL-24-HindIII 5′-ATATAAGCTTCGGGGCGGCATGCG-3′
CIL017 F-lmbM-24/28-NdeI 5′-AGTTAAGCATATGAGCGGGCGGTACTGC-3′
CIL018 R-lmbM-24-HindIII 5′-ATATAAGCTTCGGCCGCTGCCACC-3′
CIL019 F-lmbS-24/28-NdeI 5′-GGCTAAGCATATGAGCGACTACATCCCCTTCG-3′
CIL020 R-lmbS-24-HindIII 5′-ATAAAAGCTTCCGTCCCGCCTCGTCG-3′
CIL021 R-lmbS-28-HindIII 5′-ATAAAAGCTTTCACCGTCCCGCCTCG-3′
CIL022 F-lmbZ-24/28-NdeI 5′-ATCACAACATATGACCCACAGGTGCGGC-3′
CIL023 R-lmbZ-24-HindIII 5′-TGATAAGCTTCGGTTTCTCCCAGGTGAGG-3′
CIL024 R-lmbZ-28-HindIII 5′-ACATAAGCTTCACGGTTTCTCCCAGGTGAGG-3′
CIL025 F-ccbS-24/28-NdeI 5′-TCTATAACATATGAGCGACTACGTCCCCTTTGC-3′
CIL026 R-ccbS-24-HindIII 5′-ATATAAGCTTGCTCCTCGTGCCCTCG-3′
CIL027 R-ccbS-28-HindIII 5′-TTACAAGCTTCAGCTCCTCGTGCCCTCG-3′
CIL028 F-ccbZ-24/28-NdeI 5′-TCTATAACATATGACATCCCCCACCCGC-3′
CIL029 R-ccbZ-28-HindIII 5′-TTACAAGCTTCACGTGCTGGTGCGG-3′
aThe engineered restriction sites are shown in bold; the start codon is shown in bold and under-
lined; the stop codon is shown in italic.
Plasmids containing lmbL, lmbM, lmbS, lmbZ, ccbS and ccbZ were constructed
by amplifying the corresponding genes from the genomic DNA isolated from S.
lincolnensis and S. caelestic using designed primer pairs (Table 3.1). The PCR prod-
ucts were then digested with NdeI and HindIII and ligated into pET24b(+) and
pET28b(+), which had been digested with the same restriction enzymes. The ccbS
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gene was also sub-cloned into the pET-MalE vector (generated in house) to ob-
tain the nearly native protein form (i.e., possessing two additional amino acids,
Gly-His, at the N-terminus) after TEV cleavage. The resulting plasmids were se-
quenced using T7 or T7 terminal universal primer and used to transform the E. coli
BL21 star (DE3) for protein overexpression.
4.2.3 Overexpression and Purification of His-tagged Proteins in E. coli
Overexpression and purification procedures for C-His6-LmbL, C-His6-LmbM
and N-His6-CcbZ were identical to those used to purify N-His6-LmbK as described
in Sections 3.2.4 and 3.2.5. The yields of the N-His6 tagged proteins from 1 L cul-
ture were C-His6-LmbL (∼40 mg), C-His6-LmbM (∼18 mg) and N-His6-CcbZ (∼16
mg). The molecular mass and purity of the purified proteins were determined by
SDS-PAGE analysis
4.2.4 Overexpression and Purification of CcbS from Maltose Binding Protein
Fusion System
The CcbS protein without His6-tag was obtained by in vitro TEV enzyme
cleavage of the maltose binding protein (MBP)-CcbS fusion protein. A standard
procedure for protein overexpression as described in Sections 3.2.4 was applied.
However, for the induction of protein expression, the amount of IPTG was ad-
justed to 50 µM. The thawed cells (∼20 g) were resuspended in the lysis buffer
(100 mL) containing 50 mM Tris ·HCl (pH 8), 10% (v/v) glycerol and 10 mM im-
idazole. The mixture was added PLP to 1 mM as the final concentration. After
incubation with lysozyme (100 mg) for 1 h, the cells were disrupted by sonication
using 10× 10-s pulses with a 20-s cooling pause between each pulse. The resulting
lysate was centrifuged at 15,000×g for 30 min, and the supernatant was incubated
with 10 mL of the lysis buffer pre-equilibrated Ni-NTA resin for 16 h. The mixture
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was then loaded onto a column, drained, and washed with wash buffer containing
50 mM Tris ·HCl (pH 8), 300 mM NaCl, 20 mM imidazole and 10% glycerol un-
til the eluent became colorless. Bound protein was eluted using 50 mM Tris ·HCl
buffer (pH 8) containing 250 mM imidazole and 10% glycerol. The column was
then loaded with 1 mL more of the Ni-NTA resins and re-equilibrated with the
lysis buffer to be ready for the subsequent purification. The eluted proteins were
dialyzed against 3 × 1-L of the dialysis buffer containing 50 mM Tris ·HCl (pH 8),
300 mM NaCl and 15% glycerol. After 2 hours of the first time dialysis, 5% (v/v)
His6-tagged TEV protease was added to the solution containing MBP fusion pro-
teins to cleave the His10-MBP. The digestion was performed for 24 h during dial-
ysis. The protein mixture was then passed through the above-mentioned Ni-NTA
resins dropwise. The flow through was passed through the column one more time
to ensure the complete removal of His-tagged MBP and TEV. The Ni-NTA resins
were then washed with 2-column volume of wash buffer. The collected protein
fractions were combined and concentrated with an Amicon ultra-15 centrifugal fil-
ter unit with 10 kDa cut-off. The yield of CcbS was approximately 5 mg from 1 L
culture. The molecular mass and purity of CcbS were determined by SDS-PAGE
analysis.
4.2.5 Identification of Cofactors Bound to LmbL, LmbM and CcbZ
To denature the proteins, the purified C-His6-LmbL protein (4.26) and C-
His6-LmbM (2.39 nmole) in 350 µL of 50 mM Tris buffer (pH 8) were heated to
90 ◦C in a water bath for 5 min. The purified N-His6-CcbZ (1.64 nmole) in 50 µL
of 50 mM Tris buffer (pH 8) was treated with 300 µL of methanol. Each of the
denatured protein solution was then centrifuged at 16,000×g for 20 min (4 ◦C) to
remove the precipitates, and the supernatant was lyophilized to near dryness and
then re-dissolved in 50 µL of water. All samples were analyzed by HPLC using a
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Dionex CarboPac PA1 analytical column (4× 250 mm) with water as mobile phase
A was water and 1 M NH4OAc as mobile phase B. The separation was conducted
at a flow rate of 1 mL/min with a gradient program: 0-2 min 10% B, 2-10 min 10-
50% B, 10-25 min 50-90% B, 25-30 min 90% B, 30-32 min 90-10% B, 32-40 min 10%B.
The detector wavelength was set at 259 nm.
4.2.6 Transamination Half-Reactions of CcbS
The half-reaction mixture contained CcbS protein (46.8 µM), L-amino acid (1
mM) in 50 mM Tris buffer (pH 8). The mixture was incubated at ambient temper-
ature for 3 h before spectro-photoscanning by UV-Vis spectrophotometer. Amino
acids include L-alanine, L-aspartate, L-glutamine and L-glutamate.
4.2.7 LmbL, LmbM, CcbS and CcbZ Reaction Assays
Functional Characterization of LmbL, LmbM and CcbZ
The purified GDP-octose 4-18 (1 mM) was incubated with C-His6-LmbL
protein (4.26 µM final concentration), NAD+ (1.25 mM) and MgCl2 (10 mM) in
50 mM Tris buffer (pH 8.0) at ambient temperature for 6 h. Reactions contain-
ing C-His6-LmbM (4.78 µM) and/or N-His6-CcbZ (3.27 µM) were were similarly
prepared. At the end of incubation, each reaction mixture was filtered through a
YM-10 membrane to remove the protein. HPLC analysis of the filtrate was per-
formed using a Dionex CarboPac PA1 analytical column (4 × 250 mm) with water
as mobile phase A and 1 M NH4OAc as mobile phase B. The separation was con-
ducted at a flow rate of 1 mL/min with a gradient program: 0-2 min 60% B, 2-14
min 60-90% B, 14-24 min 90% B, 24-26 min 90-60% B, 26-34 min 60% B. The detector
wavelength was set at 254 nm.
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NMR characterization of LmbM product
The reaction solution (0.3 mL× 5) containing compound 4-18 (5 mM), NAD+
(0.125 mM) and C-His6-LmbM (4.78 M) in water was incubated at ambient tem-
perature for 16 h and then filtered through a YM-10 membrane using an Amicon
ultrafiltration unit to remove proteins. The filtrate was then purified using HPLC
using a Dionex CarboPac PA1 semi-prep column (9 × 250 mm) with water as mo-
bile phase A and 1 M NH4OAc as mobile phase B. The separation was conducted
at a flow rate of 3 mL/min with a gradient program: 0-2 min 60% B, 2-14 min
60-90% B, 14-24 min 90% B, 24-26 min 90-60% B, 26-34 min 60% B. The detector
wavelength was set at 254 nm. The retention time of the LmbM-product, GDP-D-
erythro-α-D-galacto-octose (4-19), was ∼19 min. 1H NMR (D2O, 600 MHz) δ (ppm)
7.99 (1 H, s, guanine), 5.82 (1 H, d, J1,2 = 5.4 Hz, ribose-H1), 5.46 (1 H, dd, J1,2 = 3.6
Hz, J1,P = 7.2 Hz, octose-H1), 4.60 (1 H, dd, J1,2 = J2,3 = 5.4 Hz ribose-H2), 4.37 (1 H,
dd, J2,3 = 5.4 Hz, J3,4 = 4.2 Hz, ribose-H3), 4.23 (1 H, brs, ribose-H4), 4.23–4.06 (2 H,
m, ribose-H5), 3.89 (1 H, dd, J5,6 = 1.2 Hz, J6,7 = 6.6 Hz, octose-H6), 3.84 (1 H, ddd,
J6,7 = 6.6 Hz, J7,8a = 3.6 Hz, J7,8b = 6.6 Hz, octose-H7), 3.82 (1 H, dd, J4,5 = 9.6 Hz,
J5,6 = 1.2 Hz, octose-H5), 3.73 (1 H, dd, J7,8a = 3.6 Hz, J8a,8b = 12.0 Hz, octose-H8a),
3.71 (1 H, brd, J2,3 = 10.2 Hz, octose-H3), 3.60 (1 H, dd, J7,8b = 6.6 Hz, J8a,8b = 12.0
Hz, octose-H8b), 3.58 (1 H, brd, J4,5 = 9.6 Hz, octose-H4), 3.52 (1 H, m, octose-H2).
31P NMR (D2O, 243 MHz) δ (ppm) −11.34 (19.0 Hz), −3.12 (19.0 Hz). ESI-HRMS
Calcd. for C18H28N5O18P2[M−Na]– 664.0910; Found: 664.6908.
LmbL and CcbZ reaction using GDO-octose 4-19 as substrate
The purified GDP-octose 4-19 (0.5 mM) was incubated with C-His6-LmbL
protein (9 µM), N-His6-CcbZ protein (9 µM) and NAD+ (0.2 mM) in 30 mM sodium
phosphate buffer (pH 7.0) at 30 ◦C. Control experiments containing only LmbL or
CcbZ were similarly prepared. Aliquots were withdrawn at different time inter-
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vals and then filtered through a YM-10 membrane to remove the protein. HPLC
analysis of the filtrate was performed using a Dionex CarboPac PA1 analytical col-
umn (4 × 250 mm) with water as mobile phase A and 1 M NH4OAc as mobile
phase B. The separation was conducted at a flow rate of 1 mL/min with a gradient
program: 0-2 min 10% B, 2-10 min 10-50% B, 10-25 min 50-90% B, 25-30 min 90%
B, 30-32 min 90-10% B, 32-40 min 10%B. The detector wavelength was set at 254
nm. Enzymatic assays described below were analyzed by HPLC using the same
separation program unless further specified.
LmbL, LmbM and CcbZ reaction using GDO-octoses 4-18 and 4-19 as substrates
The purified GDP-octose 4-18 or 4-19 (0.5 mM) was incubated with C-His6-
LmbL protein (9 µM), C-His6-LmbM protein (9 µM), N-His6-CcbZ protein (9 µM)
and NAD+ (0.2 mM) together in 30 mM sodium phosphate buffer (pH 7.0) at 30 ◦C.
The filtrates after the removal of proteins were analyzed by HPLC.
CcbS reaction using ketosugars 4-24 and 4-25 as substrates
The ketosugars 4-24 and 4-25 were generated using the condition as de-
scribed in previous section. The reaction mixtures were filtered through a YM-10
membrane to remove proteins. The filtrates were then incubated with CcbS (20
µM), L-glutamate (3 mM) and PLP (0.5 mM) at 30 ◦C for 2 h. After the removal of
proteins, the filtrates were analyzed by HPLC.
Reverse transamination of CcbS using the synthetic aminooctose 4-23 as sub-
strate
The synthetic GDP-aminooctose 4-23 (0.2 mM) was incubated with CcbS
(12 µM), α-ketoglutarate (6 mM), PLP (0.12 mM) in 100 mM sodium phosphate
buffer (pH 7.0) at 30 ◦C. Aliquots were withdrawn at different time intervals and
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then filtered through a YM-10 membrane to remove proteins. HPLC analysis of
the filtrate was performed using the similar method as described above.
4.3 Results and Discussion
4.3.1 Overexpression and Purification of LmbL, LmbM, LmbS/ CcbS and LmbZ/CcbZ
in E. coli
66.2
45.0
35.0
25.0
116.0
321 54
CcbS
Figure 4.5: SDS-PAGE gel of the purified proteins: C-His6-LmbL (47.4 kDa, lane 2), C-
His6-LmbM (37.0 kDa, lane 3), Gly-His-CcbS (41.9 kDa, lane 4) and N-His6-CcbZ (48.0
kDa, lane 5). The molecular markers are shown in lane 1. Co-elution of minor impurities
were possibly resulted from the non-specific interactions with Ni-NTA resins.
To explore further modifications of GDP-octose in lincomycin A biosynthe-
sis, the encoding genes, lmbL, lmbM, lmbS and lmbZ, were amplified and cloned
into pET24b(+) or pET28b(+) vectors. The recombinant C-His6 tagged LmbL and
LmbM could be purified as soluble proteins (Figure 4.5, lane 2 and lane 3), but
LmbS and LmbZ were expressed only as inclusion bodies. Since CcbS and CcbZ
encoded in the ccb gene cluster are expected to serve similar roles as LmbS and
LmbZ, respectively, in both lincomycin A and celesticetin biosynthetic pathways,
ccbS and ccbZ genes were also amplified and cloned into pET24b(+), pET28b(+) or
pET-MalE vectors. The N-His6-CcbZ was obtained in soluble form (Figure 4.5, lane
5).
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While both C- and N-His6-CcbS could be overexpressed in soluble forms,
the protein yields poor due to slow growth rate and low cell density after IPTG
induction (∼1 g of cells per liter). Moreover, the purified His6-tagged CcbS pro-
teins were colorless instead of lightly yellow. Considering that CcbS was pre-
dicted to be a PLP-dependent aminotransferase, the colorless of the as-purified
His6-tagged CcbS indicated the absence of PLP cofactor, which might be resulted
from improper protein folding. Thus, the MBP-CcbS construct was prepared and
expressed in E. coli BL21 star DE3. Growing of the recombinant strain gave im-
proved cell density (∼8 g of cells per liter). The soluble MBP-CcbS fusion proteins
were purified and cleaved by TEV enzyme using standard procedure. Excess PLP
was added to the lysis buffer to aid the folding process of CcbS. Although multi-
ple bands were detected in the fractions containing CcbS (Figure 4.5, lane 4), the
as-purified enzymes showed distinct yellow color indicating the presence of PLP.
4.3.2 Identification of Cofactor Bound to LmbL, LmbM and CcbZ
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Figure 4.6: HPLC analysis of cofactor bound to (1) LmbL, (2) LmbM, and (3) CcbZ.
Since LmbL, LmbM and CcbZ all belong to the short-chain dehydroge-
nase/reductase (SDR) family. Members of this family share a conserved binding
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fold for NAD(P)+ and are involved in a variety of reactions, including ketoreduc-
tion, epimerization, oxidation/dehydration, α-epimerization/ketoreduction, and
oxidation/decarboxylation. In order to determine whether the as-purified C-His6-
LmbL, C-His6-LmbM and N-His6-CcbZ contain the predicted nicotinamide cofac-
tor, these proteins were precipitated by heating or treating with methanol. The
supernatant from each proteins was then lyophilized and analyzed by HPLC. As
shown in Figure 4.6, both NAD+ and NADH were found to be bound to LmbM
(trace 2). While NADH was observed in the supernatant of denatured CcbZ (trace
3), no nicotinamide cofactor was detected in the extract of LmbL (trace 1).
4.3.3 Transamination Activity of CcbS with Different Amino Donors
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Figure 4.7: Half-reaction of the PLP-dependent aminotransferase CcbS. Control reaction
omitting the addition of amino acid was run in parallel.
The PLP-dependent transamination can be divided into two half-reactions.
The first step is the transfer of the amino group from an amino acid donor to PLP
to generate pyridoxamine 5′-phosphate (PMP) in the active site. The PMP cofactor
is then utilized to transfer the amino group to a keto-group-containing acceptor.
The purified CcbS was tested for its capability to carry out the first half-reaction of
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transamination using different amino donors, L-alanine, L-aspartate, L-glutamate
and L-glutamine (Figure 4.7). The putative aminotransferase CcbS showed the
highest activity when L-glutamate was used as the amino donor. Lower activ-
ity was also observed when CcbS was incubated with L-alanine or L-glutamine.
Hence, the half-reaction activity of CcbS purified from the MBP-fusion was con-
firmed, and L-glutamate is likely the amino acid donor for CcbS-catalyzed transam-
ination reaction.
4.3.4 Functional Characterization of LmbL, LmbM, CcbS and CcbZ
LmbM as the C-4 epimerase
To determine the sequence of the modification reactions, the GDP-octose
4-18 was incubated with LmbL, LmbM or CcbZ, separately or different combina-
tion of these three enzymes. HPLC analysis showed that there was no obvious
consumption of 4-18 in the reaction with LmbL or CcbZ (Figure 4.8, trace 2 and
4). However, in the LmbM reaction, the substrate 4-18 was fully consumed and a
new peak with a shorter retention time was observed (trace 3). This new peak was
collected from multiple injections and subjected to ESI-MS analysis. The recorded
molecular mass (calcd for C18H28N5O18P2
– [M−H]–, 664.0910; obsd, 664.0908) is
identical to that of substrate 4-18 or its stereoisomers.
The LmbM-product was further characterized by NMR spectroscopy. Al-
though no removal of hydroxyl group or formation of methyl group was observed,
the coupling constant between H3–H4 of LmbM-product becomes smaller as a
stereochemical change of the octose ring structure. The observed small J3,4 and
a large J4,5 are similar to those of the chemically synthesized galacto-octose stan-
dard (Section 2.2.5, page 42). While a smaller coupling constant between H4–H5
is expected, the extension of the carbon chain may potentially twist the conforma-
tion of the pyranose ring and cause the increase of the coupling constant. Thus,
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Figure 4.8: HPLC analysis of LmbM, LmbL and CcbZ reactions using 4-18 as the sub-
strate. (1) Control reaction containing substrate 4-18 with no enzyme added. Substrate
4-18 incubated with (2) LmbL, (3) LmbM, (4) CcbZ, (5) LmbL and LmbM, (6) LmbL and
CcbZ, (7) LmbM and CcbZ.
the product of LmbM reaction can be assigned as GDP-D-glycero-D-galacto-octose
(4-19), the C-4 epimer of 4-18. These observations indicate that the first step of the
GDP-octose modification in lincomycin A biosynthesis is the LmbM-catalyzed C-4
epimerization (Figure 4.4 route A).
Octose dehydration requires both LmbL and CcbZ
The purified LmbM-product (4-19) was then incubated with LmbL and/or
CcbZ in order to identify the putative dehydratase. The results are shown in Fig-
ure 4.9. The sugar substrate 4-19 remained practically unchanged upon incubation
with LmbL or CcbZ (trace 1 and 3). In contrast, significant consumption of the
substrate 4-19 was observed when both LmbL and CcbZ were added to the enzy-
matic reaction (trace 2, 4, 5 and 6). The formation of a new peak with a retention
time around 20 min (4-24) was independent of the addition order of enzymes. This
product was later collected and subjected to ESI-MS analysis. The recorded molec-
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Figure 4.9: HPLC analysis of LmbL and CcbZ reactions using 4-19 as the substrate. All
reaction mixtures contained NAD+ and 4-19 and were incubated at 30 ◦C. (1) Incubated
with only LmbL for 1 h. (2) Incubated with LmbL for 1 h, and then added CcbZ for an
additional 2-h incubation. (3) Incubated with only CcbZ for 1 h. (4) Incubated with CcbZ
for 1 h, and then added LmbL for an additional 2-h incubation. (5) Incubated with LmbL
and CcbZ for 1 h. (6) Incubated with LmbL and CcbZ for 3 h.
ular mass (calcd for C18H27N5O17P2
– [M−H]–, 646.0804; obsd, 646.0809) matched
the expected number of a dehydrated GDP-ketosugar (see Figure 4.14 for possible
structure of 4-24).
However, when the sugar 4-18, the substrate of LmbM, was incubated with
the three oxidoreductases, LmbM, LmbL and CcbZ, formation of the ketosugar
4-24 was not observed. Instead, the substrate 4-18 was converted to a different
product (4-25) with a retention time of ∼18 min under the reaction condition (Fig-
ure 4.10, trace 3). Based on ESI-MS analysis, the molecular mass of this new prod-
uct appeared to be 646.0800, which is identical to that of 4-24 and is also consistent
with that of a dehydrated product (calcd. for C18H27N5O17P2
– [M−H]–, 664.0800)
(see Figure 4.14 for possible structure of 4-25).
A separate experiment in which the epimerization product 4-19 was treated
with all three enzymes also yielded the ketosugar 4-25 instead of 4-24 (Figure 4.11,
trace 3 and 4). Another peak with the retention time close to 4-25 was observed
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Figure 4.10: HPLC analysis of dehydration reaction catalyzed by LmbL and CcbZ using
4-18 or 4-19 as substrates. All reaction mixtures contained NAD+. (1) GDP-sugar 4-19
incubated with LmbL and CcbZ. (2) Reaction mixture of (1) was filtered to remove pro-
teins, and then incubated with CcbS, PLP and L-glutamate. (3) GDP-sugar 4-18 incubated
with LmbL, LmbM and CcbZ. (4) Reaction mixture of (3) was filtered to remove proteins,
and then incubated with CcbS, PLP and L-glutamate. (? 1: GMP, ? 2: residual 4-18, ? 3:
NADH, #: a possible side product (4-30) due to over-reduction.) (5) Synthetic standard
GDP-aminooctose 4-23.
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Figure 4.11: HPLC analysis of dehydration reaction catalyzed by LmbL and CcbZ using
4-19 as substrates. (1) GDP-octose 4-18. (2) GDP-octose 4-19. (3) GDP-sugar 4-19 incubated
with LmbL, LmbM and CcbZ. (4) Reaction mixture (3) was filtered to remove proteins, and
then incubated with CcbS, PLP and L-glutamate. (? 1: GMP, ? 2: residual 4-18, #: a possible
side product (4-30) due to over-reduction.)
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under prolonged incubation. The recorded molecular mass of this product was
648.0960 (calcd. for C18H29N5O17P2
– [M−H]–, 648.0960), which is consistent with
that of reduced ketosugar after loss of one water molecule (664− 18 + 2 = 648).
Formation of this side product may be due to over-reduction during the dehydra-
tion reaction.
Because previous results showed that 4-18 is not a substrate for dehydra-
tion (Figure 4.8, trace 6), formation of a ketosugar product 4-25 different from 4-24
is possibly resulted from a different substrate. It is thus proposed that the inter-
mediate of C-4 epimerization, the C-4 ketosugar 4-29, could be recognized and
processed by LmbL/CcbZ to undergo dehydration as well. The C-4 ketosugar
intermediate (4-29) could be generated as the leaking product during the LmbM-
catalyzed epimerization reaction (Figure 4.12B). The reaction mechanism of LmbM
is expected to resemble that of UDP-galactose 4-epimerase (UGE), which is the
most extensively studied 4-epimerase in the SDR family. The deprotonation from
the C-4 hydroxyl group followed by the C-4 hydride transfer to NAD+ leads to
a UDP-4-ketohexose intermediate (4-26 → 4-27, Figure 4.12A). The re-orientation
of the ketosugar intermediate (4-27 → 4-27′) and the re-addition of the C-4 hy-
dride from NADH to the opposite side of the ketosugar results in the formation
of the epimer 4-28. It has been reported that the keto-intermediate 4-27 could be
occasionally prematurely released. The amount of the release 4-27 accumulated
upon extended incubation.163 Therefore, it is likely that LmbM-catalyzed reaction
produced two products, the C-4 epimer 4-19 (major) and the C-4 ketosugar 4-29
(minor), and both of them could serve as the substrates for dehydration.
Productive and non-productive ketosugars
As two different ketosugar products are generated from the LmbL/CcbZ-
catalyzed dehydration under different conditions, it is important to examine whether
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Figure 4.12: (A) Mechanism of UDP-galactose 4-epimerase. (B) Proposed mechanism of
LmbM-catalyzed epimerization.
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these ketosugars show chemical competency in the later enzymatic modifications.
If only one ketosugar is the relevant biosynthetic intermediate in the lincomycin
biosynthesis, the putative aminotrasnferase, CcbS, should be able to convert that
specific GDP-ketosugar to the corresponding GDP-aminooctose. Coupled enzyme
assays using 4-18 or 4-19 were performed to probe this hypothesis. After the for-
mation of 4-24 and 4-25 was observed in the reaction mixtures, the enzymes were
removed through filtration and the filtrate was subjected to transamination by
adding CcbS and L-glutamate. In trace 4 of Figure 4.10, a new peak with reten-
tion time ∼8 min was detected in the sample containing ketosugar 25. The ESI-MS
analysis indicated that the molecular weight matched the value predicted for a
GDP-aminooctose (calcd. for C18H30N6O16P2
– [M−H]–, 647.1121; obsd, 647.1124).
The synthetic standard of the predicted GDP-aminooctose (4-23), which was pre-
pared by another graduate student Richiro Ushimaru, showed consistent reten-
tion time on HPLC with the aminosugar generated from CcbS reaction (trace 5).
In contrast, the ketosugar 4-24 generated from LmbL/CcbZ reaction using 4-19 as
substrate could not be accepted by CcbS (trace 2). Therefore, the ketosugar 4-24
is likely a non-productive side product, while 4-25 serves as a productive biosyn-
thetic intermediate.
Reverse transamination catalyzed by CcbS
CcbS was shown to catalyze the transamination of the ketosugar 4-25 to
an aminooctose 4-23. Because PLP-dependent enzymatic transamination is a re-
versible process, CcbS should be able to convert the synthetic aminooctose 4-23
to the corresponding ketosugar 4-25.164 To verify the function of CcbS, a reaction
mixture of CcbS, α-ketoglutarate (α-KG), the synthetic aminooctose 4-23 and PLP
prepared. A new product with a retention time ∼18 min was detected by HPLC
(Figure 4.13, trace 2 and 3). This peak has the same mass value as that of a dehy-
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drated product, and its retention time is similar to that of the ketosugar 4-25 (trace
5 and 6) rather than 4-24 (trace 4). These results further support that the ketosugar
4-25 is the biosynthetically relevant intermediate in the GDP-octose modification
pathway.
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Figure 4.13: HPLC analysis of reverse transamination catalyzed by CcbS using the syn-
thetic 4-23 as substrate. (1) Synthetic standard of 4-23. (2) Aminosugar 4-23 incubated with
CcbS, PLP and α-KG at 30 ◦C for 1 h. (3) Aminosugar 4-23 incubated with CcbS, PLP and
α-KG at 30 ◦C for 3 h. (4) GDP-sugar 4-19 incubated with LmbL and CcbZ at 30 ◦C for 3 h.
(5) GDP-sugar 4-19 incubated with LmbL, LmbM and CcbZ at 30 ◦C for 3 h. (6) GDP-sugar
4-18 incubated with LmbL, LmbM and CcbZ at 30 ◦C for 3 h. (? 1: impurity from α-KG, #:
a possible side product (4-30) due to over-reduction.)
4.3.5 Mechanistic Proposal of the Epimerization/Dehydration Catalyzed by LmbL,
LmbM and CcbZ
Based on the above-mentioned results, a mechanistic proposal regarding
the epimerization and dehydration was proposed (Figure 4.14). LmbM was ini-
tially proposed as the C-4 epimerase in the lincomycin A biosynthetic pathway
(Figure 4.12B) due to its homology to UDP-galactose epimerase, TDP-glucose 4,6-
dehydratase and UDP-glucuronic acid decarboxylase in the SDR protein family.
The prediction that LmbM has the potential to oxidize the C-4 hydroxyl group
134
O
HO
HO
OHH2N
HO
Me
OGDP
4-23
O
HO
HO
OHO
O
OH
OGDP
4-31
H
H
O
HO
HO
OHO
O
OH
OGDP
4-32
H
H+
O
HO
HO
OHO
O
CH2
OGDP
4-33
H
O
HO
HO
OHO
HO
OH
OGDP
4-35
H
O
HO
HO
OHO
HO
OH
OGDP
4-36
H+
O
HO
HO
OHO
HO
CH2
OGDP
4-37
O
HO
HO
OHO
HO
Me
OGDP
4-24
O
HO
HO
OHO
HO
Me
OGDP
4-25
CcbS
LmbL
CcbZ
O
HO
HO
OHHO
O
OH
O
HO
HO
OHHO
HO
OH
OGDP
4
6
8
4-18
OGDP
4-19
O
HO
HO
OHHO
O
OH
OGDP
4-29
NAD+
O
Tyr
H
H*
rotationLmbM
[H]
C6-[O]
- H2O
LmbL
CcbZ
- H2O
O
HO
HO
OHO
O
Me
OGDP
4-34
H
LmbL
CcbZ
LmbL
CcbZ
LmbL
CcbZ
LmbL
CcbZ
LmbL
CcbZ
CcbS
O
HO
HO
OHHO
HO
Me
OGDP
4-30
LmbL
CcbZ
[O]
C6-[O]
C4-[H]
C4-[H]
C8-[H]
C6-[H]
LmbL
CcbZ
C6-[H]
NADH*
*H
majorminor
*H
*H
*H
*H
Figure 4.14: Proposed mechanism of GDP-octose 4-18 epimerization and dehydration.
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combined with the biochemical characterization of the subsequent reactions re-
vealed that the C-4 ketosugar 4-29 rather than the C-4 epimerized product 4-19
may actually be the relevant intermediate in the lincomycin A biosynthetic path-
way.
The results from the enzymatic assays suggested that both LmbL and CcbZ
are required for the formation of ketosugars (4-24 and 4-25). It is intriguing that
the overall redox-neutral dehydration reaction requires two NAD+-dependent en-
zymes. As discussed earlier (page 111), the dehydration is usually initiated with
the dehydrogenation of the nearby hydroxyl group of a NDP-sugar substrate (4-
38 → 4-39, Figure 4.15).11,165 The resulting keto group, in turn, lowers the pKa
of the α-proton facilitating α-deprotonation followed by β-elimination to expel a
water molecule (4-39→ 4-40). The subsequent hydride transfer proceeds in a 1,4-
addition manner to reduce the double bond and yields a ketosugar product (4-40
→ 4-41). These three steps, dehydrogenation, elimination of water, and hydride
transfer, are typically catalyzed by a single dehydratase and occur in the same ac-
tive site. An internal hydride return from the transiently reduced cofactor to the
α,β-unsaturated ketone intermediate is the key feature of the dehydration reac-
tion. However, if multiple enzymes are involved in the dehydration mechanism,
it is possible that these mechanistic steps may occur in the active-sites of different
proteins.
Since the equilibrium of the first C-6 dehydrogenation, catalyzed by either
LmbL or CcbZ, possibly favors the hydroxyl substrate, the amount of the C-6 keto-
sugar intermediates (4-31 and 4-35) may be too little to be detected in the reaction
solution. It is also possible that the dehydrogenase binds tightly with its oxidiza-
tion intermediate and the release of intermediate only occurs sporadically. Un-
der normal catalytic condition, the elimination of water and/or hydride transfer
would drive the overall dehydration reaction forward.
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Although the actual catalyst for each mechanistic step remains unclear based
on the current data, LmbL is proposed as the C-6 dehydrogenase based on the
amino acid sequence analysis. LmbL was annotated as a putative UDP-glucose 6-
dehydrogenase, which catalyzes the oxidation of UDP-glutose to UDP-gluconate
(4-26→ 4-45, Figure 4.16). In the reaction mechanism for UDP-6-glucose dehydro-
genase, a sequestered C-6 aldehyde intermediate 4-42 is produced in the first oxi-
dation step and a covalently bound thiohemiacetal intermediate (4-43) is the sub-
strate for the second oxidation reaction (Figure 4.16).166 The conserved L-cysteine
residue, Cys260, in the active site presumably acts as the nucleophile to trap the
aldehyde. Although LmbL is believed to be responsible for oxidizing the C-6
hydroxyl group of a NDP-sugar, a close examination of the primary sequence
of LmbL reveals a less nucleophilic amino acid, L-threonine, at the site of the
conserved L-cysteine residue in the active site. Interestingly, a C260A mutant of
UDP-glucose 6-dehydrogenase, which is similar to LmbL (C261T), has been con-
structed and reported in the literature. Mechanistic studies using the C260A mu-
tant showed that it is capable of both reducing the aldehyde intermediate 4-42
(with NADH), but is incapable of oxidizing UDP-glucose to UDP-gluconate (with
NAD+). It was thus reasoned that the C260A mutant might form a ternary com-
plex with the aldehyde intermediate and NADH. The oxidation of aldehyde to
carboxylic acid does not proceed and the release of the bound aldehyde occurs
slowly.166 This provides a probable explanation for the fact that ketosugar inter-
mediates (4-31 and 4-35) were not detected in the dehydration reaction.
Out current data did not allow a precise prediction of which enzyme is re-
sponsible for water elimination and the regiochemistry of hydride transfer. CcbZ is
proposed to catalyze the downstream reductions via hydride transfer from NADH.
Since the closest homolog of Ccbz with known function is myo-inositol dehydro-
genase,167 the substrate binding of Ccbz may not rely on the recognition of the
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nucleotide-diphosphate moiety. Instead, CcbZ may possess a relatively flexible
substrate specificity and accepts various poly-hydroxylated molecules as substrates.
The formation of the over-reduced side-product (4-30) might be resulted from the
structural tolerance of the final reductase.
4.4 Conclusion
In conclusion, we have shown the formation of GDP-aminooctose (4-23) by
combining LmbL, LmbM, CcbS and CcbZ with the GDP-octose substrate (4-18).
Although the initial characterization of LmbM as the C-4 epimerase suggested the
GDP-octose modification follows the route A in Figure 4.4, the later observation
of one productive ketosugar intermediate 4-25 and the other non-productive ke-
tosugar side product 4-24 led to a modified pathway shown in Figure 4.14. The
complicated interplay between these three SDR enzymes remains unclear. One
hypothesis is that the keto group-containing compounds are labile under physio-
logical conditions, and thus the tight-binding of the intermediates and the group-
ing of the operating enzymes may prevent the ketosugars from leaking out of the
biosynthetic machinery. It is possible that there are physical interactions between
LmbL and CcbZ, so that two proteins catalyze the dehydration reaction as a com-
plex. Nevertheless, a mechanistic proposal which incorporates results from bio-
chemical characterization and sequence analysis is proposed. This study repre-
sents the first characterization of GDP-octose modifications including C-4 epimer-
ization, C-6 amination and C-8 dehydration and sets the stage for studying the un-
usual octose biosynthetic pathways. This work also has practical implications as
it provides the enzyme tools for manipulating high-carbon chain-containing NDP-
sugars. Moreover, the GDP-aminooctose (4-23) is expected to be the final product
of the serial GDP-octose modifications and the crucial substrate for C-1 sulfur in-
corporation and N-6 amide bond formation.
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Chapter 5
Biosynthetic Studies of Lincomycin A (IV): Sulfur
Incorporation and Amide Bond Formation
5.1 Introduction
In the last chapter, biosyonthetic processing of GDP-aminooctose interme-
diate was successfully demonstrated in vitro and revealed a complicated interplay
among three GDP-sugar modifying enzymes. The identified GDP-aminoocotse
not only represents a novel type of NDP-sugar, but also serves as the immediate
precursor for the sulfur transfer reaction in lincomycin A biosynthesis. The GDP-
aminooctose is certainly an important intermediate because its structure contains
all chemical features required for sulfur incorporation and amide bond formation.
The C-1 GDP moiety is clearly a good leaving group for the substitution by a thiol
nucleophile to form a C–S bond. Likewise, the C-6 amino group may engage in the
C–N bond formation through a reaction involving an activated carboxylate.
The known examples of sulfur incorporation have been divided into two
types based on their C–S bond formation mechanisms.168 In the first type, the sul-
fur incorporation proceeds through an ionic mechanism involving nucleophilic
attack of a sulfur donor to an electrophilic acceptor. Various sulfur-containing
molecules, including inorganic bisulfide (HS–), thiocarboxylate group (R−COS–),
cysteine persulfide group (R−S−S–), and low-molecular-weight (LMW) thiols, have
been shown to be the relevant sulfur source. The second type involving radi-
cal mechanism is usually catalyzed by radical SAM-enzymes containing multiple
iron-sulfur clusters. The incorporated sulfur atom is either abstracted from the
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Figure 5.1: Proposed mechanism for OvoA-catalyzed oxidative sulfur insertion.
metal clusters or the protein-bound persulfides. One well-documented example
involving radical mechanism is the thiocycle formation of biotin catalyzed by BioB
(Section 1.1.2.1, page 4). Another interesting example of radical sulfur insertion
was recently observed in the biosynthesis of ovothiol (5-4).169,170 The C–S bond
formation between the imidazole moiety of L-histidine (5-1) and the sulfur atom
of L-cysteine (5-2) is catalyzed by a non-heme iron enzyme, OvoA. It has been
proposed that the iron(III)-superoxide likely generates a thiyl radical (5-5) which
subsequently attacks the imidazole ring (Figure 5.1).
The inorganic bisulfide ion, derived from the bacterial sulfur assimilation
pathway, is the simplest sulfur source used in the ionic sulfur insertion reaction.
For example, the PLP-dependent enzyme, O-acetylserine (5-8) sulfhydrylase (OASS),
can utilize bisulfide in L-cysteine (5-2) biosynthesis (Figure 5.2A).171 However, for
most of the ionic sulfur insertions, the actual sulfur source are protein-bound per-
sulfides (5-10) generated by cysteine desulfurases (Figure 5.2B).172 This class of
enzymes utilize the cofactor PLP (5-6) to cleave the C–S bond in the L-cysteine
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(5-2) and produce L-alanine (5-9) and sulfane sulfur (S0), the latter of which is sub-
sequently coupled to an active site cysteine residue of the desulfurase to form a
persulfide group (5-10). The terminal sulfur of the resulting persulfide is then
transferred to cysteine residues in an acceptor protein to make a new persulfide
group (5-14). In turn, the reactive terminal sulfur atom of the resulting persulfide
on the acceptor protein can act as a nucleotphile to attack an electrophilic precursor
to form a C–S bond, which is the mode of sulfur incorporation observed in thionu-
cleoside biosynthesis.173 The protein-bound persulfide can also attack an activated
carboxylate group (5-11) to form a thiocarboxylate group at the C-terminus of a
sulfur carrier proteins (5-12). Transfer of sulfur stom from a thiocarboxylate group
has been observed in thiamine and BE-7585A biosynthesis (Section 1.1.2.2, page 7).
Low-molecular-weight (LMW) thiols shown in Figure 5.3, are mostly con-
sidered as thiol-redox buffers to maintain intracellular redox balance and as post-
translational thiolation reagents to regulate protein functions.174 Occasionally, these
thiols are found to mediate the detoxification of different reactive species in xeno-
biotic metabolism174 or chaperon the metal cluster delivery in the cytoplasm.175
It is uncommon to see LMW thiols directly involved in the biosynthesis of nat-
ural products via the ionic sulfur insertion. Nevertheless, in the biosynthesis of
glucosinolates, cysteine or glutathione (GSH, 5-15) have been suggested as the sul-
fur source (Section 1.1.2.5, page 10). However, the detailed mechanism and the
identity of the enzymes catalying the sulfur transfer remain elusive. Recent in-
vestigation of the epidithiodioxopiperazine (ETP) biosynthesis demonstrated that
an unusual glutathione S-transferase (GST), GliG, is able to catalyze the C–S bond
formation between GSH and a bishydroxylated piperazine precursor.176,177 So far,
this is the only established example indicating the involvement of a LMW thiol,
GSH, in enzymatic C–S bond formation in the biosynthesis of secondary metabo-
lites.
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Combing the knowledge from the literature and the results of sequence
analysis of the lmb gene cluster discussed in Section 2.3.1, we proposed that my-
cothiol (MSH, 5-16), which also belongs to LMW thiols, may serve as the sulfur
donor in lincomycin A biosynthesis. The biosynthetic pathway describing the sul-
fur transfer, amide bond formation and post-sulfur transfer modifications is pro-
posed in Figure 5.4. A putative MSH-S-transferase, LmbV, likely recognizes and
enhances the nucleophilicity of MSH, allowing the C–S bond formation occur at
the C-1 position of GDP-aminoocotose (5-19). The electrophilicity of GDP-sugar
may be further increased by the action of LmbT, a putative glycosyltransferase
(GT). This class of enzymes are known to catalyze the reversible glycosidic bond
formation via the intermediacy of an oxocarbenium ion.178 Furthermore, consider-
ing that the GDP-aminooctose (5-19) also needs to undergo amide bond formation
at C-6 position, the amide bond may be formed prior to (5-19→ 5-24) or after the
sulfur transfer (5-20 → 5-25). In fact, it may occur at maby possible stages in the
pathway (see Figure 5.4). Hydrolysis of the MSH-sugar adducts (5-20 and 5-25) is
expected to be catalyzed by LmbE, a protein homolog of MSH S-conjugate ami-
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dase. LmbF is proposed as the PLP-dependent lyase responsible for cleaving the
C–S bond to release the free thiol intermediates (5-22 and 5-27). Anomers of 5-22 or
5-27 may interconvert to each other through the open chain form until the SAM-
dependent methylation (catalyzed by LmbG) leading to final product having an
α-configuration at C–1 position.
5.2 Experimental Procedures
5.2.1 General
Materials
All chemicals and reagents were purchased from Sigma-Aldrich Chemical
Co. (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) and were used with-
out further purification unless otherwise specified. Lincomycin hydrochloride
was purchased from Chem-Impex International, Inc (Wood Dale, IL). Oligonu-
cleotide primers were prepared by Integrated DNA Technologies (Coralville, IA).
Kits for DNA gel extraction and spin minipreps were purchased from Qiagen (Va-
lencia, CA). PureLink® Genomic DNA Mini Kit was purchased from from Invitro-
gen (Carlsbad, CA). KOD NDA polymerase was purchased from Novagen (Madi-
son, WI). QickChange site-directed mutagenesis kit was obtained from Stratagene,
which was acquired by Agilent (Santa Clara, CA). Enzymes and molecular weight
standards used for the cloning experiments were obtained from New England Bio-
labs (Ipswich, MA). Reagents for sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) were purchased from Bio-Rad (Hercules, CA), with the
exception of the protein molecular weight markers, which were obtained from
Invitrogen. Growth medium components were acquired from Becton Dickinson
(Sparks, MD). Sterile syringe filters are products of Fisher Scientific. Thiopropyl
sepharose 6B was purchased from GE Healthcare Life Sciences (Piscataway, NJ).
Amicon YM-10 ultrafiltration membranes were bought from Millipore (Billerica,
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MA). The analytical and semi-preparative CarboPac PA1 high-performance liq-
uid chromatography (HPLC) columns were obtained from Dionex (Sunnyvale,
CA). Analytical C-18 HPLC columns are products of Varian (Palo Alto, CA). Simi-
preparative C-18 HPLC columns were purchased from Fisher Scientific (Pittsburgh,
PA).
Bacterial Strains and Plasmids
Streptomyces lincolnensis NRRL ISP-5355 (identical to ATCC 25466) and Strep-
tomyces caelestis NRRL 2418 were obtained from the Agricultural Research Service
(ARS) Culture Collection of the National Center for Agricultural Utilization Re-
search (Peoria IL). Escherichia coli DH5α, acquired from Bethesda Research Labora-
tories (Gaithersburg, MD), was used for routine cloning experiments. The protein
overexpression host E. coli BL21 star (DE3) was obtained from Invitrogen. Vec-
tor pET28b(+) for protein overexpression was purchased from Novagen (Madison,
WI).
Instrumentation
Standard genetic manipulations of E. coli were performed as described by
Sambrook and Russell.142 DNA sequencing was performed at the core facility of
the Institute of Cellular and Molecular Biology, The University of Texas at Austin.
Vector NTI Advance 10.1.1 from Invitrogen was used for sequence alignments.
DNA concentrations were measured using a NanoDrop ND-1000 UVvis instru-
ment from Thermo Fisher Scientific. HPLC was performed on a Beckman Coul-
ter System Gold HPLC equipped with a UV detector or a Corona CAD (charged
aerosol detector, ESA Biosciences, Chelmsford, MA). Mass spectra were recorded
at the Mass Spectrometry core facility in the Department of Chemistry and the
Proteomics Facility in College of Pharmacy at the University of Texas, Austin.
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Table 5.1: Primers used for constructing plasmids containing genes involved in the sulfur
transfer and post-sulfur transfer modifications.
Plasmid Primer pair
pET24b(+)-lmbC-CHis6 CIL030 / CIL031
pET24b(+)-lmbD-CHis6 CIL032 / CIL033
pET28b(+)-lmbD-NHis6 CIL032 / CIL034
pET28b(+)-lmbE-NHis6 CIL035 / CIL036
pET28b(+)-lmbF-NHis6 CIL037 / CIL038
pET28b(+)-lmbG-NHis6 CIL039 / CIL040
pET24b(+)-lmbT-CHis6 CIL041 / CIL042
pET28b(+)-lmbT-NHis6 CIL041 / CIL043
pET24b(+)-lmbV-CHis6 CIL044 / CIL045
pET28b(+)-lmbV-NHis6 CIL044 / CIL046
pET28b(+)-ccbD-NHis6 CIL047 / CIL048
pET28b(+)-ccbF-NHis6 CIL049 / CIL050
pET28b(+)-ccbT-NHis6 CIL051 / CIL052
pET28b(+)-ccbV-NHis6 CIL053 / CIL054
Primer Primer Sequence
a
number name
CIL030 F-lmbC-24/28-NdeI 5′-TCTATAACATATGTCGTCCTCCGTTCGACTCTCC-3′
CIL031 R-lmbC-24-HindIII 5′-ATATAAGCTTCTCCCCGCGTGTGACG-3′
CIL032 F-lmbD-24/28-NdeI 5′-TCTATAACATATGGCGGTATCACCCCAGTCG-3′
CIL033 R-lmbD-24-HindIII 5′-ATATAAGCTTCAGGACCTCCGCGAGC-3′
CIL034 R-lmbD-28-HindIII 5′-TTACAAGCTTCACAGGACCTCCGCGAGC-3′
CIL035 F-lmbE-24/28-NdeI 5′-TCTATAACATATGACTCAGTGCCTGCTGACC-3′
CIL036 R-lmbE-28-HindIII 5′-TTACAAGCTTCACGCGGGAGCGG-3′
CIL037 F-lmbF-24/28-NdeI 5′-TACTAACCATATGACCGCCACGGCGAGC-3′
CIL038 R-lmbF-28-HindIII 5′-ATATAAGCTTCACCGGTACCGCCACTCG-3′
CIL039 F-lmbG-24/28-NdeI 5′-TACTAACCATATGCGGGACTACCGTCTCTGGC-3′
CIL040 R-lmbG-28-HindIII 5′-ATATAAGCTTGGATCAGCCAGCCGTCGTCG-3′
CIL041 F-lmbT-24/28-NdeI 5′-AGTTAAGCATATGACGGCGCGGACGG-3′
CIL042 R-lmbT-24-HindIII 5′-GGATAAGCTTTGACACCTCCGCCAGC-3′
CIL043 R-lmbT-28-HindIII 5′-GTCGAAGCTTCATGACACCTCCGCCAGC-3′
CIL044 F-lmbV-24/28-NdeI 5′-AGTTAAGCATATGCAGCGCAAGGGACTGG-3′
CIL045 R-lmbV-24-HindIII 5′-ATATAAGCTTCGGCCCCACCAGCACC-3′
CIL046 R-lmbV-28-HindIII 5′-GTAAAAGCTTCACGGCCCCACCAGC-3′
CIL047 F-ccbD-24/28-NdeI 5′-TCTATAACATATGGCCCAATCCAAGGGTTCG-3′
CIL048 R-ccbD-28-HindIII 5′-TTACAAGCTTCAGAGTTCCTTGAGCAATCG-3′
CIL049 F-ccbF-24/28-NdeI 5′-TCTATAACATATGTCCGACTTAGCTGCCG-3′
CIL050 R-ccbF-28-HindIII 5′-TTACAAGCTTCAGCGGGGCTGC-3′
CIL051 F-ccbT-24/28-NdeI 5′-TCTATAACATATGGCTGAAGCGGCTTCG-3′
CIL052 R-ccbT-28-HindIII 5′-TTACAAGCTTCACAGGTCGCTCCAGC-3′
CIL053 F-ccbV-24/28-NdeI 5′-TCTATAACATATGGAAGGGTTACGCCGACTGG-3′
CIL054 R-ccbV-28-HindIII 5′-TTACAAGCTTGGCTCACAGGAGAACTTTGAG-3′
aThe engineered restriction sites are shown in bold; the start codon is shown in bold and under-
lined; the stop codon is shown in italic.
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5.2.2 Cloning of Genes Involved in the Sulfur Transfer, Amide Bond Formaion
and Post-sulfur Transfer Modifications.
Plasmids containing lmbC, lmbD, lmbE, lmbF, lmbG, lmbT, lmbV, ccbD, ccbF,
ccbT and ccbV were constructed by amplifying the corresponding genes from ge-
nomic DNA isolated from S. lincolnensis and S. caelestic using designed primer
pairs (Table 5.1). The PCR products were then digested with NdeI and HindIII
and ligated into pET24b(+) and pET28b(+), which had been digested with the same
restriction enzymes. The resulting plasmids were sequenced using T7 or T7 termi-
nal universal primer and used to transform the E. coli BL21 star (DE3) for protein
overexpression.
Table 5.2: Primers used for constructing plasmids containing genes encoding thiolation
domains within lmbN and ccbZ.
Plasmid Primer pair
pET28b(+)-lmbN-T-NHis6 CIL055 / CIL056
pET28b(+)-ccbZ-T-NHis6 CIL057 / CIL058
Primer Primer Sequence
a
number name
CIL055 F-lmbN-T-24/28-NdeI 5′-ATCACAACATATGAGCACTCTGGACGAGGTCC-3′
CIL056 R-lmbN-T-28-HindIII 5′-TTACAAGCTTCAATGGGTGATACGGGCCACC-3′
CIL057 F-ccbZ-T-24/28-NdeI 5′-TCTATAACATATGCCGTCGCTGCTGGTCG-3′
CIL058 R-ccbZ-T-28-HindIII 5′-TTACAAGCTTCACGTGCTGGTGCGG-3′
aThe engineered restriction sites are shown in bold; the start codon is shown in bold and under-
lined; the stop codon is shown in italic.
5.2.3 Cloning of Thiolation Domains Encoded in lmbN and ccbZ
Plasmids containing genes encoding the putative thiolation domains within
lmbN and ccbZ were constructed by amplifying the corresponding fragments from
pET24b(+)-lmbN-CHis6 and pET28b(+)-ccbZ-NHis6, respectively, using designed
primer pairs (Table 5.2). The PCR products were then digested with NdeI and
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HindIII and ligated into pET28b(+), which had been digested with the same re-
striction enzymes. The resulting plasmids were sequenced using T7 or T7 terminal
universal primer, and used to transform the E. coli BL21 star (DE3) for protein
overexpression.
5.2.4 Overexpression and Purification of His-tagged Proteins in E. coli
Overexpression and purification procedures for C-His6-LmbC, N-His6-LmbE,
N-His6-LmbF, N-His6-LmbG, N-His6-CcbD, N-His6-CcbF, N-His6-CcbT and N-His6-
CcbV were identical to those used to purify N-His6-LmbK as described in Sec-
tions 3.2.4 and 3.2.5. The yields of the N-His6 tagged proteins from 1 L culture
were ∼17 mg for C-His6-LmbC, ∼55 mg for N-His6-LmbE, ∼10 mg for N-His6-
LmbF, ∼20 mg for N-His6-LmbG, ∼5 mg for N-His6-LmbN-T, ∼14 mg for N-His6-
CcbD, ∼9 mg for N-His6-CcbF, ∼9 mg for N-His6-CcbT, ∼8 mg for N-His6-CcbV
and∼1 mg for N-His6-CcbZ-T. The molecular mass and purity of the purified pro-
teins were determined by SDS-PAGE analysis.
5.2.5 Preparations of Methylthiolincosamide (5-23)
Methylthiolincosamide (5-23).
Compound 5-23 was obtained from the commercial available lincomycin A (5-29)
hydrochloride salt following a previously reported procedure.179 Lincomycin A
(0.75 g, 1.69 mmole) was added hydrazine monohydrate (7.5 mL) and heated to
reflux for 24 h. After cooling down the reaaction mixture, the volatiles were re-
moved by rotary evaporation under reduced pressure. The residues were then
treated with acetonitrile and stirred until all of the lumps had broken up. The
white solids were collected and washed with acetonitrile and then ether. This ma-
terial was then subjected to recrystallization from methanol and water. The crys-
tals separated from the solution were dried to yield methylthiolincosamide (5-23)
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(C9H19NO5S, 0.42 g, 98%) as white solids.
1H NMR (D2O, 400 MHz) δ (ppm) 5.29
(1 H, d, J1,2 = 6.4 Hz, H1), 4.21 (1 H, dd, J4,5 = 7.2 Hz, J5,6 = 0.8 Hz, H5), 4.10 (1 H,
dd, J1,2 = 6.4 Hz, J2,3 = 10.0 Hz, H2), 4.10–4.08 (1 H, m, H6), 4.05 (1 H, dq, J6,7 = 0.4
Hz, J7,8 = 6.4 Hz, H7), 3.57 (1 H, dd, J2,3 = 10.0 Hz, J3,4 = 3.2 Hz, H3), 3.25 (1 H, dd,
J4,5 = 7.2 Hz, J3,4 = 3.2 Hz, H4), 2.09 (3 H, s, SME), 1.22 (3 H, d, J7,8 = 6.4 Hz, H8).
The recorded data is consistent with the values reported in literature.180
5.2.6 Purification of Mycothiol (5-16) from S. lividans
The spores of S. lividans 1326 were striped on 2% agar containing 1% glyc-
erol, 0.5% yeast extract and 0.5% malt extract. The plates were maintained at 30 ◦C
for 2 days. Seeding cultures (7 mL) were inoculated by a piece of agar contain-
ing colonies and incubated at 30 ◦C for 48 h. Tryptic soy broth (3% TSB and 1%
glycerol) was chosen as the liquid medium since it contains very small amounts
of GSH. Bulk cultures (500 mL) were inoculated with 1% of the starting culture in
TSB medium without glycerol and shaken in 2-L flask at 200 rpm and 28 ◦C for 48
h or 72 h. Cells were then harvested and frozen at −80 ◦C until lysis.
The method for MSH preparation was modified from the reported pro-
cedure.181 The pelleted cells (∼10 g wet weight) were suspended in 60 mL of
pre-warmed lysis buffer (60 ◦C, 50% v/v aqueous acetonitrile containing 25 mM
methanesulfonic acid) and then sonicated. The lysate was incubated at 60 ◦C for
an additional 15 min. Cellular debris was removed by centrifugation, then the
CH3CN was evaporated by rotavap from the supernatant. DTT was added to reach
a final concentration of 1 mM. Solid Tris · base was added with stirring until the pH
reached 8. The supernatant was concentrated to 10 mL and kept at −20 ◦C until
thiol-affinity column purification.
Thiol-affinity chromatography was performed by using Thiopropyl sepharose
6B. Following the protocol from the manufacturer and reported procedure,181 dry
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resins (2 g) were first hydrated with ddH2O (30 mL) for 30 min and washed by
ddH2O (30 mL)×2. The wet medium reached a volume of ∼9 mL. The resins were
equilibrated with 50 mL of 50 mM Tris pH 8, and then incubated with the concen-
trated cell-free extracts (from 10 g of cells, around 10 mL) for 2 h. After loaded,
the column was rinsed first with 225 mL of 50 mM Tris pH 8 and then 100 mL of
50 mM NH4HCO3 pH 8. The bound thiols were finally eluted with 30 mL of 20 mM
DTT in 50 mM NH4HCO3 pH 8. The collected eluent (30 mL) was lyophilized and
the residues were redissolved in 10 mL of H2O. MSH was purified by HPLC on
an Econosil C-18 semiprep column, 10 µm, 250 × 10 mm (Alltech), with the fol-
lowing solvents: mobile phase A was 0.1% TFA in water and mobile phase B was
methanol. The separation was achieved at a flow rate of 3 mL/min with a gradient
program: 0-25 min 0% B, 25-27 min 0-10% B, 27-37 min 10% B, 37-39 min 10-0% B,
39-49 min 0% B. Mycothiol was eluted at the retention time of ∼10 min. Purified
MSH was lyophilized and stored as a concentrated solution (∼920 µM, determined
by DTNB assay) in 0.1% TFA. Overall yield of MSH from 10 g of cells is 1.87 mg.
5.2.7 Sulfur Transfer Reaction
The synthetic GDP-aminooctose (5-19, 120 µM) was incubated with N-His6-
CcbT protein (16 µM), a selected LMW thiol reagent (1.5 mM), dithiothreitol (DTT,
0.15 mM) in 30 mM Tris buffer (pH 8.0) at ambient temperature for 6 h. Other re-
actions containing only N-His6-CcbV protein (16 µM) or both enzymes were sim-
ilarly prepared. The LMW thiols tested included L-cysteine (5-2), GSH (5-15) and
MSH (5-16). The control reaction omitting enzymes included all three thiols. At the
end of incubation, each reaction mixture was filtered through a YM-10 membrane
to remove proteins. HPLC analysis of the filtrate was performed using a Dionex
CarboPac PA1 analytical column (4 × 250 mm) with the following solvents: mo-
bile phase A was water and mobile phase B was 1 M NH4OAc. The separation
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was conducted at a flow rate of 1 mL/min with a gradient program: 0-2 min 10%
B, 2-18 min 10-90% B, 18-22 min 90% B, 22-24 min 90-10% B, 24-30 min 10%B. The
detector wavelength was set at 254 nm.
5.2.8 Functional Characterization of the Lincosamide Synthetase
Amide bond formation using MTL (5-23) or GDP-aminooctose (5-19) as sub-
strates
The purified MTL (5-23, 1.25 mM) or GDP-aminoocotse (5-19, 150 µM) was
incubated with a selected amino acids (3 mM), ATP (2 mM), MgCl2 (12.5 mM),
coenzyma A (1 mM), Sfp (8 µM), thermostable inorganic pyrophosphatas (2 units),
C-His6-LmbN (2 µM), C-His6-LmbC (8 µM) and N-His6-CcbD (8 µM) in 15 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (pH 7.0) at am-
bient temperature for 6 h. Amino acids tested included propylproline (5-38), L-
proline, L-alanine, fusaric acid (5-39) and picolinic acid (5-40). The filtrates after
the removal of proteins were subjected to LC-MS analysis.
Functional characterization of LmbN-T and CcbZ-T
The purified MTL (5-23, 1.25 mM) was incubated with propylproline (5-38,
3 mM), ATP (2 mM), MgCl2 (12.5 mM), coenzyme A (1 mM), Sfp (8 µM), ther-
mostable inorganic pyrophosphatas (2 units), N-His6-LmbN-T or N-His6-CcbZ-T
(2 µM), C-His6-LmbC (8 µM) and N-His6-CcbD (8 µM) in 15 mM HEPES buffer
(pH 7.0) at ambient temperature for 6 h. The filtrates after the removal of proteins
were subjected to LC-MS analysis.
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Figure 5.5: SDS-PAGE gel of the purified proteins: C-His6-LmbN (47.4 kDa, lane 2), N-
His6-CcbZ (37.0 kDa, lane 3), C-His6-LmbC (37.0 kDa, lane 4), N-His6-CcbD (37.0 kDa,
lane 5), N-His6-LmbF (37.0 kDa, lane 7), N-His6-LmbG (37.0 kDa, lane 8), N-His6-CcbF
(37.0 kDa, lane 9), N-His6-LmbE (37.0 kDa, lane 11), N-His6-CcbT (37.0 kDa, lane 12) and
N-His6-CcbV (37.0 kDa, lane 13). The molecular markers are shown in lanes 1, 6 and 10.
Minor impurities were possibly resulted from the non-specific interactions with Ni-NTA
resins.
5.3 Results and Discussion
5.3.1 Overexpression and Purification of His-tagged Proteins in E. coli
To investigate the sulfur incorporation and the amide bond formation in lin-
comycin A biosynthesis, the encoding genes for the enzymes involved, lmbC, lmbD,
lmbE, lmbF, lmbG, lmbT and lmbV, were amplified and cloned into pET24b(+) or
pET28b(+) vectors. The recombinant C-His6-LmbC, N-His6-LmbE, N-His6-LmbF
and N-His6-LmbG were isolated as soluble proteins (Figure 5.5), but LmbD, LmbT
and LmbV were expressed only as inclusion bodies. The genes ccbD, ccbF, ccbT
and ccbV encoding the homologous proteins in celesticetin biosynthetic pathway
were then amplified and cloned into pET28b(+). The N-His6-CcbD, N-His6-CcbF,
N-His6-CcbT and N-His6-CcbV were obtained in soluble forms (Figure 5.5).
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5.3.2 Sulfur Transfer
To examine the hypothesis that LmbT and/or LmbV are responsible for
the sulfur transfer, the chemically prepared GDP-aminooctose 5-19 was then in-
cubated with the purified CcbT and CcbV and the potential sulfur sources includ-
ing L-cysteine (5-2), GSH (5-15) and MSH (5-16). The HPLC analysis of the reac-
tion mixtures was shown in Figure 5.6. Neither the consumption of the substrate
5-19 nor the formation of GDP was observed in all samples subjected to differ-
ent testing conditions. The negative results suggested that the attachment of the
amino acid moiety may precede the sulfur transfer reaction in the proposed path-
way (Figure 5.4). However, it is also conceivable that the LMW thiols tested in the
experiments are not relevant sulfur donors in lincomycin A biosynthesis.
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Figure 5.6: HPLC analysis of CcbT and CcbV reactions using 5-19 and different thiols
as substrates. All reaction mixtures contained DTT and 5-19. (1) Control reaction with
L-cysteine, GSH and MSH. (2) CcbT-reaction wih MSH, (3) L-cysteine, (4) GSH. (5) CcbV-
reaction wih MSH, (6) L-cysteine, (7) GSH. (8) CcbT and CcbV-reaction wih MSH, (9) L-
cysteine, (10) GSH. (11) GDP standard.
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5.3.3 Amide Bond Formation
Characterization of the putative T-domain subunits in lincosamide synthetase
In Section 2.3.1, the resemblance of the amino acid incorporation in lin-
comycin A formation and that of nonribosomal peptide (NRP) biosynthesis was
discussed. According to the results of sequence analysis, the previously missing T-
and C-domain are predicted to be encoded by lmbN and lmbD, respectively. The T-
domain of LmbN and the C-domain of LmbD inconjunction with LmbC, which has
recetnly been identified as the A-domain,137 are expected to form a protein com-
plex, lincosamide synthetase. Together, they catalyze the amide bond formation
between the propylproline (5-33) and the octose moiety (5-36) (see Figure 5.8).
 
lmbN lmbZ
ccbN ccbZ
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Figure 5.7: Alignment of the gene and amino acid sequences of the putative T-domains.
(A) Alignment of genes lmbN-lmbZ and ccbN-ccbZ. The regions encoding the putative T-
domains are shown in gray. (B) The overlapping region of the amino acids sequences of
LmbN and CcbZ. The serine residue conserved in all acyl- and peptidyl carrier proteins is
highlighted with red box.
Although the isomerase activity of LmbN has been established in Section 2.3.3
(page 72), a closer comparison of the amino acid sequence revealed that a putative
T-domain is enbeded at the C-terminus of LmbN (encoded by the 5′-terminus of
lmbN, Figure 5.7). Interestingly, the putative T-domain in celesticetin biosynthetic
gene cluster is found to be encoded at the 3′-terminus of ccbZ, which is the down-
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stream gene of ccbN (the counterpart of lmbN). The oxidoreductase activity of CcbZ
has also been characterized in Section 4.3.4 (page 128). The alignment of LmbN
and CcbZ revealed a overlapping region of 79 amino acid residues. A conserved
serine residue can be identified when aligning this fragment with known acyl- or
peptidyl-carrier proteins in database. Therefore, this fragment may function as the
T-domain subunit of lincosamide synthetase.
The chemistry of T-domain in lincosamide synthetase is expected to be anal-
ogous to that of T-domain in nonribosomal peptide synthetase (NRPS) assembly
line. That is, the apo-T-domain (5-30) must be first primed by post-translational
modification of a conserved serine residue with 4′-phosphopantetheine group (Fig-
ure 5.8). The nucleophilic thiolate of 5-32 then attacks an adenylated propylproline
(5-34), selectively activated by LmbC, to form a reactive thioester intermediate (5-
35). This protein-bound amino acid 5-35 is subsequently utilized by LmbD to form
an amide linkage with the aminosugar (5-36).
Therefore, the purified C-His6-LmbN and N-His6-CcbZ were analyzed by
LC-ESI-MS for molecular weight determination (Figure 5.9). The major form of as-
purified LmbN showed molecular weight of 31234 Da, ∼125 Da less than the cal-
culated number 31359 Da. It is likely that the C-termial His-tag of the protein was
nibbled during the expression in E. coli, so the predominate form of LmbN actually
has less than six histidine residues. The other species (observed mass: 31573 Da) of
the as-purified LmbN corresponds in molecular mass to a 4′-phosphopantetheine
modified protein (with an extra mass of 339 Da). This observation indicated that
part of the as-purified LmbN was already modified in the E. coli host and existed
in holo-form. The as-purified CcbZ also contained two species with mass values
of 48188 and 48366 Da, respectively (calcd. 47940 Da). The extra masses were
most likely attributed to the α-N-phosphogluconoylation and -gluconoylation of
the N-terminal His6 tags, respectively.182 Unlike LmbN, the predominant form of
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Figure 5.8: Proposed mechanism of the amide bond formation catalyzed by lincosamide
synthetase. Post-translational modification of apo-T-domain (5-30) by phosphopanteth-
einyl transferase, Sfp, to produce holo-T-domain (5-32). The A-domain, LmbC, catalyzes
the adenylation of propylproline (5-33) and the resulting adenylated intermediate (5-34)
then reacts with 5-32 to afford the acyl-LmbN adduct (5-35). The C-domain, LmbD, cat-
alyzes the C–N bond formation between the electrophilic peptidyl-protein (5-35) and the
nucleophilic aminosugar (5-36).
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Figure 5.9: Deconvoluted ESI-MS analysis of the (A) C-His6-LmbN (calcd. 31359 Da; obsd.
31234 and 31573 Da) and (B) N-His6-CcbZ (calcd. 47940 Da; obsd. 48188 and 48366 Da).
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the as-purified CcbZ was apo-T-domain.
Functional characterization of lincosamide synthetase
To verify the proposed function of lincosamide synthetase, the potential
substrates, GDP-aminoocotse (5-19) and methylthiolincosamide (MTL, 5-23), were
incubated with LmbC, CcbD (functional identical to LmbD), LmbN, ATP and chem-
ically synthesized propylproline (5-33). The chemical synthesis of propylproline
was performed by another graduate student, Richiro Ushimaru, using a known
procedure.183 The reaction mixtures were added coenzyme A and Sfp (phospho-
pantetheinyl transferase) to ensure the phosphopantetheinylation of the carrier
protein, LmbN.184 When using MTL (5-23) as the substrate, the production of the
amide bond-containing molecule 5-28 was detected by LC-MS (Figure 5.10). How-
ever, the installation of the amino acid derivative was not observed when using
GDP-aminosugar (5-19) as the substrate (data not shown).
Since LmbC has been shown to also catalyze adenylation using L-proline
with ∼103 times lower affinity than propylproline (5-34),137 the reaction using L-
proline as the amino acid donor was carried out to examine whether the T- and
C-domains can accept the adenylated L-proline. Based on the LC-MS analysis of
the enzymatic reaction, formation of proline-sugar conjugate 5-38 was observed
(Figure 5.11). Fusaric acid (5-39) and picolinic acid (5-40), structurally related to
propylproline (Figure 5.12), were also tested for their activities toward lincosamide
synthetase. The LC-MS analysis showed no incorporation was observed in both
cases (data not shown). The relatively strict substrate selectivity of LmbC and the
relaxed substrate specificity of LmbN and CcbD are consistent with the general
features of NRPS. The catalytic A-domain usually serves as the gate-keeper that
prevent mis-incorporation of an incorrect amino acid, while the T- and C-domains
have broader substrate specificity and accept noncognate donors.136
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Figure 5.10: LC-MS analysis of the propylproline incorporation into MTL. (1) Full-mass
chromatogram. (2) ESI-MS spectrum of species eluted at 0.37–0.45 min, (3) 1.15–1.35 min,
(4) 1.40–1.47 min, (5) 1.57–1.65 min, and (6) 2.07–2.22 min.
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Figure 5.11: LC-MS analysis of the L-proline incorporation into MTL. (1) Full-mass chro-
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Figure 5.12: Fusaric acid (5-39) and picolinic acid (5-40).
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Although the T-domain of typical NRPS are often fused to functionally re-
lated enzymes, such as A- or C-domains, this possibility is not the case in lin-
comycin A biosynthesis. The fusion partners of the two T-domains are either an
isomerase (LmbN) or an oxidoreductase (CcbZ), which are involved in the con-
struction and modification of the aminooctose. Since both fused proteins were
shown to be active in the amide bond formation, we decided to investigate whether
the thiolation activity is dependent on the fusion partners. Accordingly, the stand-
alone T-domain encoded in lmbN and ccbZ was individually cloned, overexpressed
and purified in N-His-tagged form (Figure 5.13). Both N-His6-LmbN-T and N-
His6-CcbZ-T were capable of catalyzing the formation of 5-28 using propylpro-
line (5-38) and MTL (5-23). These results indicated that the thiolation and isomer-
ization/oxidoreduction are independent of each other. Clearly, LmbN and CcbZ
serve as bi-functional enzymes, both the fusion partners and thiolation domains of
which are essential for the lincomycin A or celesticetin biosynthesis. Although fu-
sion of the T-domain to enzymes performing indirect functions is not common, few
examples related to nonribosomal peptide biosynthesis have been reported.185,186
Because propylproline (5-38) could be attached to methylthiolincosamide
(5-23) but not GDP-aminooctose 5-19, it is thus confirmed that the sulfur incor-
poration or the detachment of GDP group must proceed prior to the amide bond
formation. The failure to observe sulfur transfer using GDP-aminosugar as sub-
strate may due to the improper reaction conditions or the incorrect sulfur donors.
5.3.4 Recently Reported Sulfur Transfer in Lincomycin A Biosynthesis
Very recently, Zhao et al. have successfully demonstrated the enzymatic
sulfur incorporation in lincomycin A biosynthesis (Figure 5.15).187 The authors
identified an unprecedented coupling of two bacterial thiols, mycothiol (5-16) and
ergothioneine (EGT, 5-18), to install the sulfur atom into the lincosamide octose.
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Figure 5.13: SDS-PAGE gel of N-His6-LmbN-T (10.6 kDa, lane 2) and N-His6-CcbZ-T (10.6
kDa, lane 4). The molecular markers are shown in lanes 1 and 3. Minor impurities were
possibly resulted from the non-specific interactions with Ni-NTA resins.
The GDP-activated aminooctose 5-19 is first linked with EGT (5-18) via the gly-
cosylation catalyzed by LmbT. The EGT-octose conjugate (5-41) then serves as the
substrate for the condensation with the propylproline moiety through the catalysis
of lincosamide synthetase (LmbC, CcbD and LmbN). Mycothiol (5-16), in turn, ac-
tivating by CcbV, participate in the second S-glycosylation to exchange with EGT
to yield the MSH-octose intermediate (5-43), which is subsequently hydrolyzed by
LmbE.
This report substantiated the hypothesis that mycothiol (5-16) is the ulti-
mate sulfur source for lincomcyin A biosynthesis. Moreover, the discovery of the
EGT-mediated thiol exchange explains the observation that the displacement of
GDP did not occur when GDP-aminooctose (5-19) was incubated with MSH (5-
16) and the glycosyltransferase CcbT. Although our data suggested that the lin-
cosamide synthetase can utilize methylthiolincosamide (5-23) for the amide bond
formation, it is probably resulted from the relaxed substrate specificity of LmbN
and CcbD.
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Figure 5.14: LC-MS analysis of the propylproline incorporation into MTL catalyzed by
N-His6-LmbN-T (1–4) and N-His6-CcbZ-T (5–8). (1) Full-mass chromatogram of LmbN-
T-reaction mixture. ESI-MS spectrum of species eluted at (2) 0.35–0.46 min, (3) 1.65–1.85
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MS spectrum of species eluted at (2) 0.36–0.48 min, (3) 1.62–1.84 min, and (4) 2.94–3.07
min.
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comycin A biosynthetic pathway.
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5.4 Conclusion
In this chapter, the sulfur transfer and amide bond formation in lincomycin
A biosynthetic pathway was investigates. Although our attempts to demonstrate
the mycothiol incorporation into GDP-aminosugar were unsuccessful, a recent re-
port about the sequential thiol exchange between ergothioneine and mycothiol
as the mechanism of sulfur incorporation in lincomycin A biosynthesis comple-
mented our results and validated our hypothesis. Since ionic sulfur transfer in-
volving low-molecular weight thiols is rare, this finding expands our knowledge
regarding the biosynthesis of sulfur-containing natural products.
Moreover, the identification and characterization of a multi-component pro-
tein comples, lincosamide synthetase, reveals a unique system catalyzing the con-
densation of an unusual amino acid, propylproline, and an aminosugar, methylth-
iolincosamide. Despite the fairly low homology of LmbD/CcbD to any sequences
documented in database, fragment-based approach combined with the knowledge
of enzyme mechanism allows us to predict the catalytic function of LmbD/CcbD.
The discovery of the hidden thiolation domains of the N-terminus of LmbN and C-
terminus of CcbZ demonstrates the mobility of the carrier protein in a NRPS-like
biosynthetic machinery. This finding holds a great potential for metabolic engi-
neering of the lincomycin A biosynthesis. The relatively flexible substrate speci-
ficity of the T- and C-domains of lincosamide synthetase may allow replacing the
proline derivatives to other moieties. It may be easily accomplished by swap-
ping the proline specific A-domain (LmbC) to other carboxylic acid adenylating
enzymes.
Overall it is the novelty of chemical structure and the complexity of the pro-
posed biosynthetic pathway of lincomycin A prompted us to investigate the con-
struction of its unique thiosugar component. For fifty years since the first isolation
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of lincomycin A, the accumulated information from the feeding experiments with
radio-labeled compounds, the discovery of the biosynthetic gene cluster, and the
results of gene disruption studies have paved the road for us to reconstitute the lin-
comycin A biosynthetic pathway in vitro via biochemical characterization of each
enzyme using chemically synthesized putative substrate intermediates. Rooting in
two primary metabolites, D-sedoheptulose 7-phsophate and D-ribose 5-phosphate,
from the pentose phosphate pathway, the biosynthetic pathway of lincomycin A
consolidates the C-1 activation strategy observed in the construction of bacterial
cell wall and the GDP-octose fabrication evolved from the NDP-hexose modifica-
tion. The unprecedent sulfur transfer involving the sequential substitution of two
thiols along with the distinct NRPS system catalyzed coupling of propylproline
to the thiosugar unit represents an elegantly programmed biosynthetic machinery
emerging from evolution. The biosynthetic pathway of a lincomycin A analog,
celesticetin, was also proposed in this study. The chemical synthesis of the key
intermediates and the characterization of the subsequent enzymatic reactions are
currently in progress to elucidate the diverting point in the biosynthetic pathways
of these two thiosugar-containing natural products.
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